id	sid	tid	token	lemma	pos
bionys-650	1	1	trajchevski	trajchevski	PROPN
bionys-650	1	2	et	et	PROPN
bionys-650	1	3	al	al	PROPN
bionys-650	1	4	.	.	PROPN
bionys-650	1	5	2025	2025	NUM
bionys-650	1	6	,	,	PUNCT
bionys-650	1	7	biologica	biologica	PROPN
bionys-650	1	8	nyssana	nyssana	PROPN
bionys-650	1	9	16(2	16(2	NUM
bionys-650	1	10	)	)	PUNCT
bionys-650	1	11	16	16	NUM
bionys-650	1	12	(	(	PUNCT
bionys-650	1	13	2	2	NUM
bionys-650	1	14	)	)	PUNCT
bionys-650	1	15	december	december	PROPN
bionys-650	1	16	2025	2025	NUM
bionys-650	1	17	:	:	PUNCT
bionys-650	1	18	doi	doi	NOUN
bionys-650	1	19	:	:	PUNCT
bionys-650	1	20	10.46793	10.46793	NUM
bionys-650	1	21	/	/	SYM
bionys-650	1	22	biolnyss.16.2.11k	biolnyss.16.2.11k	VERB
bionys-650	1	23	the	the	DET
bionys-650	1	24	association	association	NOUN
bionys-650	1	25	of	of	ADP
bionys-650	1	26	vitamin	vitamin	NOUN
bionys-650	1	27	d	d	PROPN
bionys-650	1	28	,	,	PUNCT
bionys-650	1	29	vitamin	vitamin	NOUN
bionys-650	1	30	d	d	NOUN
bionys-650	1	31	-	-	ADJ
bionys-650	1	32	binding	bind	VERB
bionys-650	1	33	protein	protein	NOUN
bionys-650	1	34	,	,	PUNCT
bionys-650	1	35	and	and	CCONJ
bionys-650	1	36	ferritin	ferritin	ADJ
bionys-650	1	37	levels	level	NOUN
bionys-650	1	38	in	in	ADP
bionys-650	1	39	iraqi	iraqi	ADJ
bionys-650	1	40	men	man	NOUN
bionys-650	1	41	with	with	ADP
bionys-650	1	42	type	type	NOUN
bionys-650	1	43	2	2	NUM
bionys-650	1	44	diabetes	diabetes	NOUN
bionys-650	1	45	original	original	ADJ
bionys-650	1	46	article	article	NOUN
bionys-650	1	47	mohammed	mohammed	PROPN
bionys-650	1	48	jawad	jawad	PROPN
bionys-650	1	49	kadhim	kadhim	PROPN
bionys-650	1	50	department	department	PROPN
bionys-650	1	51	of	of	ADP
bionys-650	1	52	chemistry	chemistry	PROPN
bionys-650	1	53	,	,	PUNCT
bionys-650	1	54	institute	institute	NOUN
bionys-650	1	55	of	of	ADP
bionys-650	1	56	graduate	graduate	PROPN
bionys-650	1	57	studies	study	NOUN
bionys-650	1	58	,	,	PUNCT
bionys-650	1	59	near	near	ADP
bionys-650	1	60	east	east	PROPN
bionys-650	1	61	university	university	PROPN
bionys-650	1	62	,	,	PUNCT
bionys-650	1	63	nicosia	nicosia	PROPN
bionys-650	1	64	,	,	PUNCT
bionys-650	2	1	cyprus	cyprus	PROPN
bionys-650	2	2	mohammedjawadkd@hotmail.com	mohammedjawadkd@hotmail.com	PROPN
bionys-650	2	3	(	(	PUNCT
bionys-650	2	4	corresponding	corresponding	ADJ
bionys-650	2	5	author	author	NOUN
bionys-650	2	6	)	)	PUNCT
bionys-650	2	7	süleyman	süleyman	PROPN
bionys-650	2	8	aşir	aşir	PROPN
bionys-650	2	9	department	department	PROPN
bionys-650	2	10	of	of	ADP
bionys-650	2	11	chemistry	chemistry	PROPN
bionys-650	2	12	,	,	PUNCT
bionys-650	2	13	institute	institute	NOUN
bionys-650	2	14	of	of	ADP
bionys-650	2	15	graduate	graduate	PROPN
bionys-650	2	16	studies	study	NOUN
bionys-650	2	17	,	,	PUNCT
bionys-650	2	18	near	near	ADP
bionys-650	2	19	east	east	PROPN
bionys-650	2	20	university	university	PROPN
bionys-650	2	21	,	,	PUNCT
bionys-650	2	22	nicosia	nicosia	PROPN
bionys-650	2	23	,	,	PUNCT
bionys-650	2	24	cyprus	cyprus	PROPN
bionys-650	2	25	amer	amer	PROPN
bionys-650	2	26	hasan	hasan	PROPN
bionys-650	2	27	department	department	PROPN
bionys-650	2	28	of	of	ADP
bionys-650	2	29	chemistry	chemistry	PROPN
bionys-650	2	30	,	,	PUNCT
bionys-650	2	31	college	college	NOUN
bionys-650	2	32	of	of	ADP
bionys-650	2	33	science	science	NOUN
bionys-650	2	34	,	,	PUNCT
bionys-650	2	35	almustansiriya	almustansiriya	PROPN
bionys-650	2	36	university	university	PROPN
bionys-650	2	37	,	,	PUNCT
bionys-650	2	38	baghdad	baghdad	PROPN
bionys-650	2	39	,	,	PUNCT
bionys-650	2	40	iraq	iraq	PROPN
bionys-650	2	41	received	receive	VERB
bionys-650	2	42	:	:	PUNCT
bionys-650	2	43	july	july	PROPN
bionys-650	2	44	19	19	NUM
bionys-650	2	45	,	,	PUNCT
bionys-650	2	46	2025	2025	NUM
bionys-650	2	47	revised	revise	VERB
bionys-650	2	48	:	:	PUNCT
bionys-650	2	49	october	october	PROPN
bionys-650	2	50	01	01	NUM
bionys-650	2	51	,	,	PUNCT
bionys-650	2	52	2025	2025	NUM
bionys-650	2	53	accepted	accept	VERB
bionys-650	2	54	:	:	PUNCT
bionys-650	2	55	october	october	PROPN
bionys-650	2	56	02	02	NUM
bionys-650	2	57	,	,	PUNCT
bionys-650	2	58	2025	2025	NUM
bionys-650	2	59	abstract	abstract	NOUN
bionys-650	2	60	:	:	PUNCT
bionys-650	2	61	this	this	DET
bionys-650	2	62	study	study	NOUN
bionys-650	2	63	investigated	investigate	VERB
bionys-650	2	64	the	the	DET
bionys-650	2	65	relationship	relationship	NOUN
bionys-650	2	66	between	between	ADP
bionys-650	2	67	vitamin	vitamin	NOUN
bionys-650	2	68	d	d	PROPN
bionys-650	2	69	,	,	PUNCT
bionys-650	2	70	vitamin	vitamin	NOUN
bionys-650	2	71	d	d	NOUN
bionys-650	2	72	-	-	ADJ
bionys-650	2	73	binding	bind	VERB
bionys-650	2	74	protein	protein	NOUN
bionys-650	2	75	(	(	PUNCT
bionys-650	2	76	vdbp	vdbp	NOUN
bionys-650	2	77	)	)	PUNCT
bionys-650	2	78	,	,	PUNCT
bionys-650	2	79	and	and	CCONJ
bionys-650	2	80	ferritin	ferritin	VERB
bionys-650	2	81	in	in	ADP
bionys-650	2	82	iraqi	iraqi	ADJ
bionys-650	2	83	men	man	NOUN
bionys-650	2	84	with	with	ADP
bionys-650	2	85	type	type	NOUN
bionys-650	2	86	2	2	NUM
bionys-650	2	87	diabetes	diabetes	NOUN
bionys-650	2	88	(	(	PUNCT
bionys-650	2	89	t2d	t2d	NOUN
bionys-650	2	90	)	)	PUNCT
bionys-650	2	91	.	.	PUNCT
bionys-650	3	1	a	a	DET
bionys-650	3	2	total	total	NOUN
bionys-650	3	3	of	of	ADP
bionys-650	3	4	120	120	NUM
bionys-650	3	5	participants	participant	NOUN
bionys-650	3	6	,	,	PUNCT
bionys-650	3	7	comprising	comprise	VERB
bionys-650	3	8	60	60	NUM
bionys-650	3	9	diabetic	diabetic	ADJ
bionys-650	3	10	patients	patient	NOUN
bionys-650	3	11	and	and	CCONJ
bionys-650	3	12	60	60	NUM
bionys-650	3	13	healthy	healthy	ADJ
bionys-650	3	14	controls	control	NOUN
bionys-650	3	15	,	,	PUNCT
bionys-650	3	16	aged	aged	ADJ
bionys-650	3	17	30	30	NUM
bionys-650	3	18	years	year	NOUN
bionys-650	3	19	and	and	CCONJ
bionys-650	3	20	older	old	ADJ
bionys-650	3	21	,	,	PUNCT
bionys-650	3	22	were	be	AUX
bionys-650	3	23	matched	match	VERB
bionys-650	3	24	for	for	ADP
bionys-650	3	25	normal	normal	ADJ
bionys-650	3	26	body	body	NOUN
bionys-650	3	27	mass	mass	PROPN
bionys-650	3	28	index	index	NOUN
bionys-650	3	29	.	.	PUNCT
bionys-650	4	1	glucose	glucose	NOUN
bionys-650	4	2	levels	level	NOUN
bionys-650	4	3	were	be	AUX
bionys-650	4	4	significantly	significantly	ADV
bionys-650	4	5	elevated	elevate	VERB
bionys-650	4	6	in	in	ADP
bionys-650	4	7	the	the	DET
bionys-650	4	8	diabetic	diabetic	ADJ
bionys-650	4	9	group	group	NOUN
bionys-650	4	10	(	(	PUNCT
bionys-650	4	11	p=0.001	p=0.001	NUM
bionys-650	4	12	)	)	PUNCT
bionys-650	4	13	,	,	PUNCT
bionys-650	4	14	confirming	confirm	VERB
bionys-650	4	15	impaired	impaired	ADJ
bionys-650	4	16	glycemic	glycemic	ADJ
bionys-650	4	17	regulation	regulation	NOUN
bionys-650	4	18	.	.	PUNCT
bionys-650	5	1	liver	liver	NOUN
bionys-650	5	2	function	function	NOUN
bionys-650	5	3	markers	marker	NOUN
bionys-650	5	4	,	,	PUNCT
bionys-650	5	5	including	include	VERB
bionys-650	5	6	total	total	ADJ
bionys-650	5	7	serum	serum	NOUN
bionys-650	5	8	bilirubin	bilirubin	NOUN
bionys-650	5	9	(	(	PUNCT
bionys-650	5	10	tsb	tsb	PROPN
bionys-650	5	11	)	)	PUNCT
bionys-650	5	12	and	and	CCONJ
bionys-650	5	13	glutamate	glutamate	ADJ
bionys-650	5	14	oxaloacetate	oxaloacetate	NOUN
bionys-650	5	15	transaminase	transaminase	NOUN
bionys-650	5	16	(	(	PUNCT
bionys-650	5	17	got	got	NOUN
bionys-650	5	18	)	)	PUNCT
bionys-650	5	19	,	,	PUNCT
bionys-650	5	20	were	be	AUX
bionys-650	5	21	also	also	ADV
bionys-650	5	22	significantly	significantly	ADV
bionys-650	5	23	higher	high	ADJ
bionys-650	5	24	(	(	PUNCT
bionys-650	5	25	p=0.015	p=0.015	NOUN
bionys-650	5	26	and	and	CCONJ
bionys-650	5	27	p=0.009	p=0.009	NOUN
bionys-650	5	28	,	,	PUNCT
bionys-650	5	29	respectively	respectively	ADV
bionys-650	5	30	)	)	PUNCT
bionys-650	5	31	,	,	PUNCT
bionys-650	5	32	suggesting	suggest	VERB
bionys-650	5	33	hepatic	hepatic	ADJ
bionys-650	5	34	dysfunction	dysfunction	NOUN
bionys-650	5	35	.	.	PUNCT
bionys-650	6	1	although	although	SCONJ
bionys-650	6	2	vitamin	vitamin	NOUN
bionys-650	6	3	d3	d3	PROPN
bionys-650	6	4	concentrations	concentration	NOUN
bionys-650	6	5	did	do	AUX
bionys-650	6	6	not	not	PART
bionys-650	6	7	differ	differ	VERB
bionys-650	6	8	significantly	significantly	ADV
bionys-650	6	9	,	,	PUNCT
bionys-650	6	10	reduced	reduce	VERB
bionys-650	6	11	vitamin	vitamin	NOUN
bionys-650	6	12	d	d	NOUN
bionys-650	6	13	bioactivity	bioactivity	NOUN
bionys-650	6	14	may	may	AUX
bionys-650	6	15	result	result	VERB
bionys-650	6	16	from	from	ADP
bionys-650	6	17	liver	liver	NOUN
bionys-650	6	18	impairment	impairment	NOUN
bionys-650	6	19	and	and	CCONJ
bionys-650	6	20	significantly	significantly	ADV
bionys-650	6	21	lower	low	ADJ
bionys-650	6	22	vdbp	vdbp	NOUN
bionys-650	6	23	levels	level	NOUN
bionys-650	6	24	in	in	ADP
bionys-650	6	25	diabetic	diabetic	ADJ
bionys-650	6	26	individuals	individual	NOUN
bionys-650	6	27	(	(	PUNCT
bionys-650	6	28	p=0.001	p=0.001	NUM
bionys-650	6	29	)	)	PUNCT
bionys-650	6	30	,	,	PUNCT
bionys-650	6	31	compromising	compromise	VERB
bionys-650	6	32	its	its	PRON
bionys-650	6	33	transport	transport	NOUN
bionys-650	6	34	to	to	PART
bionys-650	6	35	target	target	VERB
bionys-650	6	36	tissues	tissue	NOUN
bionys-650	6	37	.	.	PUNCT
bionys-650	7	1	no	no	DET
bionys-650	7	2	significant	significant	ADJ
bionys-650	7	3	differences	difference	NOUN
bionys-650	7	4	were	be	AUX
bionys-650	7	5	found	find	VERB
bionys-650	7	6	in	in	ADP
bionys-650	7	7	ferritin	ferritin	ADJ
bionys-650	7	8	and	and	CCONJ
bionys-650	7	9	renal	renal	ADJ
bionys-650	7	10	markers	marker	NOUN
bionys-650	7	11	.	.	PUNCT
bionys-650	8	1	these	these	DET
bionys-650	8	2	findings	finding	NOUN
bionys-650	8	3	highlight	highlight	VERB
bionys-650	8	4	the	the	DET
bionys-650	8	5	potential	potential	ADJ
bionys-650	8	6	role	role	NOUN
bionys-650	8	7	of	of	ADP
bionys-650	8	8	disrupted	disrupt	VERB
bionys-650	8	9	vitamin	vitamin	NOUN
bionys-650	8	10	d	d	NOUN
bionys-650	8	11	metabolism	metabolism	NOUN
bionys-650	8	12	,	,	PUNCT
bionys-650	8	13	particularly	particularly	ADV
bionys-650	8	14	in	in	ADP
bionys-650	8	15	transport	transport	NOUN
bionys-650	8	16	and	and	CCONJ
bionys-650	8	17	activation	activation	NOUN
bionys-650	8	18	—	—	PUNCT
bionys-650	8	19	in	in	ADP
bionys-650	8	20	the	the	DET
bionys-650	8	21	pathogenesis	pathogenesis	NOUN
bionys-650	8	22	of	of	ADP
bionys-650	8	23	type	type	NOUN
bionys-650	8	24	2	2	NUM
bionys-650	8	25	diabetes	diabetes	NOUN
bionys-650	8	26	(	(	PUNCT
bionys-650	8	27	t2d	t2d	NOUN
bionys-650	8	28	)	)	PUNCT
bionys-650	8	29	.	.	PUNCT
bionys-650	9	1	key	key	ADJ
bionys-650	9	2	words	word	NOUN
bionys-650	9	3	:	:	PUNCT
bionys-650	9	4	vitamin	vitamin	NOUN
bionys-650	9	5	d	d	NOUN
bionys-650	9	6	,	,	PUNCT
bionys-650	9	7	vitamin	vitamin	NOUN
bionys-650	9	8	d	d	NOUN
bionys-650	9	9	binding	bind	VERB
bionys-650	9	10	protein	protein	NOUN
bionys-650	9	11	(	(	PUNCT
bionys-650	9	12	vdbp	vdbp	NOUN
bionys-650	9	13	)	)	PUNCT
bionys-650	9	14	,	,	PUNCT
bionys-650	9	15	ferritin	ferritin	ADJ
bionys-650	9	16	,	,	PUNCT
bionys-650	9	17	type	type	NOUN
bionys-650	9	18	2	2	NUM
bionys-650	9	19	diabetes	diabetes	NOUN
bionys-650	9	20	apstrakt	apstrakt	NOUN
bionys-650	9	21	:	:	PUNCT
bionys-650	9	22	povezanost	povezanost	PROPN
bionys-650	9	23	nivoa	nivoa	PROPN
bionys-650	9	24	vitamina	vitamina	PROPN
bionys-650	9	25	d	d	PROPN
bionys-650	9	26	,	,	PUNCT
bionys-650	9	27	proteina	proteina	PROPN
bionys-650	9	28	koji	koji	PROPN
bionys-650	9	29	vezuje	vezuje	PROPN
bionys-650	9	30	vitamin	vitamin	PROPN
bionys-650	10	1	d	d	NOUN
bionys-650	10	2	i	i	PRON
bionys-650	10	3	feritina	feritina	PROPN
bionys-650	10	4	kod	kod	PROPN
bionys-650	10	5	iračkih	iračkih	PROPN
bionys-650	10	6	muškaraca	muškaraca	PROPN
bionys-650	10	7	sa	sa	PROPN
bionys-650	10	8	dijabetesom	dijabetesom	PROPN
bionys-650	10	9	tipa	tipa	PROPN
bionys-650	10	10	2	2	NUM
bionys-650	10	11	ova	ova	NOUN
bionys-650	10	12	studija	studija	PROPN
bionys-650	10	13	je	je	PROPN
bionys-650	10	14	ispitivala	ispitivala	PROPN
bionys-650	10	15	odnos	odnos	PROPN
bionys-650	10	16	između	između	VERB
bionys-650	10	17	vitamina	vitamina	PROPN
bionys-650	10	18	d	d	PROPN
bionys-650	10	19	,	,	PUNCT
bionys-650	11	1	proteina	proteina	PROPN
bionys-650	11	2	koji	koji	PROPN
bionys-650	11	3	vezuje	vezuje	PROPN
bionys-650	11	4	vitamin	vitamin	PROPN
bionys-650	11	5	d	d	NOUN
bionys-650	11	6	(	(	PUNCT
bionys-650	11	7	vdbp	vdbp	NOUN
bionys-650	11	8	)	)	PUNCT
bionys-650	11	9	i	i	PRON
bionys-650	11	10	feritina	feritina	VERB
bionys-650	11	11	kod	kod	PROPN
bionys-650	11	12	iračkih	iračkih	PROPN
bionys-650	11	13	muškaraca	muškaraca	PROPN
bionys-650	11	14	sa	sa	PROPN
bionys-650	11	15	dijabetesom	dijabetesom	PROPN
bionys-650	11	16	tipa	tipa	PROPN
bionys-650	11	17	2	2	NUM
bionys-650	11	18	(	(	PUNCT
bionys-650	11	19	t2d	t2d	NOUN
bionys-650	11	20	)	)	PUNCT
bionys-650	11	21	.	.	PUNCT
bionys-650	12	1	ukupno	ukupno	PROPN
bionys-650	12	2	je	je	PROPN
bionys-650	12	3	učestvovalo	učestvovalo	PROPN
bionys-650	12	4	120	120	NUM
bionys-650	12	5	ispitanika	ispitanika	NOUN
bionys-650	12	6	—	—	PUNCT
bionys-650	12	7	60	60	NUM
bionys-650	12	8	pacijenata	pacijenata	NOUN
bionys-650	12	9	sa	sa	ADP
bionys-650	12	10	dijabetesom	dijabetesom	PROPN
bionys-650	13	1	i	i	PRON
bionys-650	13	2	60	60	NUM
bionys-650	13	3	zdravih	zdravih	VERB
bionys-650	13	4	kontrola	kontrola	PROPN
bionys-650	13	5	starijih	starijih	PROPN
bionys-650	13	6	od	od	PROPN
bionys-650	13	7	30	30	NUM
bionys-650	13	8	godina	godina	PROPN
bionys-650	13	9	,	,	PUNCT
bionys-650	13	10	sa	sa	PROPN
bionys-650	13	11	normalnim	normalnim	PROPN
bionys-650	13	12	indeksom	indeksom	PROPN
bionys-650	13	13	telesne	telesne	PROPN
bionys-650	13	14	mase	mase	PROPN
bionys-650	13	15	.	.	PUNCT
bionys-650	14	1	nivoi	nivoi	PROPN
bionys-650	14	2	glukoze	glukoze	NOUN
bionys-650	14	3	bili	bili	PROPN
bionys-650	14	4	su	su	PROPN
bionys-650	14	5	značajno	značajno	PROPN
bionys-650	14	6	povišeni	povišeni	PROPN
bionys-650	14	7	u	u	PROPN
bionys-650	14	8	grupi	grupi	PROPN
bionys-650	14	9	sa	sa	PROPN
bionys-650	14	10	dijabetesom	dijabetesom	PROPN
bionys-650	14	11	(	(	PUNCT
bionys-650	14	12	p=0.001	p=0.001	NUM
bionys-650	14	13	)	)	PUNCT
bionys-650	14	14	,	,	PUNCT
bionys-650	14	15	što	što	PROPN
bionys-650	14	16	potvrđuje	potvrđuje	PROPN
bionys-650	14	17	poremećenu	poremećenu	PROPN
bionys-650	14	18	regulaciju	regulaciju	ADJ
bionys-650	14	19	glikemije	glikemije	NOUN
bionys-650	14	20	.	.	PUNCT
bionys-650	15	1	markeri	markeri	PROPN
bionys-650	15	2	funkcije	funkcije	PROPN
bionys-650	15	3	jetre	jetre	NOUN
bionys-650	15	4	,	,	PUNCT
bionys-650	15	5	uključujući	uključujući	PROPN
bionys-650	15	6	ukupni	ukupni	PROPN
bionys-650	15	7	serumski	serumski	PROPN
bionys-650	15	8	bilirubin	bilirubin	NOUN
bionys-650	15	9	(	(	PUNCT
bionys-650	15	10	tsb	tsb	PROPN
bionys-650	15	11	)	)	PUNCT
bionys-650	15	12	i	i	PROPN
bionys-650	15	13	glutamat	glutamat	NOUN
bionys-650	15	14	-	-	PUNCT
bionys-650	15	15	oksaloacetat	oksaloacetat	NOUN
bionys-650	15	16	transaminazu	transaminazu	NOUN
bionys-650	15	17	(	(	PUNCT
bionys-650	15	18	got	got	NOUN
bionys-650	15	19	)	)	PUNCT
bionys-650	15	20	,	,	PUNCT
bionys-650	15	21	takođe	takođe	PROPN
bionys-650	15	22	su	su	PROPN
bionys-650	15	23	bili	bili	PROPN
bionys-650	15	24	značajno	značajno	PROPN
bionys-650	15	25	viši	viši	PROPN
bionys-650	15	26	(	(	PUNCT
bionys-650	15	27	p=0.015	p=0.015	NOUN
bionys-650	15	28	i	i	PRON
bionys-650	15	29	p=0.009	p=0.009	NOUN
bionys-650	15	30	)	)	PUNCT
bionys-650	15	31	,	,	PUNCT
bionys-650	15	32	što	što	NOUN
bionys-650	15	33	ukazuje	ukazuje	NOUN
bionys-650	15	34	na	na	ADP
bionys-650	15	35	disfunkciju	disfunkciju	NOUN
bionys-650	15	36	jetre	jetre	NOUN
bionys-650	15	37	.	.	PUNCT
bionys-650	16	1	iako	iako	PROPN
bionys-650	16	2	koncentracije	koncentracije	PROPN
bionys-650	16	3	vitamina	vitamina	PROPN
bionys-650	16	4	d3	d3	PROPN
bionys-650	16	5	nisu	nisu	PROPN
bionys-650	16	6	pokazale	pokazale	PROPN
bionys-650	16	7	značajne	značajne	PROPN
bionys-650	16	8	razlike	razlike	NOUN
bionys-650	16	9	,	,	PUNCT
bionys-650	16	10	smanjena	smanjena	PROPN
bionys-650	16	11	biološka	biološka	PROPN
bionys-650	16	12	aktivnost	aktivnost	PROPN
bionys-650	16	13	vitamina	vitamina	PROPN
bionys-650	16	14	d	d	PROPN
bionys-650	16	15	može	može	PROPN
bionys-650	16	16	biti	biti	PROPN
bionys-650	16	17	posledica	posledica	PROPN
bionys-650	16	18	oštećenja	oštećenja	PROPN
bionys-650	16	19	jetre	jetre	PROPN
bionys-650	16	20	i	i	PRON
bionys-650	16	21	značajno	značajno	NOUN
bionys-650	16	22	nižih	nižih	PROPN
bionys-650	16	23	nivoa	nivoa	PROPN
bionys-650	16	24	vdbp	vdbp	PROPN
bionys-650	16	25	kod	kod	PROPN
bionys-650	16	26	dijabetičara	dijabetičara	NOUN
bionys-650	16	27	(	(	PUNCT
bionys-650	16	28	p=0.001	p=0.001	NUM
bionys-650	16	29	)	)	PUNCT
bionys-650	16	30	,	,	PUNCT
bionys-650	16	31	što	što	PROPN
bionys-650	16	32	narušava	narušava	PROPN
bionys-650	16	33	njegov	njegov	ADJ
bionys-650	16	34	transport	transport	NOUN
bionys-650	16	35	do	do	VERB
bionys-650	16	36	ciljnih	ciljnih	ADJ
bionys-650	16	37	tkiva	tkiva	PROPN
bionys-650	16	38	.	.	PUNCT
bionys-650	17	1	nisu	nisu	PROPN
bionys-650	17	2	pronađene	pronađene	PROPN
bionys-650	17	3	značajne	značajne	PROPN
bionys-650	17	4	razlike	razlike	PROPN
bionys-650	17	5	u	u	PROPN
bionys-650	17	6	nivou	nivou	PROPN
bionys-650	17	7	feritina	feritina	NOUN
bionys-650	17	8	i	i	PRON
bionys-650	17	9	bubrežnim	bubrežnim	VERB
bionys-650	17	10	markerima	markerima	PROPN
bionys-650	17	11	.	.	PUNCT
bionys-650	18	1	ovi	ovi	PROPN
bionys-650	18	2	nalazi	nalazi	PROPN
bionys-650	18	3	naglašavaju	naglašavaju	PROPN
bionys-650	18	4	potencijalnu	potencijalnu	PROPN
bionys-650	18	5	ulogu	ulogu	PROPN
bionys-650	18	6	poremećenog	poremećenog	PROPN
bionys-650	18	7	metabolizma	metabolizma	PROPN
bionys-650	18	8	vitamina	vitamina	PROPN
bionys-650	18	9	d	d	PROPN
bionys-650	18	10	,	,	PUNCT
bionys-650	18	11	posebno	posebno	PROPN
bionys-650	18	12	njegovom	njegovom	NOUN
bionys-650	18	13	transportu	transportu	NOUN
bionys-650	18	14	i	i	PRON
bionys-650	18	15	aktivaciji	aktivaciji	VERB
bionys-650	18	16	,	,	PUNCT
bionys-650	18	17	u	u	PROPN
bionys-650	18	18	patogenezi	patogenezi	PROPN
bionys-650	18	19	dijabetesa	dijabetesa	PROPN
bionys-650	18	20	tipa	tipa	PROPN
bionys-650	18	21	2	2	NUM
bionys-650	18	22	(	(	PUNCT
bionys-650	18	23	t2d	t2d	NUM
bionys-650	18	24	)	)	PUNCT
bionys-650	18	25	.	.	PUNCT
bionys-650	19	1	ključne	ključne	PROPN
bionys-650	19	2	reči	reči	NOUN
bionys-650	19	3	:	:	PUNCT
bionys-650	19	4	vitamin	vitamin	NOUN
bionys-650	19	5	d	d	NOUN
bionys-650	19	6	,	,	PUNCT
bionys-650	19	7	vezujući	vezujući	ADJ
bionys-650	19	8	protein	protein	NOUN
bionys-650	19	9	vitamina	vitamina	PROPN
bionys-650	19	10	d	d	PROPN
bionys-650	19	11	(	(	PUNCT
bionys-650	19	12	vdbp	vdbp	NOUN
bionys-650	19	13	)	)	PUNCT
bionys-650	19	14	,	,	PUNCT
bionys-650	19	15	feritin	feritin	PROPN
bionys-650	19	16	,	,	PUNCT
bionys-650	19	17	dijabetes	dijabete	NOUN
bionys-650	19	18	tipa	tipa	PROPN
bionys-650	19	19	2	2	NUM
bionys-650	19	20	introduction	introduction	NOUN
bionys-650	19	21	type	type	NOUN
bionys-650	19	22	2	2	NUM
bionys-650	19	23	diabetes	diabetes	NOUN
bionys-650	19	24	(	(	PUNCT
bionys-650	19	25	t2d	t2d	NOUN
bionys-650	19	26	)	)	PUNCT
bionys-650	19	27	has	have	AUX
bionys-650	19	28	become	become	VERB
bionys-650	19	29	one	one	NUM
bionys-650	19	30	of	of	ADP
bionys-650	19	31	the	the	DET
bionys-650	19	32	most	most	ADV
bionys-650	19	33	prevalent	prevalent	ADJ
bionys-650	19	34	metabolic	metabolic	NOUN
bionys-650	19	35	disorders	disorder	NOUN
bionys-650	19	36	in	in	ADP
bionys-650	19	37	modern	modern	ADJ
bionys-650	19	38	society	society	NOUN
bionys-650	19	39	,	,	PUNCT
bionys-650	19	40	driven	drive	VERB
bionys-650	19	41	by	by	ADP
bionys-650	19	42	sedentary	sedentary	ADJ
bionys-650	19	43	lifestyles	lifestyle	NOUN
bionys-650	19	44	,	,	PUNCT
bionys-650	19	45	poor	poor	ADJ
bionys-650	19	46	dietary	dietary	ADJ
bionys-650	19	47	habits	habit	NOUN
bionys-650	19	48	,	,	PUNCT
bionys-650	19	49	and	and	CCONJ
bionys-650	19	50	urbanization	urbanization	NOUN
bionys-650	19	51	(	(	PUNCT
bionys-650	19	52	kakil	kakil	PROPN
bionys-650	19	53	&	&	CCONJ
bionys-650	19	54	meena	meena	PROPN
bionys-650	19	55	,	,	PUNCT
bionys-650	19	56	2020	2020	NUM
bionys-650	19	57	)	)	PUNCT
bionys-650	19	58	.	.	PUNCT
bionys-650	20	1	globally	globally	ADV
bionys-650	20	2	,	,	PUNCT
bionys-650	20	3	it	it	PRON
bionys-650	20	4	presents	present	VERB
bionys-650	20	5	significant	significant	ADJ
bionys-650	20	6	public	public	ADJ
bionys-650	20	7	health	health	NOUN
bionys-650	20	8	challenges	challenge	NOUN
bionys-650	20	9	due	due	ADP
bionys-650	20	10	to	to	ADP
bionys-650	20	11	its	its	PRON
bionys-650	20	12	progressive	progressive	ADJ
bionys-650	20	13	nature	nature	NOUN
bionys-650	20	14	and	and	CCONJ
bionys-650	20	15	multi	multi	ADJ
bionys-650	20	16	-	-	ADJ
bionys-650	20	17	organ	organ	ADJ
bionys-650	20	18	complications	complication	NOUN
bionys-650	20	19	(	(	PUNCT
bionys-650	20	20	antar	antar	PROPN
bionys-650	20	21	et	et	PROPN
bionys-650	20	22	al	al	PROPN
bionys-650	20	23	.	.	PROPN
bionys-650	20	24	,	,	PUNCT
bionys-650	20	25	2023	2023	NUM
bionys-650	20	26	)	)	PUNCT
bionys-650	20	27	.	.	PUNCT
bionys-650	21	1	in	in	ADP
bionys-650	21	2	iraq	iraq	PROPN
bionys-650	21	3	,	,	PUNCT
bionys-650	21	4	the	the	DET
bionys-650	21	5	rising	rise	VERB
bionys-650	21	6	incidence	incidence	NOUN
bionys-650	21	7	—	—	PUNCT
bionys-650	21	8	particularly	particularly	ADV
bionys-650	21	9	among	among	ADP
bionys-650	21	10	men	man	NOUN
bionys-650	21	11	—	—	PUNCT
bionys-650	21	12	underscores	underscore	VERB
bionys-650	21	13	the	the	DET
bionys-650	21	14	urgent	urgent	ADJ
bionys-650	21	15	need	need	NOUN
bionys-650	21	16	for	for	ADP
bionys-650	21	17	deeper	deep	ADJ
bionys-650	21	18	investigation	investigation	NOUN
bionys-650	21	19	into	into	ADP
bionys-650	21	20	contributing	contribute	VERB
bionys-650	21	21	physiological	physiological	ADJ
bionys-650	21	22	and	and	CCONJ
bionys-650	21	23	biochemical	biochemical	ADJ
bionys-650	21	24	factors	factor	NOUN
bionys-650	21	25	(	(	PUNCT
bionys-650	21	26	world	world	NOUN
bionys-650	21	27	health	health	NOUN
bionys-650	21	28	organization	organization	NOUN
bionys-650	21	29	,	,	PUNCT
bionys-650	21	30	2020	2020	NUM
bionys-650	21	31	)	)	PUNCT
bionys-650	21	32	.	.	PUNCT
bionys-650	22	1	recent	recent	ADJ
bionys-650	22	2	studies	study	NOUN
bionys-650	22	3	have	have	AUX
bionys-650	22	4	highlighted	highlight	VERB
bionys-650	22	5	a	a	DET
bionys-650	22	6	strong	strong	ADJ
bionys-650	22	7	correlation	correlation	NOUN
bionys-650	22	8	between	between	ADP
bionys-650	22	9	vitamin	vitamin	NOUN
bionys-650	22	10	d	d	NOUN
bionys-650	22	11	deficiency	deficiency	NOUN
bionys-650	22	12	and	and	CCONJ
bionys-650	22	13	the	the	DET
bionys-650	22	14	onset	onset	NOUN
bionys-650	22	15	of	of	ADP
bionys-650	22	16	type	type	NOUN
bionys-650	22	17	2	2	NUM
bionys-650	22	18	diabetes	diabetes	NOUN
bionys-650	22	19	(	(	PUNCT
bionys-650	22	20	t2d	t2d	NOUN
bionys-650	22	21	)	)	PUNCT
bionys-650	22	22	(	(	PUNCT
bionys-650	22	23	zhao	zhao	PROPN
bionys-650	22	24	et	et	PROPN
bionys-650	22	25	al	al	PROPN
bionys-650	22	26	.	.	PROPN
bionys-650	22	27	,	,	PUNCT
bionys-650	22	28	2024	2024	NUM
bionys-650	22	29	)	)	PUNCT
bionys-650	22	30	.	.	PUNCT
bionys-650	23	1	vitamin	vitamin	NOUN
bionys-650	23	2	d	d	NOUN
bionys-650	23	3	plays	play	VERB
bionys-650	23	4	a	a	DET
bionys-650	23	5	pivotal	pivotal	ADJ
bionys-650	23	6	role	role	NOUN
bionys-650	23	7	in	in	ADP
bionys-650	23	8	regulating	regulate	VERB
bionys-650	23	9	immune	immune	ADJ
bionys-650	23	10	responses	response	NOUN
bionys-650	23	11	,	,	PUNCT
bionys-650	23	12	promoting	promote	VERB
bionys-650	23	13	calcium	calcium	NOUN
bionys-650	23	14	absorption	absorption	NOUN
bionys-650	23	15	,	,	PUNCT
bionys-650	23	16	and	and	CCONJ
bionys-650	23	17	supporting	support	VERB
bionys-650	23	18	the	the	DET
bionys-650	23	19	differentiation	differentiation	NOUN
bionys-650	23	20	and	and	CCONJ
bionys-650	23	21	protection	protection	NOUN
bionys-650	23	22	of	of	ADP
bionys-650	23	23	various	various	ADJ
bionys-650	23	24	cell	cell	NOUN
bionys-650	23	25	types	type	NOUN
bionys-650	23	26	(	(	PUNCT
bionys-650	23	27	janoušek	janoušek	NOUN
bionys-650	23	28	et	et	PROPN
bionys-650	23	29	al	al	PROPN
bionys-650	23	30	.	.	PROPN
bionys-650	23	31	,	,	PUNCT
bionys-650	23	32	2022	2022	NUM
bionys-650	23	33	)	)	PUNCT
bionys-650	23	34	.	.	PUNCT
bionys-650	24	1	as	as	ADP
bionys-650	24	2	a	a	DET
bionys-650	24	3	fatsoluble	fatsoluble	ADJ
bionys-650	24	4	hormone	hormone	NOUN
bionys-650	24	5	,	,	PUNCT
bionys-650	24	6	its	its	PRON
bionys-650	24	7	bioavailability	bioavailability	NOUN
bionys-650	24	8	and	and	CCONJ
bionys-650	24	9	metabolic	metabolic	NOUN
bionys-650	24	10	function	function	NOUN
bionys-650	24	11	heavily	heavily	ADV
bionys-650	24	12	rely	rely	VERB
bionys-650	24	13	on	on	ADP
bionys-650	24	14	vitamin	vitamin	NOUN
bionys-650	24	15	d	d	NOUN
bionys-650	24	16	binding	bind	VERB
bionys-650	24	17	protein	protein	NOUN
bionys-650	24	18	©	©	PROPN
bionys-650	24	19	2025	2025	NUM
bionys-650	24	20	kadhim	kadhim	X
bionys-650	24	21	et	et	PROPN
bionys-650	24	22	al	al	PROPN
bionys-650	24	23	.	.	PUNCT
bionys-650	25	1	this	this	PRON
bionys-650	25	2	is	be	AUX
bionys-650	25	3	an	an	DET
bionys-650	25	4	open	open	ADJ
bionys-650	25	5	-	-	PUNCT
bionys-650	25	6	access	access	NOUN
bionys-650	25	7	article	article	NOUN
bionys-650	25	8	distributed	distribute	VERB
bionys-650	25	9	under	under	ADP
bionys-650	25	10	the	the	DET
bionys-650	25	11	terms	term	NOUN
bionys-650	25	12	of	of	ADP
bionys-650	25	13	the	the	DET
bionys-650	25	14	creative	creative	ADJ
bionys-650	25	15	commons	common	NOUN
bionys-650	25	16	attribution	attribution	NOUN
bionys-650	25	17	license	license	NOUN
bionys-650	25	18	,	,	PUNCT
bionys-650	25	19	which	which	PRON
bionys-650	25	20	permits	permit	VERB
bionys-650	25	21	unrestricted	unrestricted	ADJ
bionys-650	25	22	use	use	NOUN
bionys-650	25	23	,	,	PUNCT
bionys-650	25	24	distribution	distribution	NOUN
bionys-650	25	25	,	,	PUNCT
bionys-650	25	26	and	and	CCONJ
bionys-650	25	27	build	build	VERB
bionys-650	25	28	upon	upon	SCONJ
bionys-650	25	29	your	your	PRON
bionys-650	25	30	work	work	NOUN
bionys-650	25	31	non	non	ADJ
bionys-650	25	32	-	-	ADJ
bionys-650	25	33	commercially	commercially	ADV
bionys-650	25	34	under	under	ADP
bionys-650	25	35	the	the	DET
bionys-650	25	36	same	same	ADJ
bionys-650	25	37	license	license	NOUN
bionys-650	25	38	as	as	ADP
bionys-650	25	39	the	the	DET
bionys-650	25	40	original	original	NOUN
bionys-650	25	41	.	.	PUNCT
bionys-650	26	1	(	(	PUNCT
bionys-650	26	2	vdbp	vdbp	NOUN
bionys-650	26	3	)	)	PUNCT
bionys-650	26	4	,	,	PUNCT
bionys-650	26	5	which	which	PRON
bionys-650	26	6	transports	transport	VERB
bionys-650	26	7	vitamin	vitamin	NOUN
bionys-650	26	8	d	d	NOUN
bionys-650	26	9	metabolites	metabolite	NOUN
bionys-650	26	10	throughout	throughout	ADP
bionys-650	26	11	the	the	DET
bionys-650	26	12	bloodstream	bloodstream	NOUN
bionys-650	26	13	(	(	PUNCT
bionys-650	26	14	wu	wu	PROPN
bionys-650	26	15	et	et	PROPN
bionys-650	26	16	al	al	PROPN
bionys-650	26	17	.	.	PROPN
bionys-650	26	18	,	,	PUNCT
bionys-650	26	19	2023	2023	NUM
bionys-650	26	20	;	;	PUNCT
bionys-650	26	21	abu	abu	PROPN
bionys-650	26	22	-	-	PUNCT
bionys-650	26	23	shana	shana	PROPN
bionys-650	26	24	et	et	PROPN
bionys-650	26	25	al	al	PROPN
bionys-650	26	26	.	.	PROPN
bionys-650	26	27	,	,	PUNCT
bionys-650	26	28	2024	2024	NUM
bionys-650	26	29	)	)	PUNCT
bionys-650	26	30	.	.	PUNCT
bionys-650	27	1	evidence	evidence	NOUN
bionys-650	27	2	suggests	suggest	VERB
bionys-650	27	3	that	that	SCONJ
bionys-650	27	4	inadequate	inadequate	ADJ
bionys-650	27	5	levels	level	NOUN
bionys-650	27	6	of	of	ADP
bionys-650	27	7	vitamin	vitamin	NOUN
bionys-650	27	8	d	d	NOUN
bionys-650	27	9	can	can	AUX
bionys-650	27	10	impair	impair	VERB
bionys-650	27	11	glucose	glucose	NOUN
bionys-650	27	12	metabolism	metabolism	NOUN
bionys-650	27	13	and	and	CCONJ
bionys-650	27	14	insulin	insulin	NOUN
bionys-650	27	15	sensitivity	sensitivity	NOUN
bionys-650	27	16	,	,	PUNCT
bionys-650	27	17	two	two	NUM
bionys-650	27	18	key	key	ADJ
bionys-650	27	19	processes	process	NOUN
bionys-650	27	20	in	in	ADP
bionys-650	27	21	the	the	DET
bionys-650	27	22	pathophysiology	pathophysiology	NOUN
bionys-650	27	23	of	of	ADP
bionys-650	27	24	t2d	t2d	PROPN
bionys-650	27	25	(	(	PUNCT
bionys-650	27	26	zhang	zhang	X
bionys-650	27	27	et	et	PROPN
bionys-650	27	28	al	al	PROPN
bionys-650	27	29	.	.	PROPN
bionys-650	27	30	,	,	PUNCT
bionys-650	27	31	2020	2020	NUM
bionys-650	27	32	)	)	PUNCT
bionys-650	27	33	.	.	PUNCT
bionys-650	28	1	furthermore	furthermore	ADV
bionys-650	28	2	,	,	PUNCT
bionys-650	28	3	deficiencies	deficiency	NOUN
bionys-650	28	4	in	in	ADP
bionys-650	28	5	vitamin	vitamin	NOUN
bionys-650	28	6	d	d	X
bionys-650	28	7	have	have	AUX
bionys-650	28	8	been	be	AUX
bionys-650	28	9	linked	link	VERB
bionys-650	28	10	to	to	ADP
bionys-650	28	11	reduced	reduce	VERB
bionys-650	28	12	pancreatic	pancreatic	ADJ
bionys-650	28	13	β	β	NOUN
bionys-650	28	14	-	-	NOUN
bionys-650	28	15	cell	cell	NOUN
bionys-650	28	16	activity	activity	NOUN
bionys-650	28	17	,	,	PUNCT
bionys-650	28	18	which	which	PRON
bionys-650	28	19	compromises	compromise	VERB
bionys-650	28	20	insulin	insulin	NOUN
bionys-650	28	21	secretion	secretion	NOUN
bionys-650	28	22	and	and	CCONJ
bionys-650	28	23	exacerbates	exacerbate	VERB
bionys-650	28	24	insulin	insulin	NOUN
bionys-650	28	25	resistance	resistance	NOUN
bionys-650	28	26	(	(	PUNCT
bionys-650	28	27	szymczak	szymczak	NOUN
bionys-650	28	28	-	-	PUNCT
bionys-650	28	29	pajor	pajor	NOUN
bionys-650	28	30	&	&	CCONJ
bionys-650	28	31	śliwińska	śliwińska	NOUN
bionys-650	28	32	,	,	PUNCT
bionys-650	28	33	2019	2019	NUM
bionys-650	28	34	)	)	PUNCT
bionys-650	28	35	.	.	PUNCT
bionys-650	29	1	despite	despite	SCONJ
bionys-650	29	2	iraq	iraq	PROPN
bionys-650	29	3	’s	’s	PART
bionys-650	29	4	abundant	abundant	ADJ
bionys-650	29	5	sunshine	sunshine	NOUN
bionys-650	29	6	,	,	PUNCT
bionys-650	29	7	many	many	ADJ
bionys-650	29	8	individuals	individual	NOUN
bionys-650	29	9	—	—	PUNCT
bionys-650	29	10	especially	especially	ADV
bionys-650	29	11	older	old	ADJ
bionys-650	29	12	males	male	NOUN
bionys-650	29	13	—	—	PUNCT
bionys-650	29	14	exhibit	exhibit	VERB
bionys-650	29	15	low	low	ADJ
bionys-650	29	16	serum	serum	NOUN
bionys-650	29	17	levels	level	NOUN
bionys-650	29	18	of	of	ADP
bionys-650	29	19	vitamin	vitamin	NOUN
bionys-650	29	20	d	d	PROPN
bionys-650	29	21	,	,	PUNCT
bionys-650	29	22	a	a	DET
bionys-650	29	23	paradox	paradox	NOUN
bionys-650	29	24	that	that	PRON
bionys-650	29	25	may	may	AUX
bionys-650	29	26	reflect	reflect	VERB
bionys-650	29	27	underlying	underlying	ADJ
bionys-650	29	28	metabolic	metabolic	NOUN
bionys-650	29	29	or	or	CCONJ
bionys-650	29	30	organ	organ	NOUN
bionys-650	29	31	-	-	PUNCT
bionys-650	29	32	specific	specific	ADJ
bionys-650	29	33	dysfunction	dysfunction	NOUN
bionys-650	29	34	,	,	PUNCT
bionys-650	29	35	such	such	ADJ
bionys-650	29	36	as	as	ADP
bionys-650	29	37	impaired	impair	VERB
bionys-650	29	38	liver	liver	NOUN
bionys-650	29	39	hydroxylation	hydroxylation	NOUN
bionys-650	29	40	or	or	CCONJ
bionys-650	29	41	kidney	kidney	NOUN
bionys-650	29	42	conversion	conversion	NOUN
bionys-650	29	43	of	of	ADP
bionys-650	29	44	inactive	inactive	ADJ
bionys-650	29	45	vitamin	vitamin	NOUN
bionys-650	29	46	d	d	NOUN
bionys-650	29	47	into	into	ADP
bionys-650	29	48	its	its	PRON
bionys-650	29	49	biologically	biologically	ADV
bionys-650	29	50	active	active	ADJ
bionys-650	29	51	form	form	NOUN
bionys-650	29	52	(	(	PUNCT
bionys-650	29	53	salim	salim	PROPN
bionys-650	29	54	et	et	PROPN
bionys-650	29	55	al	al	PROPN
bionys-650	29	56	.	.	PROPN
bionys-650	29	57	,	,	PUNCT
bionys-650	29	58	2023	2023	NUM
bionys-650	29	59	)	)	PUNCT
bionys-650	29	60	.	.	PUNCT
bionys-650	30	1	the	the	DET
bionys-650	30	2	current	current	ADJ
bionys-650	30	3	study	study	NOUN
bionys-650	30	4	aims	aim	VERB
bionys-650	30	5	to	to	PART
bionys-650	30	6	evaluate	evaluate	VERB
bionys-650	30	7	the	the	DET
bionys-650	30	8	levels	level	NOUN
bionys-650	30	9	of	of	ADP
bionys-650	30	10	serum	serum	NOUN
bionys-650	30	11	vitamin	vitamin	NOUN
bionys-650	30	12	d	d	NOUN
bionys-650	30	13	,	,	PUNCT
bionys-650	30	14	vdbp	vdbp	NOUN
bionys-650	30	15	,	,	PUNCT
bionys-650	30	16	and	and	CCONJ
bionys-650	30	17	ferritin	ferritin	VERB
bionys-650	30	18	in	in	ADP
bionys-650	30	19	iraqi	iraqi	ADJ
bionys-650	30	20	males	male	NOUN
bionys-650	30	21	diagnosed	diagnose	VERB
bionys-650	30	22	with	with	ADP
bionys-650	30	23	t2d	t2d	NOUN
bionys-650	30	24	,	,	PUNCT
bionys-650	30	25	compared	compare	VERB
bionys-650	30	26	to	to	ADP
bionys-650	30	27	healthy	healthy	ADJ
bionys-650	30	28	controls	control	NOUN
bionys-650	30	29	matched	match	VERB
bionys-650	30	30	for	for	ADP
bionys-650	30	31	age	age	NOUN
bionys-650	30	32	,	,	PUNCT
bionys-650	30	33	body	body	NOUN
bionys-650	30	34	mass	mass	NOUN
bionys-650	30	35	index	index	NOUN
bionys-650	30	36	(	(	PUNCT
bionys-650	30	37	bmi	bmi	PROPN
bionys-650	30	38	)	)	PUNCT
bionys-650	30	39	,	,	PUNCT
bionys-650	30	40	and	and	CCONJ
bionys-650	30	41	lifestyle	lifestyle	NOUN
bionys-650	30	42	factors	factor	NOUN
bionys-650	30	43	.	.	PUNCT
bionys-650	31	1	the	the	DET
bionys-650	31	2	study	study	NOUN
bionys-650	31	3	excludes	exclude	VERB
bionys-650	31	4	individuals	individual	NOUN
bionys-650	31	5	with	with	ADP
bionys-650	31	6	existing	exist	VERB
bionys-650	31	7	kidney	kidney	NOUN
bionys-650	31	8	,	,	PUNCT
bionys-650	31	9	liver	liver	NOUN
bionys-650	31	10	,	,	PUNCT
bionys-650	31	11	or	or	CCONJ
bionys-650	31	12	thyroid	thyroid	NOUN
bionys-650	31	13	disorders	disorder	NOUN
bionys-650	31	14	,	,	PUNCT
bionys-650	31	15	ensuring	ensure	VERB
bionys-650	31	16	a	a	DET
bionys-650	31	17	focused	focused	ADJ
bionys-650	31	18	analysis	analysis	NOUN
bionys-650	31	19	on	on	ADP
bionys-650	31	20	diabetes	diabetes	NOUN
bionys-650	31	21	-	-	PUNCT
bionys-650	31	22	related	relate	VERB
bionys-650	31	23	variables	variable	NOUN
bionys-650	31	24	.	.	PUNCT
bionys-650	32	1	through	through	ADP
bionys-650	32	2	this	this	DET
bionys-650	32	3	investigation	investigation	NOUN
bionys-650	32	4	,	,	PUNCT
bionys-650	32	5	we	we	PRON
bionys-650	32	6	aim	aim	VERB
bionys-650	32	7	to	to	PART
bionys-650	32	8	generate	generate	VERB
bionys-650	32	9	region	region	NOUN
bionys-650	32	10	-	-	PUNCT
bionys-650	32	11	specific	specific	ADJ
bionys-650	32	12	biochemical	biochemical	ADJ
bionys-650	32	13	data	datum	NOUN
bionys-650	32	14	that	that	PRON
bionys-650	32	15	may	may	AUX
bionys-650	32	16	guide	guide	VERB
bionys-650	32	17	preventive	preventive	ADJ
bionys-650	32	18	,	,	PUNCT
bionys-650	32	19	diagnostic	diagnostic	ADJ
bionys-650	32	20	,	,	PUNCT
bionys-650	32	21	and	and	CCONJ
bionys-650	32	22	therapeutic	therapeutic	ADJ
bionys-650	32	23	approaches	approach	NOUN
bionys-650	32	24	.	.	PUNCT
bionys-650	33	1	an	an	DET
bionys-650	33	2	enhanced	enhance	VERB
bionys-650	33	3	understanding	understanding	NOUN
bionys-650	33	4	of	of	ADP
bionys-650	33	5	vitamin	vitamin	NOUN
bionys-650	33	6	d	d	NOUN
bionys-650	33	7	’s	’s	PART
bionys-650	33	8	role	role	NOUN
bionys-650	33	9	and	and	CCONJ
bionys-650	33	10	transport	transport	NOUN
bionys-650	33	11	mechanisms	mechanism	NOUN
bionys-650	33	12	could	could	AUX
bionys-650	33	13	provide	provide	VERB
bionys-650	33	14	novel	novel	ADJ
bionys-650	33	15	strategies	strategy	NOUN
bionys-650	33	16	for	for	ADP
bionys-650	33	17	managing	manage	VERB
bionys-650	33	18	type	type	NOUN
bionys-650	33	19	2	2	NUM
bionys-650	33	20	diabetes	diabetes	NOUN
bionys-650	33	21	(	(	PUNCT
bionys-650	33	22	t2d	t2d	NOUN
bionys-650	33	23	)	)	PUNCT
bionys-650	33	24	,	,	PUNCT
bionys-650	33	25	particularly	particularly	ADV
bionys-650	33	26	in	in	ADP
bionys-650	33	27	populations	population	NOUN
bionys-650	33	28	with	with	ADP
bionys-650	33	29	limited	limited	ADJ
bionys-650	33	30	access	access	NOUN
bionys-650	33	31	to	to	ADP
bionys-650	33	32	specialized	specialized	ADJ
bionys-650	33	33	care	care	NOUN
bionys-650	33	34	.	.	PUNCT
bionys-650	34	1	moreover	moreover	ADV
bionys-650	34	2	,	,	PUNCT
bionys-650	34	3	findings	finding	NOUN
bionys-650	34	4	may	may	AUX
bionys-650	34	5	serve	serve	VERB
bionys-650	34	6	as	as	ADP
bionys-650	34	7	a	a	DET
bionys-650	34	8	foundation	foundation	NOUN
bionys-650	34	9	for	for	ADP
bionys-650	34	10	future	future	ADJ
bionys-650	34	11	research	research	NOUN
bionys-650	34	12	into	into	ADP
bionys-650	34	13	the	the	DET
bionys-650	34	14	interplay	interplay	NOUN
bionys-650	34	15	between	between	ADP
bionys-650	34	16	micronutrient	micronutrient	NOUN
bionys-650	34	17	metabolism	metabolism	NOUN
bionys-650	34	18	and	and	CCONJ
bionys-650	34	19	chronic	chronic	ADJ
bionys-650	34	20	disease	disease	NOUN
bionys-650	34	21	.	.	PUNCT
bionys-650	35	1	materials	material	NOUN
bionys-650	35	2	and	and	CCONJ
bionys-650	35	3	methods	method	NOUN
bionys-650	35	4	this	this	DET
bionys-650	35	5	study	study	NOUN
bionys-650	35	6	employed	employ	VERB
bionys-650	35	7	a	a	DET
bionys-650	35	8	comparative	comparative	ADJ
bionys-650	35	9	design	design	NOUN
bionys-650	35	10	to	to	PART
bionys-650	35	11	investigate	investigate	VERB
bionys-650	35	12	biochemical	biochemical	ADJ
bionys-650	35	13	variables	variable	NOUN
bionys-650	35	14	associated	associate	VERB
bionys-650	35	15	with	with	ADP
bionys-650	35	16	t2d	t2d	NUM
bionys-650	35	17	,	,	PUNCT
bionys-650	35	18	with	with	ADP
bionys-650	35	19	a	a	DET
bionys-650	35	20	focus	focus	NOUN
bionys-650	35	21	on	on	ADP
bionys-650	35	22	vitamin	vitamin	NOUN
bionys-650	35	23	d	d	NOUN
bionys-650	35	24	,	,	PUNCT
bionys-650	35	25	vdbp	vdbp	NOUN
bionys-650	35	26	,	,	PUNCT
bionys-650	35	27	and	and	CCONJ
bionys-650	35	28	ferritin	ferritin	ADJ
bionys-650	35	29	.	.	PUNCT
bionys-650	36	1	a	a	DET
bionys-650	36	2	total	total	NOUN
bionys-650	36	3	of	of	ADP
bionys-650	36	4	120	120	NUM
bionys-650	36	5	iraqi	iraqi	ADJ
bionys-650	36	6	male	male	ADJ
bionys-650	36	7	participants	participant	NOUN
bionys-650	36	8	,	,	PUNCT
bionys-650	36	9	all	all	DET
bionys-650	36	10	aged	aged	ADJ
bionys-650	36	11	≥30	≥30	PROPN
bionys-650	36	12	years	year	NOUN
bionys-650	36	13	,	,	PUNCT
bionys-650	36	14	were	be	AUX
bionys-650	36	15	carefully	carefully	ADV
bionys-650	36	16	selected	select	VERB
bionys-650	36	17	based	base	VERB
bionys-650	36	18	on	on	ADP
bionys-650	36	19	stringent	stringent	ADJ
bionys-650	36	20	inclusion	inclusion	NOUN
bionys-650	36	21	criteria	criterion	NOUN
bionys-650	36	22	.	.	PUNCT
bionys-650	37	1	among	among	ADP
bionys-650	37	2	them	they	PRON
bionys-650	37	3	,	,	PUNCT
bionys-650	37	4	60	60	NUM
bionys-650	37	5	were	be	AUX
bionys-650	37	6	clinically	clinically	ADV
bionys-650	37	7	diagnosed	diagnose	VERB
bionys-650	37	8	with	with	ADP
bionys-650	37	9	t2d	t2d	NOUN
bionys-650	37	10	and	and	CCONJ
bionys-650	37	11	were	be	AUX
bionys-650	37	12	managing	manage	VERB
bionys-650	37	13	their	their	PRON
bionys-650	37	14	condition	condition	NOUN
bionys-650	37	15	with	with	ADP
bionys-650	37	16	oral	oral	ADJ
bionys-650	37	17	hypoglycemic	hypoglycemic	ADJ
bionys-650	37	18	medication	medication	NOUN
bionys-650	37	19	.	.	PUNCT
bionys-650	38	1	the	the	DET
bionys-650	38	2	control	control	PROPN
bionys-650	38	3	group	group	NOUN
bionys-650	38	4	consisted	consist	VERB
bionys-650	38	5	of	of	ADP
bionys-650	38	6	60	60	NUM
bionys-650	38	7	healthy	healthy	ADJ
bionys-650	38	8	males	male	NOUN
bionys-650	38	9	who	who	PRON
bionys-650	38	10	were	be	AUX
bionys-650	38	11	matched	match	VERB
bionys-650	38	12	in	in	ADP
bionys-650	38	13	age	age	NOUN
bionys-650	38	14	and	and	CCONJ
bionys-650	38	15	maintained	maintain	VERB
bionys-650	38	16	a	a	DET
bionys-650	38	17	bmi	bmi	NOUN
bionys-650	38	18	between	between	ADP
bionys-650	38	19	19	19	NUM
bionys-650	38	20	and	and	CCONJ
bionys-650	38	21	24	24	NUM
bionys-650	38	22	kg	kg	PROPN
bionys-650	38	23	/	/	SYM
bionys-650	38	24	m²	m²	PROPN
bionys-650	38	25	.	.	PUNCT
bionys-650	39	1	all	all	DET
bionys-650	39	2	individuals	individual	NOUN
bionys-650	39	3	underwent	undergo	VERB
bionys-650	39	4	preliminary	preliminary	ADJ
bionys-650	39	5	interviews	interview	NOUN
bionys-650	39	6	to	to	PART
bionys-650	39	7	confirm	confirm	VERB
bionys-650	39	8	eligibility	eligibility	NOUN
bionys-650	39	9	and	and	CCONJ
bionys-650	39	10	received	receive	VERB
bionys-650	39	11	written	write	VERB
bionys-650	39	12	information	information	NOUN
bionys-650	39	13	outlining	outline	VERB
bionys-650	39	14	study	study	NOUN
bionys-650	39	15	details	detail	NOUN
bionys-650	39	16	.	.	PUNCT
bionys-650	40	1	informed	inform	VERB
bionys-650	40	2	consent	consent	NOUN
bionys-650	40	3	was	be	AUX
bionys-650	40	4	obtained	obtain	VERB
bionys-650	40	5	from	from	ADP
bionys-650	40	6	each	each	DET
bionys-650	40	7	participant	participant	NOUN
bionys-650	40	8	in	in	ADP
bionys-650	40	9	accordance	accordance	NOUN
bionys-650	40	10	with	with	ADP
bionys-650	40	11	research	research	NOUN
bionys-650	40	12	ethics	ethic	NOUN
bionys-650	40	13	protocols	protocol	NOUN
bionys-650	40	14	.	.	PUNCT
bionys-650	41	1	blood	blood	NOUN
bionys-650	41	2	samples	sample	NOUN
bionys-650	41	3	were	be	AUX
bionys-650	41	4	collected	collect	VERB
bionys-650	41	5	from	from	ADP
bionys-650	41	6	each	each	DET
bionys-650	41	7	subject	subject	NOUN
bionys-650	41	8	after	after	ADP
bionys-650	41	9	an	an	DET
bionys-650	41	10	overnight	overnight	ADJ
bionys-650	41	11	fast	fast	ADV
bionys-650	41	12	ranging	ranging	NOUN
bionys-650	41	13	from	from	ADP
bionys-650	41	14	8	8	NUM
bionys-650	41	15	to	to	PART
bionys-650	41	16	12	12	NUM
bionys-650	41	17	hours	hour	NOUN
bionys-650	41	18	,	,	PUNCT
bionys-650	41	19	at	at	ADP
bionys-650	41	20	al	al	PROPN
bionys-650	41	21	-	-	PROPN
bionys-650	41	22	qanah	qanah	PROPN
bionys-650	41	23	medical	medical	PROPN
bionys-650	41	24	laboratory	laboratory	NOUN
bionys-650	41	25	in	in	ADP
bionys-650	41	26	baghdad	baghdad	PROPN
bionys-650	41	27	,	,	PUNCT
bionys-650	41	28	iraq	iraq	PROPN
bionys-650	41	29	,	,	PUNCT
bionys-650	41	30	between	between	ADP
bionys-650	41	31	15	15	NUM
bionys-650	41	32	january	january	NOUN
bionys-650	41	33	and	and	CCONJ
bionys-650	41	34	1	1	NUM
bionys-650	41	35	march	march	NOUN
bionys-650	41	36	2025	2025	NUM
bionys-650	41	37	.	.	PUNCT
bionys-650	42	1	samples	sample	NOUN
bionys-650	42	2	were	be	AUX
bionys-650	42	3	processed	process	VERB
bionys-650	42	4	promptly	promptly	ADV
bionys-650	42	5	following	follow	VERB
bionys-650	42	6	standard	standard	ADJ
bionys-650	42	7	clinical	clinical	ADJ
bionys-650	42	8	guidelines	guideline	NOUN
bionys-650	42	9	.	.	PUNCT
bionys-650	43	1	laboratory	laboratory	NOUN
bionys-650	43	2	analyses	analyse	VERB
bionys-650	43	3	approximately	approximately	ADV
bionys-650	43	4	5	5	NUM
bionys-650	43	5	ml	ml	NOUN
bionys-650	43	6	of	of	ADP
bionys-650	43	7	blood	blood	NOUN
bionys-650	43	8	was	be	AUX
bionys-650	43	9	drawn	draw	VERB
bionys-650	43	10	from	from	ADP
bionys-650	43	11	each	each	DET
bionys-650	43	12	participant	participant	NOUN
bionys-650	43	13	using	use	VERB
bionys-650	43	14	sterile	sterile	ADJ
bionys-650	43	15	needles	needle	NOUN
bionys-650	43	16	.	.	PUNCT
bionys-650	44	1	the	the	DET
bionys-650	44	2	collected	collect	VERB
bionys-650	44	3	blood	blood	NOUN
bionys-650	44	4	was	be	AUX
bionys-650	44	5	placed	place	VERB
bionys-650	44	6	in	in	ADP
bionys-650	44	7	gel	gel	NOUN
bionys-650	44	8	tubes	tube	NOUN
bionys-650	44	9	designed	design	VERB
bionys-650	44	10	to	to	PART
bionys-650	44	11	separate	separate	VERB
bionys-650	44	12	serum	serum	NOUN
bionys-650	44	13	through	through	ADP
bionys-650	44	14	centrifugation	centrifugation	NOUN
bionys-650	44	15	.	.	PUNCT
bionys-650	45	1	after	after	ADP
bionys-650	45	2	separation	separation	NOUN
bionys-650	45	3	,	,	PUNCT
bionys-650	45	4	the	the	DET
bionys-650	45	5	serum	serum	NOUN
bionys-650	45	6	was	be	AUX
bionys-650	45	7	transferred	transfer	VERB
bionys-650	45	8	using	use	VERB
bionys-650	45	9	micropipettes	micropipette	NOUN
bionys-650	45	10	into	into	ADP
bionys-650	45	11	cuvette	cuvette	NOUN
bionys-650	45	12	tubes	tube	NOUN
bionys-650	45	13	for	for	ADP
bionys-650	45	14	analysis	analysis	NOUN
bionys-650	45	15	.	.	PUNCT
bionys-650	46	1	serum	serum	NOUN
bionys-650	46	2	biomarker	biomarker	NOUN
bionys-650	46	3	levels	level	NOUN
bionys-650	46	4	were	be	AUX
bionys-650	46	5	assessed	assess	VERB
bionys-650	46	6	using	use	VERB
bionys-650	46	7	standardized	standardized	ADJ
bionys-650	46	8	clinical	clinical	ADJ
bionys-650	46	9	analyzers	analyzer	NOUN
bionys-650	46	10	and	and	CCONJ
bionys-650	46	11	kits	kit	NOUN
bionys-650	46	12	.	.	PUNCT
bionys-650	47	1	insulin	insulin	NOUN
bionys-650	47	2	,	,	PUNCT
bionys-650	47	3	ferritin	ferritin	ADJ
bionys-650	47	4	,	,	PUNCT
bionys-650	47	5	and	and	CCONJ
bionys-650	47	6	vitamin	vitamin	NOUN
bionys-650	47	7	d	d	NOUN
bionys-650	47	8	concentrations	concentration	NOUN
bionys-650	47	9	were	be	AUX
bionys-650	47	10	determined	determine	VERB
bionys-650	47	11	using	use	VERB
bionys-650	47	12	the	the	DET
bionys-650	47	13	cobas	cobas	PROPN
bionys-650	47	14	e	e	PROPN
bionys-650	47	15	411	411	NUM
bionys-650	47	16	analyzer	analyzer	NOUN
bionys-650	47	17	and	and	CCONJ
bionys-650	47	18	diagnostic	diagnostic	ADJ
bionys-650	47	19	kits	kit	NOUN
bionys-650	47	20	manufactured	manufacture	VERB
bionys-650	47	21	by	by	ADP
bionys-650	47	22	roche	roche	PROPN
bionys-650	47	23	(	(	PUNCT
bionys-650	47	24	germany	germany	PROPN
bionys-650	47	25	)	)	PUNCT
bionys-650	47	26	.	.	PUNCT
bionys-650	48	1	vitamin	vitamin	NOUN
bionys-650	48	2	d	d	NOUN
bionys-650	48	3	binding	bind	VERB
bionys-650	48	4	protein	protein	NOUN
bionys-650	48	5	(	(	PUNCT
bionys-650	48	6	vdbp	vdbp	NOUN
bionys-650	48	7	)	)	PUNCT
bionys-650	48	8	levels	level	NOUN
bionys-650	48	9	were	be	AUX
bionys-650	48	10	measured	measure	VERB
bionys-650	48	11	via	via	ADP
bionys-650	48	12	immunoassay	immunoassay	PROPN
bionys-650	48	13	kits	kit	NOUN
bionys-650	48	14	obtained	obtain	VERB
bionys-650	48	15	from	from	ADP
bionys-650	48	16	shanghai	shanghai	PROPN
bionys-650	48	17	coon	coon	PROPN
bionys-650	48	18	koon	koon	PROPN
bionys-650	48	19	biotech	biotech	PROPN
bionys-650	48	20	co.	co.	PROPN
bionys-650	48	21	,	,	PUNCT
bionys-650	48	22	ltd	ltd	PROPN
bionys-650	48	23	(	(	PUNCT
bionys-650	48	24	china	china	PROPN
bionys-650	48	25	)	)	PUNCT
bionys-650	48	26	.	.	PUNCT
bionys-650	49	1	glucose	glucose	NOUN
bionys-650	49	2	levels	level	NOUN
bionys-650	49	3	were	be	AUX
bionys-650	49	4	evaluated	evaluate	VERB
bionys-650	49	5	using	use	VERB
bionys-650	49	6	glucosespecific	glucosespecific	ADJ
bionys-650	49	7	test	test	NOUN
bionys-650	49	8	kits	kit	NOUN
bionys-650	49	9	,	,	PUNCT
bionys-650	49	10	while	while	SCONJ
bionys-650	49	11	renal	renal	ADJ
bionys-650	49	12	function	function	NOUN
bionys-650	49	13	indicators	indicator	NOUN
bionys-650	49	14	—	—	PUNCT
bionys-650	49	15	blood	blood	NOUN
bionys-650	49	16	urea	urea	NOUN
bionys-650	49	17	and	and	CCONJ
bionys-650	49	18	serum	serum	NOUN
bionys-650	49	19	creatinine	creatinine	NOUN
bionys-650	49	20	—	—	PUNCT
bionys-650	49	21	were	be	AUX
bionys-650	49	22	analyzed	analyze	VERB
bionys-650	49	23	using	use	VERB
bionys-650	49	24	renal	renal	ADJ
bionys-650	49	25	function	function	NOUN
bionys-650	49	26	kits	kit	NOUN
bionys-650	49	27	.	.	PUNCT
bionys-650	50	1	liver	liver	NOUN
bionys-650	50	2	function	function	NOUN
bionys-650	50	3	biomarkers	biomarker	NOUN
bionys-650	50	4	,	,	PUNCT
bionys-650	50	5	including	include	VERB
bionys-650	50	6	total	total	ADJ
bionys-650	50	7	serum	serum	NOUN
bionys-650	50	8	bilirubin	bilirubin	NOUN
bionys-650	50	9	(	(	PUNCT
bionys-650	50	10	tsb	tsb	PROPN
bionys-650	50	11	)	)	PUNCT
bionys-650	50	12	,	,	PUNCT
bionys-650	50	13	glutamate	glutamate	ADJ
bionys-650	50	14	pyruvate	pyruvate	NOUN
bionys-650	50	15	transaminase	transaminase	NOUN
bionys-650	50	16	(	(	PUNCT
bionys-650	50	17	gpt	gpt	NOUN
bionys-650	50	18	)	)	PUNCT
bionys-650	50	19	,	,	PUNCT
bionys-650	50	20	glutamate	glutamate	ADJ
bionys-650	50	21	oxaloacetate	oxaloacetate	NOUN
bionys-650	50	22	transaminase	transaminase	NOUN
bionys-650	50	23	(	(	PUNCT
bionys-650	50	24	got	got	NOUN
bionys-650	50	25	)	)	PUNCT
bionys-650	50	26	,	,	PUNCT
bionys-650	50	27	and	and	CCONJ
bionys-650	50	28	alkaline	alkaline	ADJ
bionys-650	50	29	phosphatase	phosphatase	NOUN
bionys-650	50	30	(	(	PUNCT
bionys-650	50	31	alp	alp	PROPN
bionys-650	50	32	)	)	PUNCT
bionys-650	50	33	,	,	PUNCT
bionys-650	50	34	were	be	AUX
bionys-650	50	35	quantified	quantify	VERB
bionys-650	50	36	using	use	VERB
bionys-650	50	37	liver	liver	NOUN
bionys-650	50	38	function	function	NOUN
bionys-650	50	39	kits	kit	NOUN
bionys-650	50	40	.	.	PUNCT
bionys-650	51	1	all	all	DET
bionys-650	51	2	biochemical	biochemical	ADJ
bionys-650	51	3	reagents	reagent	NOUN
bionys-650	51	4	for	for	ADP
bionys-650	51	5	glucose	glucose	NOUN
bionys-650	51	6	,	,	PUNCT
bionys-650	51	7	renal	renal	ADJ
bionys-650	51	8	,	,	PUNCT
bionys-650	51	9	and	and	CCONJ
bionys-650	51	10	hepatic	hepatic	ADJ
bionys-650	51	11	assessments	assessment	NOUN
bionys-650	51	12	were	be	AUX
bionys-650	51	13	provided	provide	VERB
bionys-650	51	14	by	by	ADP
bionys-650	51	15	elitech	elitech	ADJ
bionys-650	51	16	clinical	clinical	ADJ
bionys-650	51	17	systems	system	NOUN
bionys-650	51	18	sas	sas	PROPN
bionys-650	51	19	(	(	PUNCT
bionys-650	51	20	france	france	PROPN
bionys-650	51	21	)	)	PUNCT
bionys-650	51	22	.	.	PUNCT
bionys-650	52	1	participant	participant	ADJ
bionys-650	52	2	height	height	NOUN
bionys-650	52	3	and	and	CCONJ
bionys-650	52	4	weight	weight	NOUN
bionys-650	52	5	were	be	AUX
bionys-650	52	6	recorded	record	VERB
bionys-650	52	7	using	use	VERB
bionys-650	52	8	the	the	DET
bionys-650	52	9	anker	anker	NOUN
bionys-650	52	10	eufy	eufy	VERB
bionys-650	52	11	smart	smart	ADJ
bionys-650	52	12	scale	scale	NOUN
bionys-650	52	13	p2	p2	NOUN
bionys-650	52	14	pro	pro	ADJ
bionys-650	52	15	,	,	PUNCT
bionys-650	52	16	which	which	PRON
bionys-650	52	17	includes	include	VERB
bionys-650	52	18	an	an	DET
bionys-650	52	19	integrated	integrated	ADJ
bionys-650	52	20	tape	tape	NOUN
bionys-650	52	21	measure	measure	NOUN
bionys-650	52	22	for	for	ADP
bionys-650	52	23	height	height	NOUN
bionys-650	52	24	calculations	calculation	NOUN
bionys-650	52	25	.	.	PUNCT
bionys-650	53	1	bmi	bmi	PROPN
bionys-650	53	2	was	be	AUX
bionys-650	53	3	computed	compute	VERB
bionys-650	53	4	using	use	VERB
bionys-650	53	5	the	the	DET
bionys-650	53	6	equation	equation	NOUN
bionys-650	53	7	:	:	PUNCT
bionys-650	53	8	bmi	bmi	PROPN
bionys-650	53	9	=	=	SYM
bionys-650	53	10	weight	weight	NOUN
bionys-650	53	11	in	in	ADP
bionys-650	53	12	kilograms	kilogram	NOUN
bionys-650	53	13	/height	/height	PUNCT
bionys-650	53	14	in	in	ADP
bionys-650	53	15	square	square	ADJ
bionys-650	53	16	meters	meter	NOUN
bionys-650	53	17	.	.	PUNCT
bionys-650	54	1	insulin	insulin	NOUN
bionys-650	54	2	resistance	resistance	NOUN
bionys-650	54	3	was	be	AUX
bionys-650	54	4	measured	measure	VERB
bionys-650	54	5	using	use	VERB
bionys-650	54	6	the	the	DET
bionys-650	54	7	homa	homa	NOUN
bionys-650	54	8	-	-	PUNCT
bionys-650	54	9	ir	ir	NOUN
bionys-650	54	10	equation	equation	NOUN
bionys-650	54	11	:	:	PUNCT
bionys-650	54	12	homa	homa	NOUN
bionys-650	54	13	-	-	PUNCT
bionys-650	54	14	ir	ir	NOUN
bionys-650	55	1	=	=	PUNCT
bionys-650	56	1	[	[	X
bionys-650	56	2	glucose	glucose	NOUN
bionys-650	56	3	(	(	PUNCT
bionys-650	56	4	mg	mg	PROPN
bionys-650	56	5	/	/	SYM
bionys-650	56	6	dl	dl	NOUN
bionys-650	56	7	)	)	PUNCT
bionys-650	56	8	×	×	NOUN
bionys-650	56	9	insulin	insulin	NOUN
bionys-650	56	10	(	(	PUNCT
bionys-650	56	11	mu	mu	NOUN
bionys-650	56	12	/	/	SYM
bionys-650	56	13	l	l	NOUN
bionys-650	56	14	)	)	PUNCT
bionys-650	56	15	]	]	PUNCT
bionys-650	57	1	÷	÷	NUM
bionys-650	57	2	405	405	NUM
bionys-650	57	3	.	.	PUNCT
bionys-650	58	1	for	for	ADP
bionys-650	58	2	reference	reference	NOUN
bionys-650	58	3	,	,	PUNCT
bionys-650	58	4	18	18	NUM
bionys-650	58	5	mg	mg	PROPN
bionys-650	58	6	/	/	SYM
bionys-650	58	7	dl	dl	PROPN
bionys-650	58	8	≈	≈	PROPN
bionys-650	58	9	1	1	NUM
bionys-650	58	10	mmol	mmol	NOUN
bionys-650	58	11	/	/	SYM
bionys-650	58	12	l.	l.	NOUN
bionys-650	58	13	a	a	DET
bionys-650	58	14	homa	homa	NOUN
bionys-650	58	15	-	-	PUNCT
bionys-650	58	16	ir	ir	NOUN
bionys-650	58	17	value	value	NOUN
bionys-650	58	18	≥2.5	≥2.5	NOUN
bionys-650	58	19	typically	typically	ADV
bionys-650	58	20	indicates	indicate	VERB
bionys-650	58	21	insulin	insulin	NOUN
bionys-650	58	22	resistance	resistance	NOUN
bionys-650	58	23	,	,	PUNCT
bionys-650	58	24	as	as	SCONJ
bionys-650	58	25	it	it	PRON
bionys-650	58	26	is	be	AUX
bionys-650	58	27	associated	associate	VERB
bionys-650	58	28	with	with	ADP
bionys-650	58	29	impaired	impaired	ADJ
bionys-650	58	30	insulin	insulin	NOUN
bionys-650	58	31	sensitivity	sensitivity	NOUN
bionys-650	58	32	(	(	PUNCT
bionys-650	58	33	crook	crook	NOUN
bionys-650	58	34	&	&	CCONJ
bionys-650	58	35	godsland	godsland	PROPN
bionys-650	58	36	,	,	PUNCT
bionys-650	58	37	1998	1998	NUM
bionys-650	58	38	;	;	PUNCT
bionys-650	58	39	porchia	porchia	NOUN
bionys-650	58	40	et	et	PROPN
bionys-650	58	41	al	al	PROPN
bionys-650	58	42	.	.	PROPN
bionys-650	58	43	,	,	PUNCT
bionys-650	58	44	2024	2024	NUM
bionys-650	58	45	)	)	PUNCT
bionys-650	58	46	.	.	PUNCT
bionys-650	59	1	it	it	PRON
bionys-650	59	2	should	should	AUX
bionys-650	59	3	be	be	AUX
bionys-650	59	4	noted	note	VERB
bionys-650	59	5	that	that	SCONJ
bionys-650	59	6	individual	individual	ADJ
bionys-650	59	7	factors	factor	NOUN
bionys-650	59	8	such	such	ADJ
bionys-650	59	9	as	as	ADP
bionys-650	59	10	age	age	NOUN
bionys-650	59	11	,	,	PUNCT
bionys-650	59	12	weight	weight	NOUN
bionys-650	59	13	,	,	PUNCT
bionys-650	59	14	and	and	CCONJ
bionys-650	59	15	health	health	NOUN
bionys-650	59	16	status	status	NOUN
bionys-650	59	17	may	may	AUX
bionys-650	59	18	influence	influence	VERB
bionys-650	59	19	reference	reference	NOUN
bionys-650	59	20	values	value	NOUN
bionys-650	59	21	(	(	PUNCT
bionys-650	59	22	polonsky	polonsky	NOUN
bionys-650	59	23	&	&	CCONJ
bionys-650	59	24	burant	burant	NOUN
bionys-650	59	25	,	,	PUNCT
bionys-650	59	26	2015	2015	NUM
bionys-650	59	27	)	)	PUNCT
bionys-650	59	28	.	.	PUNCT
bionys-650	60	1	as	as	ADP
bionys-650	60	2	for	for	ADP
bionys-650	60	3	determining	determine	VERB
bionys-650	60	4	vdbp	vdbp	ADJ
bionys-650	60	5	concentrations	concentration	NOUN
bionys-650	60	6	,	,	PUNCT
bionys-650	60	7	absorbance	absorbance	NOUN
bionys-650	60	8	was	be	AUX
bionys-650	60	9	measured	measure	VERB
bionys-650	60	10	using	use	VERB
bionys-650	60	11	a	a	DET
bionys-650	60	12	uquant	uquant	ADJ
bionys-650	60	13	bio	bio	PROPN
bionys-650	60	14	-	-	ADJ
bionys-650	60	15	tek	tek	PROPN
bionys-650	60	16	microplate	microplate	PROPN
bionys-650	60	17	spectrophotometer	spectrophotometer	PROPN
bionys-650	60	18	(	(	PUNCT
bionys-650	60	19	usa	usa	PROPN
bionys-650	60	20	)	)	PUNCT
bionys-650	60	21	.	.	PUNCT
bionys-650	61	1	temperature	temperature	NOUN
bionys-650	61	2	stability	stability	NOUN
bionys-650	61	3	and	and	CCONJ
bionys-650	61	4	sample	sample	NOUN
bionys-650	61	5	preservation	preservation	NOUN
bionys-650	61	6	were	be	AUX
bionys-650	61	7	maintained	maintain	VERB
bionys-650	61	8	using	use	VERB
bionys-650	61	9	a	a	DET
bionys-650	61	10	laboratory	laboratory	NOUN
bionys-650	61	11	refrigerator	refrigerator	NOUN
bionys-650	61	12	and	and	CCONJ
bionys-650	61	13	incubator	incubator	NOUN
bionys-650	61	14	.	.	PUNCT
bionys-650	62	1	statistical	statistical	ADJ
bionys-650	62	2	analysis	analysis	NOUN
bionys-650	62	3	all	all	DET
bionys-650	62	4	data	datum	NOUN
bionys-650	62	5	obtained	obtain	VERB
bionys-650	62	6	were	be	AUX
bionys-650	62	7	analyzed	analyze	VERB
bionys-650	62	8	using	use	VERB
bionys-650	62	9	spss	spss	PROPN
bionys-650	62	10	,	,	PUNCT
bionys-650	62	11	medcalc	medcalc	ADJ
bionys-650	62	12	,	,	PUNCT
bionys-650	62	13	and	and	CCONJ
bionys-650	62	14	graphpad	graphpad	NOUN
bionys-650	62	15	prism	prism	NOUN
bionys-650	62	16	for	for	ADP
bionys-650	62	17	descriptive	descriptive	ADJ
bionys-650	62	18	statistics	statistic	NOUN
bionys-650	62	19	and	and	CCONJ
bionys-650	62	20	inferential	inferential	ADJ
bionys-650	62	21	comparisons	comparison	NOUN
bionys-650	62	22	.	.	PUNCT
bionys-650	63	1	the	the	DET
bionys-650	63	2	gen5	gen5	NOUN
bionys-650	63	3	–	–	PUNCT
bionys-650	63	4	biotek	biotek	NOUN
bionys-650	63	5	software	software	NOUN
bionys-650	63	6	was	be	AUX
bionys-650	63	7	used	use	VERB
bionys-650	63	8	in	in	ADP
bionys-650	63	9	conjunction	conjunction	NOUN
bionys-650	63	10	with	with	ADP
bionys-650	63	11	the	the	DET
bionys-650	63	12	microplate	microplate	NOUN
bionys-650	63	13	reader	reader	NOUN
bionys-650	63	14	to	to	PART
bionys-650	63	15	record	record	VERB
bionys-650	63	16	optical	optical	ADJ
bionys-650	63	17	density	density	NOUN
bionys-650	63	18	and	and	CCONJ
bionys-650	63	19	biologica	biologica	PROPN
bionys-650	63	20	nyssana	nyssana	PROPN
bionys-650	64	1	●	●	PUNCT
bionys-650	64	2	16	16	NUM
bionys-650	64	3	(	(	PUNCT
bionys-650	64	4	2	2	NUM
bionys-650	64	5	)	)	PUNCT
bionys-650	64	6	december	december	PROPN
bionys-650	64	7	2025	2025	NUM
bionys-650	64	8	:	:	PUNCT
bionys-650	64	9	kadhim	kadhim	PROPN
bionys-650	64	10	et	et	PROPN
bionys-650	64	11	al	al	PROPN
bionys-650	64	12	.	.	PUNCT
bionys-650	65	1	●	●	PUNCT
bionys-650	65	2	the	the	DET
bionys-650	65	3	association	association	NOUN
bionys-650	65	4	of	of	ADP
bionys-650	65	5	vitamin	vitamin	NOUN
bionys-650	65	6	d	d	PROPN
bionys-650	65	7	,	,	PUNCT
bionys-650	65	8	vitamin	vitamin	NOUN
bionys-650	65	9	d	d	NOUN
bionys-650	65	10	-	-	ADJ
bionys-650	65	11	binding	bind	VERB
bionys-650	65	12	protein	protein	NOUN
bionys-650	65	13	,	,	PUNCT
bionys-650	65	14	and	and	CCONJ
bionys-650	65	15	ferritin	ferritin	ADJ
bionys-650	65	16	levels	level	NOUN
bionys-650	65	17	in	in	ADP
bionys-650	65	18	iraqi	iraqi	ADJ
bionys-650	65	19	men	man	NOUN
bionys-650	65	20	with	with	ADP
bionys-650	65	21	type	type	NOUN
bionys-650	65	22	2	2	NUM
bionys-650	65	23	diabetes	diabetes	NOUN
bionys-650	65	24	biologica	biologica	PROPN
bionys-650	65	25	nyssana	nyssana	PROPN
bionys-650	65	26	●	●	PUNCT
bionys-650	65	27	16	16	NUM
bionys-650	65	28	(	(	PUNCT
bionys-650	65	29	2	2	NUM
bionys-650	65	30	)	)	PUNCT
bionys-650	65	31	december	december	PROPN
bionys-650	65	32	2025	2025	NUM
bionys-650	65	33	:	:	PUNCT
bionys-650	65	34	kadhim	kadhim	PROPN
bionys-650	65	35	et	et	PROPN
bionys-650	65	36	al	al	PROPN
bionys-650	65	37	.	.	PUNCT
bionys-650	66	1	●	●	PUNCT
bionys-650	66	2	the	the	DET
bionys-650	66	3	association	association	NOUN
bionys-650	66	4	of	of	ADP
bionys-650	66	5	vitamin	vitamin	NOUN
bionys-650	66	6	d	d	PROPN
bionys-650	66	7	,	,	PUNCT
bionys-650	66	8	vitamin	vitamin	NOUN
bionys-650	66	9	d	d	NOUN
bionys-650	66	10	-	-	ADJ
bionys-650	66	11	binding	bind	VERB
bionys-650	66	12	protein	protein	NOUN
bionys-650	66	13	,	,	PUNCT
bionys-650	66	14	and	and	CCONJ
bionys-650	66	15	ferritin	ferritin	ADJ
bionys-650	66	16	levels	level	NOUN
bionys-650	66	17	in	in	ADP
bionys-650	66	18	iraqi	iraqi	ADJ
bionys-650	66	19	men	man	NOUN
bionys-650	66	20	with	with	ADP
bionys-650	66	21	type	type	NOUN
bionys-650	66	22	2	2	NUM
bionys-650	66	23	diabetes	diabetes	NOUN
bionys-650	66	24	calculate	calculate	VERB
bionys-650	66	25	vdbp	vdbp	NOUN
bionys-650	66	26	concentrations	concentration	NOUN
bionys-650	66	27	using	use	VERB
bionys-650	66	28	a	a	DET
bionys-650	66	29	quadratic	quadratic	ADJ
bionys-650	66	30	fit	fit	ADJ
bionys-650	66	31	model	model	NOUN
bionys-650	66	32	.	.	PUNCT
bionys-650	67	1	a	a	DET
bionys-650	67	2	p	p	NOUN
bionys-650	67	3	-	-	PUNCT
bionys-650	67	4	value	value	NOUN
bionys-650	67	5	of	of	ADP
bionys-650	67	6	<	<	NOUN
bionys-650	67	7	0.05	0.05	NUM
bionys-650	67	8	was	be	AUX
bionys-650	67	9	considered	consider	VERB
bionys-650	67	10	statistically	statistically	ADV
bionys-650	67	11	significant	significant	ADJ
bionys-650	67	12	across	across	ADP
bionys-650	67	13	tests	test	NOUN
bionys-650	67	14	.	.	PUNCT
bionys-650	68	1	the	the	DET
bionys-650	68	2	rigorous	rigorous	ADJ
bionys-650	68	3	design	design	NOUN
bionys-650	68	4	and	and	CCONJ
bionys-650	68	5	use	use	NOUN
bionys-650	68	6	of	of	ADP
bionys-650	68	7	matched	match	VERB
bionys-650	68	8	samples	sample	NOUN
bionys-650	68	9	enhance	enhance	VERB
bionys-650	68	10	the	the	DET
bionys-650	68	11	validity	validity	NOUN
bionys-650	68	12	and	and	CCONJ
bionys-650	68	13	reproducibility	reproducibility	NOUN
bionys-650	68	14	of	of	ADP
bionys-650	68	15	the	the	DET
bionys-650	68	16	findings	finding	NOUN
bionys-650	68	17	,	,	PUNCT
bionys-650	68	18	aligning	align	VERB
bionys-650	68	19	with	with	ADP
bionys-650	68	20	established	establish	VERB
bionys-650	68	21	research	research	NOUN
bionys-650	68	22	protocols	protocol	NOUN
bionys-650	68	23	and	and	CCONJ
bionys-650	68	24	literature	literature	NOUN
bionys-650	68	25	standards	standard	NOUN
bionys-650	68	26	.	.	PUNCT
bionys-650	69	1	results	result	NOUN
bionys-650	69	2	and	and	CCONJ
bionys-650	69	3	discussion	discussion	NOUN
bionys-650	69	4	the	the	DET
bionys-650	69	5	demographic	demographic	ADJ
bionys-650	69	6	and	and	CCONJ
bionys-650	69	7	anthropometric	anthropometric	ADJ
bionys-650	69	8	characteristics	characteristic	NOUN
bionys-650	69	9	of	of	ADP
bionys-650	69	10	the	the	DET
bionys-650	69	11	participants	participant	NOUN
bionys-650	69	12	are	be	AUX
bionys-650	69	13	presented	present	VERB
bionys-650	69	14	in	in	ADP
bionys-650	69	15	tab	tab	NOUN
bionys-650	69	16	.	.	PUNCT
bionys-650	70	1	1	1	X
bionys-650	70	2	.	.	PUNCT
bionys-650	70	3	the	the	DET
bionys-650	70	4	mean	mean	ADJ
bionys-650	70	5	age	age	NOUN
bionys-650	70	6	of	of	ADP
bionys-650	70	7	the	the	DET
bionys-650	70	8	control	control	NOUN
bionys-650	70	9	group	group	NOUN
bionys-650	70	10	was	be	AUX
bionys-650	70	11	35.52	35.52	NUM
bionys-650	70	12	years	year	NOUN
bionys-650	70	13	(	(	PUNCT
bionys-650	70	14	±2.81	±2.81	PROPN
bionys-650	70	15	)	)	PUNCT
bionys-650	70	16	,	,	PUNCT
bionys-650	70	17	and	and	CCONJ
bionys-650	70	18	35.25	35.25	NUM
bionys-650	70	19	years	year	NOUN
bionys-650	70	20	(	(	PUNCT
bionys-650	70	21	±3.24	±3.24	PROPN
bionys-650	70	22	)	)	PUNCT
bionys-650	70	23	for	for	ADP
bionys-650	70	24	the	the	DET
bionys-650	70	25	t2d	t2d	NUM
bionys-650	70	26	group	group	NOUN
bionys-650	70	27	.	.	PUNCT
bionys-650	71	1	no	no	DET
bionys-650	71	2	significant	significant	ADJ
bionys-650	71	3	difference	difference	NOUN
bionys-650	71	4	was	be	AUX
bionys-650	71	5	observed	observe	VERB
bionys-650	71	6	(	(	PUNCT
bionys-650	71	7	p=0.631	p=0.631	NOUN
bionys-650	71	8	)	)	PUNCT
bionys-650	71	9	,	,	PUNCT
bionys-650	71	10	indicating	indicate	VERB
bionys-650	71	11	age	age	NOUN
bionys-650	71	12	homogeneity	homogeneity	NOUN
bionys-650	71	13	between	between	ADP
bionys-650	71	14	groups	group	NOUN
bionys-650	71	15	.	.	PUNCT
bionys-650	72	1	mean	mean	VERB
bionys-650	72	2	body	body	NOUN
bionys-650	72	3	weight	weight	NOUN
bionys-650	72	4	also	also	ADV
bionys-650	72	5	showed	show	VERB
bionys-650	72	6	similarity	similarity	NOUN
bionys-650	72	7	,	,	PUNCT
bionys-650	72	8	measured	measure	VERB
bionys-650	72	9	at	at	ADP
bionys-650	72	10	65.65	65.65	NUM
bionys-650	72	11	kg	kg	NOUN
bionys-650	72	12	(	(	PUNCT
bionys-650	72	13	±4.96	±4.96	PROPN
bionys-650	72	14	)	)	PUNCT
bionys-650	72	15	in	in	ADP
bionys-650	72	16	controls	control	NOUN
bionys-650	72	17	and	and	CCONJ
bionys-650	72	18	65.07	65.07	NUM
bionys-650	72	19	kg	kg	NOUN
bionys-650	72	20	(	(	PUNCT
bionys-650	72	21	±4.78	±4.78	PROPN
bionys-650	72	22	)	)	PUNCT
bionys-650	72	23	in	in	ADP
bionys-650	72	24	t2d	t2d	NOUN
bionys-650	72	25	patients	patient	NOUN
bionys-650	72	26	(	(	PUNCT
bionys-650	72	27	p=0.513	p=0.513	PROPN
bionys-650	72	28	)	)	PUNCT
bionys-650	72	29	.	.	PUNCT
bionys-650	73	1	in	in	ADP
bionys-650	73	2	terms	term	NOUN
bionys-650	73	3	of	of	ADP
bionys-650	73	4	height	height	NOUN
bionys-650	73	5	,	,	PUNCT
bionys-650	73	6	however	however	ADV
bionys-650	73	7	,	,	PUNCT
bionys-650	73	8	a	a	DET
bionys-650	73	9	statistically	statistically	ADV
bionys-650	73	10	significant	significant	ADJ
bionys-650	73	11	difference	difference	NOUN
bionys-650	73	12	was	be	AUX
bionys-650	73	13	noted	note	VERB
bionys-650	73	14	(	(	PUNCT
bionys-650	73	15	p=0.020	p=0.020	NOUN
bionys-650	73	16	)	)	PUNCT
bionys-650	73	17	,	,	PUNCT
bionys-650	73	18	with	with	ADP
bionys-650	73	19	mean	mean	ADJ
bionys-650	73	20	values	value	NOUN
bionys-650	73	21	of	of	ADP
bionys-650	73	22	1.741	1.741	NUM
bionys-650	73	23	m	m	NOUN
bionys-650	73	24	(	(	PUNCT
bionys-650	73	25	±0.047	±0.047	PROPN
bionys-650	73	26	)	)	PUNCT
bionys-650	73	27	in	in	ADP
bionys-650	73	28	controls	control	NOUN
bionys-650	73	29	and	and	CCONJ
bionys-650	73	30	1.717	1.717	NUM
bionys-650	73	31	m	m	PROPN
bionys-650	73	32	(	(	PUNCT
bionys-650	73	33	±0.047	±0.047	PROPN
bionys-650	73	34	)	)	PUNCT
bionys-650	73	35	in	in	ADP
bionys-650	73	36	the	the	DET
bionys-650	73	37	diabetic	diabetic	ADJ
bionys-650	73	38	group	group	NOUN
bionys-650	73	39	.	.	PUNCT
bionys-650	74	1	bmi	bmi	PROPN
bionys-650	74	2	values	value	NOUN
bionys-650	74	3	were	be	AUX
bionys-650	74	4	closely	closely	ADV
bionys-650	74	5	aligned	align	VERB
bionys-650	74	6	,	,	PUNCT
bionys-650	74	7	with	with	ADP
bionys-650	74	8	means	mean	NOUN
bionys-650	74	9	of	of	ADP
bionys-650	74	10	21.62	21.62	NUM
bionys-650	74	11	kg	kg	NOUN
bionys-650	74	12	/	/	SYM
bionys-650	74	13	m²	m²	PROPN
bionys-650	74	14	(	(	PUNCT
bionys-650	74	15	±1.26	±1.26	PROPN
bionys-650	74	16	)	)	PUNCT
bionys-650	74	17	and	and	CCONJ
bionys-650	74	18	22.06	22.06	NUM
bionys-650	74	19	kg/	kg/	NOUN
bionys-650	74	20	m²	m²	PROPN
bionys-650	74	21	(	(	PUNCT
bionys-650	74	22	±1.51	±1.51	PROPN
bionys-650	74	23	)	)	PUNCT
bionys-650	74	24	respectively	respectively	ADV
bionys-650	74	25	,	,	PUNCT
bionys-650	74	26	and	and	CCONJ
bionys-650	74	27	the	the	DET
bionys-650	74	28	difference	difference	NOUN
bionys-650	74	29	was	be	AUX
bionys-650	74	30	not	not	PART
bionys-650	74	31	statistically	statistically	ADV
bionys-650	74	32	significant	significant	ADJ
bionys-650	74	33	(	(	PUNCT
bionys-650	74	34	p=0.085	p=0.085	NOUN
bionys-650	74	35	)	)	PUNCT
bionys-650	74	36	,	,	PUNCT
bionys-650	74	37	in	in	ADP
bionys-650	74	38	accordance	accordance	NOUN
bionys-650	74	39	with	with	ADP
bionys-650	74	40	the	the	DET
bionys-650	74	41	study	study	NOUN
bionys-650	74	42	’s	’s	PART
bionys-650	74	43	inclusion	inclusion	NOUN
bionys-650	74	44	criteria	criterion	NOUN
bionys-650	74	45	(	(	PUNCT
bionys-650	74	46	bmi	bmi	PROPN
bionys-650	74	47	19–24	19–24	NUM
bionys-650	74	48	kg	kg	PROPN
bionys-650	74	49	/	/	SYM
bionys-650	74	50	m²	m²	PROPN
bionys-650	74	51	)	)	PUNCT
bionys-650	74	52	.	.	PUNCT
bionys-650	75	1	fig	fig	NOUN
bionys-650	75	2	.	.	PUNCT
bionys-650	76	1	1	1	X
bionys-650	76	2	.	.	NOUN
bionys-650	76	3	illustrates	illustrate	VERB
bionys-650	76	4	a	a	DET
bionys-650	76	5	near	near	ADV
bionys-650	76	6	-	-	PUNCT
bionys-650	76	7	balanced	balanced	ADJ
bionys-650	76	8	bmi	bmi	NOUN
bionys-650	76	9	distribution	distribution	NOUN
bionys-650	76	10	,	,	PUNCT
bionys-650	76	11	with	with	ADP
bionys-650	76	12	49	49	NUM
bionys-650	76	13	%	%	NOUN
bionys-650	76	14	of	of	ADP
bionys-650	76	15	participants	participant	NOUN
bionys-650	76	16	belonging	belong	VERB
bionys-650	76	17	to	to	ADP
bionys-650	76	18	the	the	DET
bionys-650	76	19	control	control	NOUN
bionys-650	76	20	group	group	NOUN
bionys-650	76	21	and	and	CCONJ
bionys-650	76	22	51	51	NUM
bionys-650	76	23	%	%	NOUN
bionys-650	76	24	to	to	ADP
bionys-650	76	25	the	the	DET
bionys-650	76	26	diabetic	diabetic	ADJ
bionys-650	76	27	group	group	NOUN
bionys-650	76	28	.	.	PUNCT
bionys-650	77	1	the	the	DET
bionys-650	77	2	second	second	ADJ
bionys-650	77	3	graph	graph	NOUN
bionys-650	77	4	shows	show	VERB
bionys-650	77	5	that	that	SCONJ
bionys-650	77	6	participant	participant	ADJ
bionys-650	77	7	distribution	distribution	NOUN
bionys-650	77	8	across	across	ADP
bionys-650	77	9	ages	age	NOUN
bionys-650	77	10	was	be	AUX
bionys-650	77	11	evenly	evenly	ADV
bionys-650	77	12	split	split	ADJ
bionys-650	77	13	,	,	PUNCT
bionys-650	77	14	with	with	ADP
bionys-650	77	15	both	both	CCONJ
bionys-650	77	16	control	control	NOUN
bionys-650	77	17	and	and	CCONJ
bionys-650	77	18	diabetic	diabetic	ADJ
bionys-650	77	19	groups	group	NOUN
bionys-650	77	20	comprising	comprise	VERB
bionys-650	77	21	50	50	NUM
bionys-650	77	22	%	%	NOUN
bionys-650	77	23	of	of	ADP
bionys-650	77	24	the	the	DET
bionys-650	77	25	sample	sample	NOUN
bionys-650	77	26	.	.	PUNCT
bionys-650	78	1	tab	tab	NOUN
bionys-650	78	2	.	.	PUNCT
bionys-650	79	1	2	2	X
bionys-650	79	2	.	.	X
bionys-650	79	3	summarizes	summarize	NOUN
bionys-650	79	4	t2d	t2d	VERB
bionys-650	79	5	biochemical	biochemical	ADJ
bionys-650	79	6	variables	variable	NOUN
bionys-650	79	7	.	.	PUNCT
bionys-650	80	1	glucose	glucose	NOUN
bionys-650	80	2	levels	level	NOUN
bionys-650	80	3	were	be	AUX
bionys-650	80	4	significantly	significantly	ADV
bionys-650	80	5	elevated	elevate	VERB
bionys-650	80	6	in	in	ADP
bionys-650	80	7	the	the	DET
bionys-650	80	8	t2d	t2d	NOUN
bionys-650	80	9	group	group	NOUN
bionys-650	80	10	,	,	PUNCT
bionys-650	80	11	with	with	ADP
bionys-650	80	12	a	a	DET
bionys-650	80	13	mean	mean	NOUN
bionys-650	80	14	of	of	ADP
bionys-650	80	15	152.32	152.32	NUM
bionys-650	80	16	mg	mg	PROPN
bionys-650	80	17	/	/	SYM
bionys-650	80	18	dl	dl	PROPN
bionys-650	80	19	(	(	PUNCT
bionys-650	80	20	±40.00	±40.00	PROPN
bionys-650	80	21	)	)	PUNCT
bionys-650	80	22	compared	compare	VERB
bionys-650	80	23	to	to	ADP
bionys-650	80	24	87.67	87.67	NUM
bionys-650	80	25	mg	mg	PROPN
bionys-650	80	26	/	/	SYM
bionys-650	80	27	dl	dl	PROPN
bionys-650	80	28	(	(	PUNCT
bionys-650	80	29	±5.94	±5.94	PROPN
bionys-650	80	30	)	)	PUNCT
bionys-650	80	31	in	in	ADP
bionys-650	80	32	the	the	DET
bionys-650	80	33	control	control	NOUN
bionys-650	80	34	group	group	NOUN
bionys-650	80	35	(	(	PUNCT
bionys-650	80	36	p=0.001	p=0.001	NUM
bionys-650	80	37	)	)	PUNCT
bionys-650	80	38	.	.	PUNCT
bionys-650	81	1	this	this	PRON
bionys-650	81	2	confirms	confirm	VERB
bionys-650	81	3	the	the	DET
bionys-650	81	4	expected	expect	VERB
bionys-650	81	5	glycemic	glycemic	ADJ
bionys-650	81	6	dysregulation	dysregulation	NOUN
bionys-650	81	7	in	in	ADP
bionys-650	81	8	patients	patient	NOUN
bionys-650	81	9	with	with	ADP
bionys-650	81	10	diabetes	diabetes	NOUN
bionys-650	81	11	.	.	PUNCT
bionys-650	82	1	insulin	insulin	NOUN
bionys-650	82	2	levels	level	NOUN
bionys-650	82	3	showed	show	VERB
bionys-650	82	4	no	no	DET
bionys-650	82	5	significant	significant	ADJ
bionys-650	82	6	difference	difference	NOUN
bionys-650	82	7	between	between	ADP
bionys-650	82	8	groups	group	NOUN
bionys-650	82	9	,	,	PUNCT
bionys-650	82	10	with	with	ADP
bionys-650	82	11	values	value	NOUN
bionys-650	82	12	of	of	ADP
bionys-650	82	13	12.60	12.60	NUM
bionys-650	82	14	mu	mu	NOUN
bionys-650	82	15	/	/	SYM
bionys-650	82	16	l	l	NOUN
bionys-650	82	17	(	(	PUNCT
bionys-650	82	18	±5.23	±5.23	PROPN
bionys-650	82	19	)	)	PUNCT
bionys-650	82	20	in	in	ADP
bionys-650	82	21	the	the	DET
bionys-650	82	22	t2d	t2d	NOUN
bionys-650	82	23	group	group	NOUN
bionys-650	82	24	and	and	CCONJ
bionys-650	82	25	11.63	11.63	NUM
bionys-650	82	26	mu	mu	NOUN
bionys-650	82	27	/	/	SYM
bionys-650	82	28	l	l	NOUN
bionys-650	82	29	(	(	PUNCT
bionys-650	82	30	±3.89	±3.89	PROPN
bionys-650	82	31	)	)	PUNCT
bionys-650	82	32	in	in	ADP
bionys-650	82	33	the	the	DET
bionys-650	82	34	control	control	NOUN
bionys-650	82	35	group	group	NOUN
bionys-650	82	36	(	(	PUNCT
bionys-650	82	37	p=0.252	p=0.252	NOUN
bionys-650	82	38	)	)	PUNCT
bionys-650	82	39	.	.	PUNCT
bionys-650	83	1	however	however	ADV
bionys-650	83	2	,	,	PUNCT
bionys-650	83	3	insulin	insulin	NOUN
bionys-650	83	4	resistance	resistance	NOUN
bionys-650	83	5	was	be	AUX
bionys-650	83	6	markedly	markedly	ADV
bionys-650	83	7	higher	high	ADJ
bionys-650	83	8	in	in	ADP
bionys-650	83	9	diabetic	diabetic	ADJ
bionys-650	83	10	subjects	subject	NOUN
bionys-650	83	11	,	,	PUNCT
bionys-650	83	12	control	control	NOUN
bionys-650	83	13	group	group	NOUN
bionys-650	83	14	,	,	PUNCT
bionys-650	83	15	n=60	n=60	PROPN
bionys-650	83	16	t2d	t2d	NOUN
bionys-650	83	17	patients	patient	NOUN
bionys-650	83	18	,	,	PUNCT
bionys-650	83	19	n=60	n=60	NOUN
bionys-650	83	20	parameters	parameter	NOUN
bionys-650	83	21	mean	mean	VERB
bionys-650	83	22	sd	sd	INTJ
bionys-650	83	23	mean	mean	VERB
bionys-650	83	24	sd	sd	ADP
bionys-650	83	25	p	p	ADJ
bionys-650	83	26	-	-	PUNCT
bionys-650	83	27	value	value	NOUN
bionys-650	83	28	age	age	NOUN
bionys-650	83	29	(	(	PUNCT
bionys-650	83	30	year	year	NOUN
bionys-650	83	31	)	)	PUNCT
bionys-650	84	1	35.52	35.52	NUM
bionys-650	84	2	2.8134	2.8134	NUM
bionys-650	84	3	35.25	35.25	NUM
bionys-650	84	4	3.245	3.245	NUM
bionys-650	84	5	0.631	0.631	NUM
bionys-650	84	6	weight	weight	NOUN
bionys-650	84	7	(	(	PUNCT
bionys-650	84	8	kg	kg	NOUN
bionys-650	84	9	)	)	PUNCT
bionys-650	84	10	65.65	65.65	NUM
bionys-650	84	11	4.957	4.957	NUM
bionys-650	84	12	65.067	65.067	NUM
bionys-650	84	13	4.779	4.779	NUM
bionys-650	84	14	0.513	0.513	NUM
bionys-650	84	15	height	height	NOUN
bionys-650	84	16	(	(	PUNCT
bionys-650	84	17	m	m	NOUN
bionys-650	84	18	)	)	PUNCT
bionys-650	84	19	1.741	1.741	NUM
bionys-650	84	20	0.047	0.047	NUM
bionys-650	84	21	1.717	1.717	NUM
bionys-650	84	22	0.047	0.047	NUM
bionys-650	84	23	0.02	0.02	NUM
bionys-650	84	24	*	*	NOUN
bionys-650	84	25	bmi	bmi	X
bionys-650	84	26	(	(	PUNCT
bionys-650	84	27	kg	kg	NOUN
bionys-650	84	28	/	/	SYM
bionys-650	84	29	m2	m2	PROPN
bionys-650	84	30	)	)	PUNCT
bionys-650	84	31	21.618	21.618	NUM
bionys-650	84	32	1.258	1.258	NUM
bionys-650	84	33	22.058	22.058	NUM
bionys-650	84	34	1.508	1.508	NUM
bionys-650	84	35	0.085	0.085	NUM
bionys-650	84	36	table	table	NOUN
bionys-650	84	37	1	1	NUM
bionys-650	84	38	.	.	PUNCT
bionys-650	85	1	the	the	DET
bionys-650	85	2	statistical	statistical	ADJ
bionys-650	85	3	disparities	disparity	NOUN
bionys-650	85	4	among	among	ADP
bionys-650	85	5	control	control	NOUN
bionys-650	85	6	and	and	CCONJ
bionys-650	85	7	t2d	t2d	NOUN
bionys-650	85	8	patients	patient	NOUN
bionys-650	85	9	for	for	ADP
bionys-650	85	10	age	age	NOUN
bionys-650	85	11	and	and	CCONJ
bionys-650	85	12	anthropometric	anthropometric	ADJ
bionys-650	85	13	measurements	measurement	NOUN
bionys-650	85	14	*	*	PUNCT
bionys-650	85	15	significant	significant	ADJ
bionys-650	85	16	at	at	ADP
bionys-650	85	17	p≤0.05	p≤0.05	NOUN
bionys-650	85	18	,	,	PUNCT
bionys-650	85	19	*	*	PUNCT
bionys-650	85	20	*	*	PUNCT
bionys-650	85	21	highly	highly	ADV
bionys-650	85	22	significant	significant	ADJ
bionys-650	85	23	p<0.001	p<0.001	NOUN
bionys-650	85	24	,	,	PUNCT
bionys-650	85	25	ns	ns	NUM
bionys-650	85	26	:	:	PUNCT
bionys-650	85	27	non	non	ADJ
bionys-650	85	28	-	-	ADJ
bionys-650	85	29	significant	significant	ADJ
bionys-650	85	30	with	with	ADP
bionys-650	85	31	a	a	DET
bionys-650	85	32	mean	mean	ADJ
bionys-650	85	33	value	value	NOUN
bionys-650	85	34	of	of	ADP
bionys-650	85	35	4.72	4.72	NUM
bionys-650	85	36	(	(	PUNCT
bionys-650	85	37	±2.34	±2.34	NOUN
bionys-650	85	38	)	)	PUNCT
bionys-650	85	39	compared	compare	VERB
bionys-650	85	40	to	to	ADP
bionys-650	85	41	2.52	2.52	NUM
bionys-650	85	42	(	(	PUNCT
bionys-650	85	43	±0.85	±0.85	NOUN
bionys-650	85	44	)	)	PUNCT
bionys-650	85	45	in	in	ADP
bionys-650	85	46	controls	control	NOUN
bionys-650	85	47	(	(	PUNCT
bionys-650	85	48	p=0.001	p=0.001	NUM
bionys-650	85	49	)	)	PUNCT
bionys-650	85	50	,	,	PUNCT
bionys-650	85	51	underscoring	underscore	VERB
bionys-650	85	52	its	its	PRON
bionys-650	85	53	role	role	NOUN
bionys-650	85	54	in	in	ADP
bionys-650	85	55	the	the	DET
bionys-650	85	56	pathophysiology	pathophysiology	NOUN
bionys-650	85	57	of	of	ADP
bionys-650	85	58	t2d	t2d	PROPN
bionys-650	85	59	.	.	PUNCT
bionys-650	86	1	ferritin	ferritin	PROPN
bionys-650	86	2	levels	level	NOUN
bionys-650	86	3	did	do	AUX
bionys-650	86	4	not	not	PART
bionys-650	86	5	differ	differ	VERB
bionys-650	86	6	significantly	significantly	ADV
bionys-650	86	7	between	between	ADP
bionys-650	86	8	groups	group	NOUN
bionys-650	86	9	;	;	PUNCT
bionys-650	86	10	control	control	NOUN
bionys-650	86	11	group	group	NOUN
bionys-650	86	12	had	have	VERB
bionys-650	86	13	a	a	DET
bionys-650	86	14	mean	mean	NOUN
bionys-650	86	15	of	of	ADP
bionys-650	86	16	61.32	61.32	NUM
bionys-650	86	17	ng	ng	PROPN
bionys-650	86	18	/	/	SYM
bionys-650	86	19	ml	ml	PROPN
bionys-650	86	20	(	(	PUNCT
bionys-650	86	21	±16.08	±16.08	NOUN
bionys-650	86	22	)	)	PUNCT
bionys-650	86	23	,	,	PUNCT
bionys-650	86	24	figure	figure	NOUN
bionys-650	86	25	1	1	NUM
bionys-650	86	26	.	.	PUNCT
bionys-650	86	27	distribution	distribution	NOUN
bionys-650	86	28	of	of	ADP
bionys-650	86	29	age	age	NOUN
bionys-650	86	30	and	and	CCONJ
bionys-650	86	31	bmi	bmi	NOUN
bionys-650	86	32	between	between	ADP
bionys-650	86	33	t2d	t2d	NOUN
bionys-650	86	34	patients	patient	NOUN
bionys-650	86	35	and	and	CCONJ
bionys-650	86	36	the	the	DET
bionys-650	86	37	control	control	PROPN
bionys-650	86	38	group	group	PROPN
bionys-650	87	1	biologica	biologica	PROPN
bionys-650	87	2	nyssana	nyssana	PROPN
bionys-650	87	3	●	●	PUNCT
bionys-650	87	4	16	16	NUM
bionys-650	87	5	(	(	PUNCT
bionys-650	87	6	2	2	NUM
bionys-650	87	7	)	)	PUNCT
bionys-650	87	8	december	december	PROPN
bionys-650	87	9	2025	2025	NUM
bionys-650	87	10	:	:	PUNCT
bionys-650	87	11	kadhim	kadhim	PROPN
bionys-650	87	12	et	et	PROPN
bionys-650	87	13	al	al	PROPN
bionys-650	87	14	.	.	PUNCT
bionys-650	88	1	●	●	PUNCT
bionys-650	88	2	the	the	DET
bionys-650	88	3	association	association	NOUN
bionys-650	88	4	of	of	ADP
bionys-650	88	5	vitamin	vitamin	NOUN
bionys-650	88	6	d	d	PROPN
bionys-650	88	7	,	,	PUNCT
bionys-650	88	8	vitamin	vitamin	NOUN
bionys-650	88	9	d	d	NOUN
bionys-650	88	10	-	-	ADJ
bionys-650	88	11	binding	bind	VERB
bionys-650	88	12	protein	protein	NOUN
bionys-650	88	13	,	,	PUNCT
bionys-650	88	14	and	and	CCONJ
bionys-650	88	15	ferritin	ferritin	ADJ
bionys-650	88	16	levels	level	NOUN
bionys-650	88	17	in	in	ADP
bionys-650	88	18	iraqi	iraqi	ADJ
bionys-650	88	19	men	man	NOUN
bionys-650	88	20	with	with	ADP
bionys-650	88	21	type	type	NOUN
bionys-650	88	22	2	2	NUM
bionys-650	88	23	diabetes	diabetes	NOUN
bionys-650	88	24	2	2	NUM
bionys-650	88	25	diabetes	diabetes	NOUN
bionys-650	88	26	(	(	PUNCT
bionys-650	88	27	152.32±40.00	152.32±40.00	NUM
bionys-650	88	28	mg	mg	PROPN
bionys-650	88	29	/	/	SYM
bionys-650	88	30	dl	dl	PROPN
bionys-650	88	31	)	)	PUNCT
bionys-650	88	32	compared	compare	VERB
bionys-650	88	33	to	to	ADP
bionys-650	88	34	the	the	DET
bionys-650	88	35	non	non	ADJ
bionys-650	88	36	-	-	ADJ
bionys-650	88	37	diabetic	diabetic	ADJ
bionys-650	88	38	control	control	NOUN
bionys-650	88	39	group	group	NOUN
bionys-650	88	40	(	(	PUNCT
bionys-650	88	41	87.67±5.94	87.67±5.94	NUM
bionys-650	88	42	mg	mg	PROPN
bionys-650	88	43	/	/	SYM
bionys-650	88	44	dl	dl	PROPN
bionys-650	88	45	)	)	PUNCT
bionys-650	88	46	,	,	PUNCT
bionys-650	88	47	with	with	ADP
bionys-650	88	48	the	the	DET
bionys-650	88	49	difference	difference	NOUN
bionys-650	88	50	reaching	reach	VERB
bionys-650	88	51	high	high	ADJ
bionys-650	88	52	statistical	statistical	ADJ
bionys-650	88	53	significance	significance	NOUN
bionys-650	88	54	(	(	PUNCT
bionys-650	88	55	p<0.001	p<0.001	PROPN
bionys-650	88	56	)	)	PUNCT
bionys-650	88	57	.	.	PUNCT
bionys-650	89	1	this	this	DET
bionys-650	89	2	hyperglycemic	hyperglycemic	ADJ
bionys-650	89	3	state	state	NOUN
bionys-650	89	4	is	be	AUX
bionys-650	89	5	indicative	indicative	ADJ
bionys-650	89	6	of	of	ADP
bionys-650	89	7	impaired	impaired	ADJ
bionys-650	89	8	glucose	glucose	NOUN
bionys-650	89	9	homeostasis	homeostasis	NOUN
bionys-650	89	10	,	,	PUNCT
bionys-650	89	11	primarily	primarily	ADV
bionys-650	89	12	driven	drive	VERB
bionys-650	89	13	by	by	ADP
bionys-650	89	14	insulin	insulin	NOUN
bionys-650	89	15	resistance	resistance	NOUN
bionys-650	89	16	,	,	PUNCT
bionys-650	89	17	a	a	DET
bionys-650	89	18	central	central	ADJ
bionys-650	89	19	mechanism	mechanism	NOUN
bionys-650	89	20	in	in	ADP
bionys-650	89	21	the	the	DET
bionys-650	89	22	pathogenesis	pathogenesis	NOUN
bionys-650	89	23	of	of	ADP
bionys-650	89	24	t2d	t2d	NOUN
bionys-650	89	25	.	.	PUNCT
bionys-650	90	1	the	the	DET
bionys-650	90	2	finding	finding	NOUN
bionys-650	90	3	aligns	align	VERB
bionys-650	90	4	with	with	ADP
bionys-650	90	5	established	establish	VERB
bionys-650	90	6	literature	literature	NOUN
bionys-650	90	7	recognizing	recognize	VERB
bionys-650	90	8	persistently	persistently	ADV
bionys-650	90	9	elevated	elevate	VERB
bionys-650	90	10	glucose	glucose	NOUN
bionys-650	90	11	levels	level	NOUN
bionys-650	90	12	as	as	ADP
bionys-650	90	13	a	a	DET
bionys-650	90	14	key	key	ADJ
bionys-650	90	15	clinical	clinical	ADJ
bionys-650	90	16	marker	marker	NOUN
bionys-650	90	17	in	in	ADP
bionys-650	90	18	the	the	DET
bionys-650	90	19	diagnosis	diagnosis	NOUN
bionys-650	90	20	and	and	CCONJ
bionys-650	90	21	progression	progression	NOUN
bionys-650	90	22	of	of	ADP
bionys-650	90	23	type	type	NOUN
bionys-650	90	24	2	2	NUM
bionys-650	90	25	diabetes	diabetes	NOUN
bionys-650	90	26	.	.	PUNCT
bionys-650	91	1	although	although	SCONJ
bionys-650	91	2	insulin	insulin	NOUN
bionys-650	91	3	levels	level	NOUN
bionys-650	91	4	did	do	AUX
bionys-650	91	5	not	not	PART
bionys-650	91	6	differ	differ	VERB
bionys-650	91	7	significantly	significantly	ADV
bionys-650	91	8	between	between	ADP
bionys-650	91	9	the	the	DET
bionys-650	91	10	diabetic	diabetic	ADJ
bionys-650	91	11	and	and	CCONJ
bionys-650	91	12	control	control	NOUN
bionys-650	91	13	groups	group	NOUN
bionys-650	91	14	(	(	PUNCT
bionys-650	91	15	12.60±5.23	12.60±5.23	NUM
bionys-650	91	16	mu	mu	NOUN
bionys-650	91	17	/	/	SYM
bionys-650	91	18	l	l	NOUN
bionys-650	91	19	vs.	vs.	ADP
bionys-650	91	20	11.63±3.89	11.63±3.89	NUM
bionys-650	91	21	mu	mu	NOUN
bionys-650	91	22	/	/	SYM
bionys-650	91	23	l	l	NOUN
bionys-650	91	24	;	;	PUNCT
bionys-650	91	25	p=0.252	p=0.252	NUM
bionys-650	91	26	)	)	PUNCT
bionys-650	91	27	,	,	PUNCT
bionys-650	91	28	this	this	PRON
bionys-650	91	29	does	do	AUX
bionys-650	91	30	not	not	PART
bionys-650	91	31	reflect	reflect	VERB
bionys-650	91	32	practical	practical	ADJ
bionys-650	91	33	metabolic	metabolic	NOUN
bionys-650	91	34	function	function	NOUN
bionys-650	91	35	in	in	ADP
bionys-650	91	36	t2d	t2d	NOUN
bionys-650	91	37	patients	patient	NOUN
bionys-650	91	38	.	.	PUNCT
bionys-650	92	1	despite	despite	SCONJ
bionys-650	92	2	near	near	ADV
bionys-650	92	3	-	-	PUNCT
bionys-650	92	4	normal	normal	ADJ
bionys-650	92	5	circulating	circulate	VERB
bionys-650	92	6	insulin	insulin	NOUN
bionys-650	92	7	levels	level	NOUN
bionys-650	92	8	,	,	PUNCT
bionys-650	92	9	the	the	DET
bionys-650	92	10	elevated	elevated	ADJ
bionys-650	92	11	blood	blood	NOUN
bionys-650	92	12	glucose	glucose	NOUN
bionys-650	92	13	observed	observe	VERB
bionys-650	92	14	in	in	ADP
bionys-650	92	15	the	the	DET
bionys-650	92	16	diabetic	diabetic	ADJ
bionys-650	92	17	group	group	NOUN
bionys-650	92	18	suggests	suggest	VERB
bionys-650	92	19	underlying	underlie	VERB
bionys-650	92	20	insulin	insulin	NOUN
bionys-650	92	21	resistance	resistance	NOUN
bionys-650	92	22	.	.	PUNCT
bionys-650	93	1	this	this	DET
bionys-650	93	2	condition	condition	NOUN
bionys-650	93	3	impairs	impair	VERB
bionys-650	93	4	the	the	DET
bionys-650	93	5	hormone	hormone	NOUN
bionys-650	93	6	’s	’s	PART
bionys-650	93	7	ability	ability	NOUN
bionys-650	93	8	to	to	PART
bionys-650	93	9	facilitate	facilitate	VERB
bionys-650	93	10	glucose	glucose	NOUN
bionys-650	93	11	uptake	uptake	NOUN
bionys-650	93	12	in	in	ADP
bionys-650	93	13	peripheral	peripheral	ADJ
bionys-650	93	14	tissues	tissue	NOUN
bionys-650	93	15	,	,	PUNCT
bionys-650	93	16	a	a	DET
bionys-650	93	17	hallmark	hallmark	NOUN
bionys-650	93	18	of	of	ADP
bionys-650	93	19	type	type	NOUN
bionys-650	93	20	2	2	NUM
bionys-650	93	21	diabetes	diabetes	NOUN
bionys-650	93	22	.	.	PUNCT
bionys-650	94	1	previous	previous	ADJ
bionys-650	94	2	studies	study	NOUN
bionys-650	94	3	have	have	AUX
bionys-650	94	4	similarly	similarly	ADV
bionys-650	94	5	reported	report	VERB
bionys-650	94	6	that	that	SCONJ
bionys-650	94	7	individuals	individual	NOUN
bionys-650	94	8	with	with	ADP
bionys-650	94	9	t2d	t2d	NUM
bionys-650	94	10	may	may	AUX
bionys-650	94	11	exhibit	exhibit	VERB
bionys-650	94	12	normal	normal	ADJ
bionys-650	94	13	or	or	CCONJ
bionys-650	94	14	even	even	ADV
bionys-650	94	15	elevated	elevated	ADJ
bionys-650	94	16	insulin	insulin	NOUN
bionys-650	94	17	concentrations	concentration	NOUN
bionys-650	94	18	due	due	ADJ
bionys-650	94	19	to	to	ADP
bionys-650	94	20	compensatory	compensatory	ADJ
bionys-650	94	21	β	β	NOUN
bionys-650	94	22	-	-	NOUN
bionys-650	94	23	cell	cell	NOUN
bionys-650	94	24	activity	activity	NOUN
bionys-650	94	25	.	.	PUNCT
bionys-650	95	1	however	however	ADV
bionys-650	95	2	,	,	PUNCT
bionys-650	95	3	the	the	DET
bionys-650	95	4	presence	presence	NOUN
bionys-650	95	5	of	of	ADP
bionys-650	95	6	insulin	insulin	NOUN
bionys-650	95	7	alone	alone	ADV
bionys-650	95	8	is	be	AUX
bionys-650	95	9	not	not	PART
bionys-650	95	10	indicative	indicative	ADJ
bionys-650	95	11	of	of	ADP
bionys-650	95	12	glycemic	glycemic	ADJ
bionys-650	95	13	control	control	NOUN
bionys-650	95	14	in	in	ADP
bionys-650	95	15	the	the	DET
bionys-650	95	16	context	context	NOUN
bionys-650	95	17	of	of	ADP
bionys-650	95	18	resistance	resistance	NOUN
bionys-650	95	19	.	.	PUNCT
bionys-650	96	1	consistent	consistent	ADJ
bionys-650	96	2	with	with	ADP
bionys-650	96	3	this	this	PRON
bionys-650	96	4	,	,	PUNCT
bionys-650	96	5	the	the	DET
bionys-650	96	6	current	current	ADJ
bionys-650	96	7	study	study	NOUN
bionys-650	96	8	demonstrated	demonstrate	VERB
bionys-650	96	9	a	a	DET
bionys-650	96	10	significant	significant	ADJ
bionys-650	96	11	rise	rise	NOUN
bionys-650	96	12	in	in	ADP
bionys-650	96	13	insulin	insulin	NOUN
bionys-650	96	14	resistance	resistance	NOUN
bionys-650	96	15	among	among	ADP
bionys-650	96	16	diabetic	diabetic	ADJ
bionys-650	96	17	participants	participant	NOUN
bionys-650	96	18	(	(	PUNCT
bionys-650	96	19	4.72±2.34	4.72±2.34	NOUN
bionys-650	96	20	)	)	PUNCT
bionys-650	96	21	compared	compare	VERB
bionys-650	96	22	to	to	ADP
bionys-650	96	23	controls	control	NOUN
bionys-650	96	24	(	(	PUNCT
bionys-650	96	25	2.52±0.85	2.52±0.85	NOUN
bionys-650	96	26	)	)	PUNCT
bionys-650	96	27	,	,	PUNCT
bionys-650	96	28	with	with	ADP
bionys-650	96	29	a	a	DET
bionys-650	96	30	p	p	NOUN
bionys-650	96	31	-	-	PUNCT
bionys-650	96	32	value	value	NOUN
bionys-650	96	33	<	<	X
bionys-650	96	34	0.001	0.001	NUM
bionys-650	96	35	.	.	PUNCT
bionys-650	97	1	these	these	DET
bionys-650	97	2	findings	finding	NOUN
bionys-650	97	3	reinforce	reinforce	VERB
bionys-650	97	4	the	the	DET
bionys-650	97	5	clinical	clinical	ADJ
bionys-650	97	6	understanding	understanding	NOUN
bionys-650	97	7	that	that	SCONJ
bionys-650	97	8	insulin	insulin	NOUN
bionys-650	97	9	resistance	resistance	NOUN
bionys-650	97	10	plays	play	VERB
bionys-650	97	11	a	a	DET
bionys-650	97	12	central	central	ADJ
bionys-650	97	13	role	role	NOUN
bionys-650	97	14	in	in	ADP
bionys-650	97	15	the	the	DET
bionys-650	97	16	pathogenesis	pathogenesis	NOUN
bionys-650	97	17	and	and	CCONJ
bionys-650	97	18	progression	progression	NOUN
bionys-650	97	19	of	of	ADP
bionys-650	97	20	t2d	t2d	NOUN
bionys-650	97	21	(	(	PUNCT
bionys-650	97	22	american	american	ADJ
bionys-650	97	23	diabetes	diabetes	PROPN
bionys-650	97	24	association	association	NOUN
bionys-650	97	25	,	,	PUNCT
bionys-650	97	26	2018	2018	NUM
bionys-650	97	27	)	)	PUNCT
bionys-650	97	28	.	.	PUNCT
bionys-650	98	1	no	no	DET
bionys-650	98	2	statistically	statistically	ADV
bionys-650	98	3	significant	significant	ADJ
bionys-650	98	4	difference	difference	NOUN
bionys-650	98	5	in	in	ADP
bionys-650	98	6	serum	serum	NOUN
bionys-650	98	7	ferritin	ferritin	ADJ
bionys-650	98	8	levels	level	NOUN
bionys-650	98	9	was	be	AUX
bionys-650	98	10	observed	observe	VERB
bionys-650	98	11	between	between	ADP
bionys-650	98	12	type	type	NOUN
bionys-650	98	13	2	2	NUM
bionys-650	98	14	diabetes	diabetes	NOUN
bionys-650	98	15	patients	patient	NOUN
bionys-650	98	16	and	and	CCONJ
bionys-650	98	17	the	the	DET
bionys-650	98	18	control	control	NOUN
bionys-650	98	19	group	group	NOUN
bionys-650	98	20	(	(	PUNCT
bionys-650	98	21	64.65±19.32	64.65±19.32	NOUN
bionys-650	98	22	ng/	ng/	ADJ
bionys-650	98	23	ml	ml	NOUN
bionys-650	98	24	vs.	vs.	ADP
bionys-650	98	25	61.32±16.08	61.32±16.08	NUM
bionys-650	98	26	ng	ng	PROPN
bionys-650	98	27	/	/	SYM
bionys-650	98	28	ml	ml	PROPN
bionys-650	98	29	;	;	PUNCT
bionys-650	98	30	p=0.307	p=0.307	NUM
bionys-650	98	31	)	)	PUNCT
bionys-650	98	32	.	.	PUNCT
bionys-650	99	1	this	this	DET
bionys-650	99	2	result	result	VERB
bionys-650	99	3	while	while	SCONJ
bionys-650	99	4	t2d	t2d	NOUN
bionys-650	99	5	patients	patient	NOUN
bionys-650	99	6	had	have	VERB
bionys-650	99	7	a	a	DET
bionys-650	99	8	mean	mean	NOUN
bionys-650	99	9	of	of	ADP
bionys-650	99	10	64.65	64.65	NUM
bionys-650	99	11	ng	ng	NOUN
bionys-650	99	12	/	/	SYM
bionys-650	99	13	ml	ml	PROPN
bionys-650	99	14	(	(	PUNCT
bionys-650	99	15	±19.32	±19.32	PROPN
bionys-650	99	16	)	)	PUNCT
bionys-650	99	17	(	(	PUNCT
bionys-650	99	18	p=0.307	p=0.307	NOUN
bionys-650	99	19	)	)	PUNCT
bionys-650	99	20	,	,	PUNCT
bionys-650	99	21	suggesting	suggest	VERB
bionys-650	99	22	limited	limited	ADJ
bionys-650	99	23	relevance	relevance	NOUN
bionys-650	99	24	in	in	ADP
bionys-650	99	25	differentiating	differentiate	VERB
bionys-650	99	26	disease	disease	NOUN
bionys-650	99	27	status	status	NOUN
bionys-650	99	28	.	.	PUNCT
bionys-650	100	1	tab	tab	NOUN
bionys-650	100	2	.	.	PUNCT
bionys-650	101	1	3	3	X
bionys-650	101	2	.	.	X
bionys-650	101	3	presents	present	VERB
bionys-650	101	4	the	the	DET
bionys-650	101	5	serum	serum	NOUN
bionys-650	101	6	concentrations	concentration	NOUN
bionys-650	101	7	of	of	ADP
bionys-650	101	8	vitamin	vitamin	NOUN
bionys-650	101	9	d3	d3	PROPN
bionys-650	101	10	and	and	CCONJ
bionys-650	101	11	vdbp	vdbp	NOUN
bionys-650	101	12	parameters	parameter	NOUN
bionys-650	101	13	in	in	ADP
bionys-650	101	14	both	both	DET
bionys-650	101	15	study	study	NOUN
bionys-650	101	16	groups	group	NOUN
bionys-650	101	17	.	.	PUNCT
bionys-650	102	1	the	the	DET
bionys-650	102	2	mean	mean	ADJ
bionys-650	102	3	vitamin	vitamin	NOUN
bionys-650	102	4	d3	d3	PROPN
bionys-650	102	5	level	level	NOUN
bionys-650	102	6	in	in	ADP
bionys-650	102	7	the	the	DET
bionys-650	102	8	control	control	NOUN
bionys-650	102	9	group	group	NOUN
bionys-650	102	10	was	be	AUX
bionys-650	102	11	26.63	26.63	NUM
bionys-650	102	12	ng	ng	PROPN
bionys-650	102	13	/	/	SYM
bionys-650	102	14	ml	ml	PROPN
bionys-650	102	15	(	(	PUNCT
bionys-650	102	16	±14.68	±14.68	NOUN
bionys-650	102	17	)	)	PUNCT
bionys-650	102	18	,	,	PUNCT
bionys-650	102	19	slightly	slightly	ADV
bionys-650	102	20	higher	high	ADJ
bionys-650	102	21	than	than	ADP
bionys-650	102	22	in	in	ADP
bionys-650	102	23	the	the	DET
bionys-650	102	24	t2d	t2d	NOUN
bionys-650	102	25	group	group	NOUN
bionys-650	102	26	,	,	PUNCT
bionys-650	102	27	which	which	PRON
bionys-650	102	28	averaged	average	VERB
bionys-650	102	29	22.11	22.11	NUM
bionys-650	102	30	ng	ng	PROPN
bionys-650	102	31	/	/	SYM
bionys-650	102	32	ml	ml	PROPN
bionys-650	102	33	(	(	PUNCT
bionys-650	102	34	±12.55	±12.55	NOUN
bionys-650	102	35	)	)	PUNCT
bionys-650	102	36	.	.	PUNCT
bionys-650	103	1	although	although	SCONJ
bionys-650	103	2	the	the	DET
bionys-650	103	3	diabetic	diabetic	ADJ
bionys-650	103	4	group	group	NOUN
bionys-650	103	5	demonstrated	demonstrate	VERB
bionys-650	103	6	lower	low	ADJ
bionys-650	103	7	levels	level	NOUN
bionys-650	103	8	,	,	PUNCT
bionys-650	103	9	the	the	DET
bionys-650	103	10	difference	difference	NOUN
bionys-650	103	11	was	be	AUX
bionys-650	103	12	not	not	PART
bionys-650	103	13	statistically	statistically	ADV
bionys-650	103	14	significant	significant	ADJ
bionys-650	103	15	(	(	PUNCT
bionys-650	103	16	p=0.072	p=0.072	NOUN
bionys-650	103	17	)	)	PUNCT
bionys-650	103	18	.	.	PUNCT
bionys-650	104	1	vdbp	vdbp	NOUN
bionys-650	104	2	levels	level	NOUN
bionys-650	104	3	were	be	AUX
bionys-650	104	4	significantly	significantly	ADV
bionys-650	104	5	reduced	reduce	VERB
bionys-650	104	6	in	in	ADP
bionys-650	104	7	the	the	DET
bionys-650	104	8	diabetic	diabetic	ADJ
bionys-650	104	9	group	group	NOUN
bionys-650	104	10	,	,	PUNCT
bionys-650	104	11	averaging	average	VERB
bionys-650	104	12	135.71	135.71	NUM
bionys-650	104	13	ng/	ng/	ADJ
bionys-650	104	14	ml	ml	NOUN
bionys-650	104	15	(	(	PUNCT
bionys-650	104	16	±20.29	±20.29	NOUN
bionys-650	104	17	)	)	PUNCT
bionys-650	104	18	compared	compare	VERB
bionys-650	104	19	to	to	ADP
bionys-650	104	20	159.66	159.66	NUM
bionys-650	104	21	ng	ng	PROPN
bionys-650	104	22	/	/	SYM
bionys-650	104	23	ml	ml	PROPN
bionys-650	104	24	(	(	PUNCT
bionys-650	104	25	±28.36	±28.36	NOUN
bionys-650	104	26	)	)	PUNCT
bionys-650	104	27	in	in	ADP
bionys-650	104	28	controls	control	NOUN
bionys-650	104	29	(	(	PUNCT
bionys-650	104	30	p=0.001	p=0.001	NUM
bionys-650	104	31	)	)	PUNCT
bionys-650	104	32	,	,	PUNCT
bionys-650	104	33	suggesting	suggest	VERB
bionys-650	104	34	impaired	impaired	ADJ
bionys-650	104	35	vitamin	vitamin	NOUN
bionys-650	104	36	d	d	NOUN
bionys-650	104	37	transport	transport	NOUN
bionys-650	104	38	capacity	capacity	NOUN
bionys-650	104	39	.	.	PUNCT
bionys-650	105	1	liver	liver	NOUN
bionys-650	105	2	function	function	NOUN
bionys-650	105	3	results	result	NOUN
bionys-650	105	4	(	(	PUNCT
bionys-650	105	5	tab	tab	NOUN
bionys-650	105	6	.	.	PUNCT
bionys-650	105	7	4	4	NUM
bionys-650	105	8	.	.	PUNCT
bionys-650	105	9	)	)	PUNCT
bionys-650	105	10	indicate	indicate	VERB
bionys-650	105	11	that	that	SCONJ
bionys-650	105	12	tsb	tsb	PROPN
bionys-650	105	13	was	be	AUX
bionys-650	105	14	significantly	significantly	ADV
bionys-650	105	15	higher	high	ADJ
bionys-650	105	16	in	in	ADP
bionys-650	105	17	t2d	t2d	NOUN
bionys-650	105	18	patients	patient	NOUN
bionys-650	105	19	(	(	PUNCT
bionys-650	105	20	0.83	0.83	NUM
bionys-650	105	21	mg	mg	PROPN
bionys-650	105	22	/	/	SYM
bionys-650	105	23	dl	dl	PROPN
bionys-650	105	24	±	±	PROPN
bionys-650	105	25	0.087	0.087	NUM
bionys-650	105	26	)	)	PUNCT
bionys-650	105	27	compared	compare	VERB
bionys-650	105	28	to	to	ADP
bionys-650	105	29	the	the	DET
bionys-650	105	30	control	control	NOUN
bionys-650	105	31	group	group	NOUN
bionys-650	105	32	(	(	PUNCT
bionys-650	105	33	0.79	0.79	NUM
bionys-650	105	34	mg	mg	PROPN
bionys-650	105	35	/	/	SYM
bionys-650	105	36	dl	dl	PROPN
bionys-650	105	37	±	±	NUM
bionys-650	105	38	0.090	0.090	NUM
bionys-650	105	39	)	)	PUNCT
bionys-650	105	40	,	,	PUNCT
bionys-650	105	41	with	with	ADP
bionys-650	105	42	a	a	DET
bionys-650	105	43	p	p	NOUN
bionys-650	105	44	-	-	PUNCT
bionys-650	105	45	value	value	NOUN
bionys-650	105	46	of	of	ADP
bionys-650	105	47	0.015	0.015	NUM
bionys-650	105	48	.	.	PUNCT
bionys-650	106	1	no	no	DET
bionys-650	106	2	significant	significant	ADJ
bionys-650	106	3	difference	difference	NOUN
bionys-650	106	4	was	be	AUX
bionys-650	106	5	observed	observe	VERB
bionys-650	106	6	in	in	ADP
bionys-650	106	7	gpt	gpt	NOUN
bionys-650	106	8	levels	level	NOUN
bionys-650	106	9	(	(	PUNCT
bionys-650	106	10	t2d	t2d	NUM
bionys-650	106	11	:	:	PUNCT
bionys-650	106	12	30.42±5.91	30.42±5.91	NUM
bionys-650	106	13	iu	iu	PROPN
bionys-650	106	14	/	/	SYM
bionys-650	106	15	l	l	NOUN
bionys-650	106	16	;	;	PUNCT
bionys-650	106	17	control	control	NOUN
bionys-650	106	18	:	:	PUNCT
bionys-650	106	19	31.38±6.02	31.38±6.02	NUM
bionys-650	106	20	iu	iu	ADP
bionys-650	106	21	/	/	SYM
bionys-650	106	22	l	l	NOUN
bionys-650	106	23	;	;	PUNCT
bionys-650	106	24	p=0.377	p=0.377	NUM
bionys-650	106	25	)	)	PUNCT
bionys-650	106	26	.	.	PUNCT
bionys-650	107	1	however	however	ADV
bionys-650	107	2	,	,	PUNCT
bionys-650	107	3	got	get	VERB
bionys-650	107	4	levels	level	NOUN
bionys-650	107	5	were	be	AUX
bionys-650	107	6	significantly	significantly	ADV
bionys-650	107	7	elevated	elevate	VERB
bionys-650	107	8	in	in	ADP
bionys-650	107	9	t2d	t2d	NOUN
bionys-650	107	10	patients	patient	NOUN
bionys-650	107	11	(	(	PUNCT
bionys-650	107	12	29.38±5.52	29.38±5.52	NUM
bionys-650	107	13	iu	iu	ADP
bionys-650	107	14	/	/	SYM
bionys-650	107	15	l	l	NOUN
bionys-650	107	16	)	)	PUNCT
bionys-650	107	17	compared	compare	VERB
bionys-650	107	18	to	to	ADP
bionys-650	107	19	controls	control	NOUN
bionys-650	107	20	(	(	PUNCT
bionys-650	107	21	26.73±5.46	26.73±5.46	NUM
bionys-650	107	22	iu	iu	PROPN
bionys-650	107	23	/	/	SYM
bionys-650	107	24	l	l	NOUN
bionys-650	107	25	)	)	PUNCT
bionys-650	107	26	,	,	PUNCT
bionys-650	107	27	with	with	ADP
bionys-650	107	28	a	a	DET
bionys-650	107	29	p	p	NOUN
bionys-650	107	30	-	-	PUNCT
bionys-650	107	31	value	value	NOUN
bionys-650	107	32	of	of	ADP
bionys-650	107	33	0.009	0.009	NUM
bionys-650	107	34	.	.	PUNCT
bionys-650	108	1	alp	alp	PROPN
bionys-650	108	2	levels	level	NOUN
bionys-650	108	3	did	do	AUX
bionys-650	108	4	not	not	PART
bionys-650	108	5	differ	differ	VERB
bionys-650	108	6	significantly	significantly	ADV
bionys-650	108	7	between	between	ADP
bionys-650	108	8	the	the	DET
bionys-650	108	9	groups	group	NOUN
bionys-650	108	10	(	(	PUNCT
bionys-650	108	11	t2d	t2d	NUM
bionys-650	108	12	:	:	PUNCT
bionys-650	108	13	78.70	78.70	NUM
bionys-650	108	14	iu	iu	PROPN
bionys-650	108	15	/	/	SYM
bionys-650	108	16	l	l	NOUN
bionys-650	108	17	±9.97	±9.97	NOUN
bionys-650	108	18	;	;	PUNCT
bionys-650	108	19	control	control	NOUN
bionys-650	108	20	:	:	PUNCT
bionys-650	108	21	76.63	76.63	NUM
bionys-650	108	22	iu	iu	PROPN
bionys-650	108	23	/	/	SYM
bionys-650	108	24	l	l	NOUN
bionys-650	108	25	±10.84	±10.84	NOUN
bionys-650	108	26	;	;	PUNCT
bionys-650	108	27	p=0.279	p=0.279	NUM
bionys-650	108	28	)	)	PUNCT
bionys-650	108	29	.	.	PUNCT
bionys-650	109	1	kidney	kidney	NOUN
bionys-650	109	2	function	function	NOUN
bionys-650	109	3	assessments	assessment	NOUN
bionys-650	109	4	(	(	PUNCT
bionys-650	109	5	tab	tab	NOUN
bionys-650	109	6	.	.	PUNCT
bionys-650	110	1	5	5	NUM
bionys-650	110	2	.	.	PUNCT
bionys-650	110	3	)	)	PUNCT
bionys-650	111	1	showed	show	VERB
bionys-650	111	2	no	no	DET
bionys-650	111	3	significant	significant	ADJ
bionys-650	111	4	differences	difference	NOUN
bionys-650	111	5	.	.	PUNCT
bionys-650	112	1	blood	blood	NOUN
bionys-650	112	2	urea	urea	NOUN
bionys-650	112	3	levels	level	NOUN
bionys-650	112	4	were	be	AUX
bionys-650	112	5	comparable	comparable	ADJ
bionys-650	112	6	between	between	ADP
bionys-650	112	7	t2d	t2d	NOUN
bionys-650	112	8	(	(	PUNCT
bionys-650	112	9	31.85±4.70	31.85±4.70	NUM
bionys-650	112	10	mg	mg	PROPN
bionys-650	112	11	/	/	SYM
bionys-650	112	12	dl	dl	PROPN
bionys-650	112	13	)	)	PUNCT
bionys-650	112	14	and	and	CCONJ
bionys-650	112	15	control	control	NOUN
bionys-650	112	16	subjects	subject	NOUN
bionys-650	112	17	(	(	PUNCT
bionys-650	112	18	32.05±4.25	32.05±4.25	NUM
bionys-650	112	19	mg	mg	PROPN
bionys-650	112	20	/	/	SYM
bionys-650	112	21	dl	dl	PROPN
bionys-650	112	22	;	;	PUNCT
bionys-650	112	23	p=0.807	p=0.807	NUM
bionys-650	112	24	)	)	PUNCT
bionys-650	112	25	.	.	PUNCT
bionys-650	113	1	similarly	similarly	ADV
bionys-650	113	2	,	,	PUNCT
bionys-650	113	3	serum	serum	PROPN
bionys-650	113	4	creatinine	creatinine	NOUN
bionys-650	113	5	values	value	NOUN
bionys-650	113	6	were	be	AUX
bionys-650	113	7	consistent	consistent	ADJ
bionys-650	113	8	,	,	PUNCT
bionys-650	113	9	with	with	ADP
bionys-650	113	10	t2d	t2d	NOUN
bionys-650	113	11	patients	patient	NOUN
bionys-650	113	12	recording	record	VERB
bionys-650	113	13	0.76	0.76	NUM
bionys-650	113	14	mg	mg	PROPN
bionys-650	113	15	/	/	SYM
bionys-650	113	16	dl	dl	PROPN
bionys-650	113	17	(	(	PUNCT
bionys-650	113	18	±0.12	±0.12	PROPN
bionys-650	113	19	)	)	PUNCT
bionys-650	113	20	and	and	CCONJ
bionys-650	113	21	controls	control	NOUN
bionys-650	113	22	at	at	ADP
bionys-650	113	23	0.73	0.73	NUM
bionys-650	113	24	mg	mg	PROPN
bionys-650	113	25	/	/	SYM
bionys-650	113	26	dl	dl	PROPN
bionys-650	113	27	(	(	PUNCT
bionys-650	113	28	±0.13	±0.13	PROPN
bionys-650	113	29	)	)	PUNCT
bionys-650	113	30	,	,	PUNCT
bionys-650	113	31	yielding	yield	VERB
bionys-650	113	32	a	a	DET
bionys-650	113	33	non	non	ADJ
bionys-650	113	34	-	-	ADJ
bionys-650	113	35	significant	significant	ADJ
bionys-650	113	36	p	p	NOUN
bionys-650	113	37	-	-	PUNCT
bionys-650	113	38	value	value	NOUN
bionys-650	113	39	of	of	ADP
bionys-650	113	40	0.185	0.185	NUM
bionys-650	113	41	.	.	PUNCT
bionys-650	114	1	a	a	DET
bionys-650	114	2	substantial	substantial	ADJ
bionys-650	114	3	elevation	elevation	NOUN
bionys-650	114	4	in	in	ADP
bionys-650	114	5	fasting	fast	VERB
bionys-650	114	6	blood	blood	NOUN
bionys-650	114	7	glucose	glucose	NOUN
bionys-650	114	8	was	be	AUX
bionys-650	114	9	identified	identify	VERB
bionys-650	114	10	in	in	ADP
bionys-650	114	11	individuals	individual	NOUN
bionys-650	114	12	with	with	ADP
bionys-650	114	13	type	type	NOUN
bionys-650	114	14	control	control	NOUN
bionys-650	114	15	group	group	NOUN
bionys-650	114	16	,	,	PUNCT
bionys-650	114	17	n=60	n=60	PROPN
bionys-650	114	18	t2d	t2d	NOUN
bionys-650	114	19	patients	patient	NOUN
bionys-650	114	20	,	,	PUNCT
bionys-650	114	21	n=60	n=60	NOUN
bionys-650	114	22	parameters	parameter	NOUN
bionys-650	114	23	mean	mean	VERB
bionys-650	114	24	sd	sd	INTJ
bionys-650	114	25	mean	mean	VERB
bionys-650	114	26	sd	sd	ADP
bionys-650	114	27	p	p	ADJ
bionys-650	114	28	-	-	PUNCT
bionys-650	114	29	value	value	NOUN
bionys-650	114	30	glucose	glucose	NOUN
bionys-650	114	31	(	(	PUNCT
bionys-650	114	32	mg	mg	PROPN
bionys-650	114	33	/	/	SYM
bionys-650	114	34	dl	dl	PROPN
bionys-650	114	35	)	)	PUNCT
bionys-650	114	36	87.666	87.666	NUM
bionys-650	114	37	5.942	5.942	NUM
bionys-650	114	38	152.316	152.316	NUM
bionys-650	114	39	40.004	40.004	NUM
bionys-650	114	40	0.001	0.001	NUM
bionys-650	114	41	*	*	NOUN
bionys-650	114	42	*	*	NOUN
bionys-650	114	43	insulin	insulin	NOUN
bionys-650	114	44	(	(	PUNCT
bionys-650	114	45	mu	mu	NOUN
bionys-650	114	46	/	/	SYM
bionys-650	114	47	l	l	NOUN
bionys-650	114	48	)	)	PUNCT
bionys-650	114	49	11.633	11.633	NUM
bionys-650	114	50	3.894	3.894	NUM
bionys-650	114	51	12.601	12.601	NUM
bionys-650	114	52	5.229	5.229	NUM
bionys-650	114	53	0.252	0.252	NUM
bionys-650	114	54	insuline	insuline	ADJ
bionys-650	114	55	resistance	resistance	NOUN
bionys-650	114	56	2.516	2.516	NUM
bionys-650	114	57	0.852	0.852	NUM
bionys-650	114	58	4.722	4.722	NUM
bionys-650	114	59	2.338	2.338	NUM
bionys-650	114	60	0.001	0.001	NUM
bionys-650	114	61	*	*	PUNCT
bionys-650	114	62	ferritin	ferritin	ADJ
bionys-650	114	63	(	(	PUNCT
bionys-650	114	64	ng	ng	NOUN
bionys-650	114	65	/	/	SYM
bionys-650	114	66	ml	ml	PROPN
bionys-650	114	67	)	)	PUNCT
bionys-650	114	68	61.316	61.316	NUM
bionys-650	114	69	16.082	16.082	NUM
bionys-650	114	70	64.648	64.648	NUM
bionys-650	114	71	19.315	19.315	NUM
bionys-650	114	72	0.307	0.307	NUM
bionys-650	114	73	table	table	NOUN
bionys-650	114	74	2	2	NUM
bionys-650	114	75	.	.	PUNCT
bionys-650	115	1	the	the	DET
bionys-650	115	2	statistical	statistical	ADJ
bionys-650	115	3	disparities	disparity	NOUN
bionys-650	115	4	among	among	ADP
bionys-650	115	5	control	control	NOUN
bionys-650	115	6	and	and	CCONJ
bionys-650	115	7	t2d	t2d	NOUN
bionys-650	115	8	patients	patient	NOUN
bionys-650	115	9	for	for	ADP
bionys-650	115	10	t2d	t2d	NOUN
bionys-650	115	11	parameters	parameter	NOUN
bionys-650	115	12	*	*	PUNCT
bionys-650	115	13	significant	significant	ADJ
bionys-650	115	14	at	at	ADP
bionys-650	115	15	p≤0.05	p≤0.05	NOUN
bionys-650	115	16	,	,	PUNCT
bionys-650	115	17	*	*	PUNCT
bionys-650	115	18	*	*	PUNCT
bionys-650	115	19	highly	highly	ADV
bionys-650	115	20	significant	significant	ADJ
bionys-650	115	21	p<0.001	p<0.001	NOUN
bionys-650	115	22	,	,	PUNCT
bionys-650	115	23	ns	ns	NUM
bionys-650	115	24	:	:	PUNCT
bionys-650	115	25	non	non	ADJ
bionys-650	115	26	-	-	ADJ
bionys-650	115	27	significant	significant	ADJ
bionys-650	115	28	control	control	NOUN
bionys-650	115	29	group	group	NOUN
bionys-650	115	30	,	,	PUNCT
bionys-650	115	31	n=60	n=60	PROPN
bionys-650	115	32	t2d	t2d	NOUN
bionys-650	115	33	patients	patient	NOUN
bionys-650	115	34	,	,	PUNCT
bionys-650	115	35	n=60	n=60	NOUN
bionys-650	115	36	parameters	parameter	NOUN
bionys-650	115	37	mean	mean	VERB
bionys-650	115	38	sd	sd	INTJ
bionys-650	115	39	mean	mean	VERB
bionys-650	115	40	sd	sd	ADP
bionys-650	115	41	p	p	NOUN
bionys-650	115	42	-	-	PUNCT
bionys-650	115	43	value	value	NOUN
bionys-650	115	44	vita	vita	NOUN
bionys-650	115	45	.	.	PUNCT
bionys-650	116	1	d3	d3	PROPN
bionys-650	116	2	(	(	PUNCT
bionys-650	116	3	ng	ng	PROPN
bionys-650	116	4	/	/	SYM
bionys-650	116	5	ml	ml	PROPN
bionys-650	116	6	)	)	PUNCT
bionys-650	116	7	26.632	26.632	NUM
bionys-650	117	1	14.682	14.682	NUM
bionys-650	117	2	22.106	22.106	NUM
bionys-650	117	3	12.554	12.554	NUM
bionys-650	117	4	0.072	0.072	NUM
bionys-650	117	5	vdbp	vdbp	NOUN
bionys-650	117	6	(	(	PUNCT
bionys-650	117	7	ng	ng	NOUN
bionys-650	117	8	/	/	SYM
bionys-650	117	9	ml	ml	PROPN
bionys-650	117	10	)	)	PUNCT
bionys-650	117	11	159.66	159.66	NUM
bionys-650	117	12	28.362	28.362	NUM
bionys-650	117	13	135.71	135.71	NUM
bionys-650	117	14	20.286	20.286	NUM
bionys-650	117	15	0.001	0.001	NUM
bionys-650	117	16	*	*	NOUN
bionys-650	117	17	*	*	NOUN
bionys-650	117	18	table	table	NOUN
bionys-650	117	19	3	3	X
bionys-650	117	20	.	.	PUNCT
bionys-650	118	1	the	the	DET
bionys-650	118	2	statistical	statistical	ADJ
bionys-650	118	3	disparities	disparity	NOUN
bionys-650	118	4	among	among	ADP
bionys-650	118	5	control	control	NOUN
bionys-650	118	6	and	and	CCONJ
bionys-650	118	7	t2d	t2d	NOUN
bionys-650	118	8	patients	patient	NOUN
bionys-650	118	9	for	for	ADP
bionys-650	118	10	vitamin	vitamin	NOUN
bionys-650	118	11	d3	d3	PROPN
bionys-650	118	12	and	and	CCONJ
bionys-650	118	13	vdbp	vdbp	NOUN
bionys-650	118	14	*	*	PUNCT
bionys-650	118	15	significant	significant	ADJ
bionys-650	118	16	at	at	ADP
bionys-650	118	17	p≤0.05	p≤0.05	NOUN
bionys-650	118	18	,	,	PUNCT
bionys-650	118	19	*	*	PUNCT
bionys-650	118	20	*	*	PUNCT
bionys-650	118	21	highly	highly	ADV
bionys-650	118	22	significant	significant	ADJ
bionys-650	118	23	p<0.001	p<0.001	NOUN
bionys-650	118	24	,	,	PUNCT
bionys-650	118	25	ns	ns	NUM
bionys-650	118	26	:	:	PUNCT
bionys-650	118	27	non	non	ADJ
bionys-650	118	28	-	-	ADJ
bionys-650	118	29	significant	significant	ADJ
bionys-650	118	30	biologica	biologica	NOUN
bionys-650	118	31	nyssana	nyssana	PROPN
bionys-650	118	32	●	●	PUNCT
bionys-650	118	33	16	16	NUM
bionys-650	118	34	(	(	PUNCT
bionys-650	118	35	2	2	NUM
bionys-650	118	36	)	)	PUNCT
bionys-650	118	37	december	december	PROPN
bionys-650	118	38	2025	2025	NUM
bionys-650	118	39	:	:	PUNCT
bionys-650	118	40	kadhim	kadhim	PROPN
bionys-650	118	41	et	et	PROPN
bionys-650	118	42	al	al	PROPN
bionys-650	118	43	.	.	PUNCT
bionys-650	119	1	●	●	PUNCT
bionys-650	119	2	the	the	DET
bionys-650	119	3	association	association	NOUN
bionys-650	119	4	of	of	ADP
bionys-650	119	5	vitamin	vitamin	NOUN
bionys-650	119	6	d	d	PROPN
bionys-650	119	7	,	,	PUNCT
bionys-650	119	8	vitamin	vitamin	NOUN
bionys-650	119	9	d	d	NOUN
bionys-650	119	10	-	-	ADJ
bionys-650	119	11	binding	bind	VERB
bionys-650	119	12	protein	protein	NOUN
bionys-650	119	13	,	,	PUNCT
bionys-650	119	14	and	and	CCONJ
bionys-650	119	15	ferritin	ferritin	ADJ
bionys-650	119	16	levels	level	NOUN
bionys-650	119	17	in	in	ADP
bionys-650	119	18	iraqi	iraqi	ADJ
bionys-650	119	19	men	man	NOUN
bionys-650	119	20	with	with	ADP
bionys-650	119	21	type	type	NOUN
bionys-650	119	22	2	2	NUM
bionys-650	119	23	diabetes	diabetes	NOUN
bionys-650	119	24	in	in	ADP
bionys-650	119	25	diabetic	diabetic	ADJ
bionys-650	119	26	populations	population	NOUN
bionys-650	119	27	and	and	CCONJ
bionys-650	119	28	correlates	correlate	VERB
bionys-650	119	29	with	with	ADP
bionys-650	119	30	poorer	poor	ADJ
bionys-650	119	31	clinical	clinical	ADJ
bionys-650	119	32	outcomes	outcome	NOUN
bionys-650	119	33	,	,	PUNCT
bionys-650	119	34	supporting	support	VERB
bionys-650	119	35	its	its	PRON
bionys-650	119	36	role	role	NOUN
bionys-650	119	37	in	in	ADP
bionys-650	119	38	both	both	DET
bionys-650	119	39	disease	disease	NOUN
bionys-650	119	40	pathogenesis	pathogenesis	NOUN
bionys-650	119	41	and	and	CCONJ
bionys-650	119	42	therapeutic	therapeutic	ADJ
bionys-650	119	43	monitoring	monitoring	NOUN
bionys-650	119	44	(	(	PUNCT
bionys-650	119	45	arafat	arafat	PROPN
bionys-650	119	46	et	et	PROPN
bionys-650	119	47	al	al	PROPN
bionys-650	119	48	.	.	PROPN
bionys-650	119	49	,	,	PUNCT
bionys-650	119	50	2020	2020	NUM
bionys-650	119	51	)	)	PUNCT
bionys-650	119	52	.	.	PUNCT
bionys-650	120	1	the	the	DET
bionys-650	120	2	current	current	ADJ
bionys-650	120	3	study	study	NOUN
bionys-650	120	4	revealed	reveal	VERB
bionys-650	120	5	a	a	DET
bionys-650	120	6	highly	highly	ADV
bionys-650	120	7	significant	significant	ADJ
bionys-650	120	8	reduction	reduction	NOUN
bionys-650	120	9	in	in	ADP
bionys-650	120	10	vdbp	vdbp	NOUN
bionys-650	120	11	concentrations	concentration	NOUN
bionys-650	120	12	among	among	ADP
bionys-650	120	13	patients	patient	NOUN
bionys-650	120	14	with	with	ADP
bionys-650	120	15	type	type	NOUN
bionys-650	120	16	2	2	NUM
bionys-650	120	17	diabetes	diabetes	NOUN
bionys-650	120	18	(	(	PUNCT
bionys-650	120	19	135.71±20.29	135.71±20.29	NUM
bionys-650	120	20	ng	ng	NOUN
bionys-650	120	21	/	/	SYM
bionys-650	120	22	ml	ml	VERB
bionys-650	120	23	)	)	PUNCT
bionys-650	120	24	compared	compare	VERB
bionys-650	120	25	to	to	ADP
bionys-650	120	26	the	the	DET
bionys-650	120	27	control	control	NOUN
bionys-650	120	28	group	group	NOUN
bionys-650	120	29	(	(	PUNCT
bionys-650	120	30	159.66±28.36	159.66±28.36	NUM
bionys-650	120	31	ng/	ng/	ADJ
bionys-650	120	32	ml	ml	NOUN
bionys-650	120	33	)	)	PUNCT
bionys-650	120	34	,	,	PUNCT
bionys-650	120	35	with	with	ADP
bionys-650	120	36	a	a	DET
bionys-650	120	37	p	p	NOUN
bionys-650	120	38	-	-	PUNCT
bionys-650	120	39	value	value	NOUN
bionys-650	120	40	of	of	ADP
bionys-650	120	41	0.001	0.001	NUM
bionys-650	120	42	.	.	PUNCT
bionys-650	121	1	this	this	DET
bionys-650	121	2	decline	decline	NOUN
bionys-650	121	3	in	in	ADP
bionys-650	121	4	vdbp	vdbp	NOUN
bionys-650	121	5	may	may	AUX
bionys-650	121	6	compromise	compromise	VERB
bionys-650	121	7	the	the	DET
bionys-650	121	8	transport	transport	NOUN
bionys-650	121	9	efficiency	efficiency	NOUN
bionys-650	121	10	of	of	ADP
bionys-650	121	11	vitamin	vitamin	NOUN
bionys-650	121	12	d	d	NOUN
bionys-650	121	13	metabolites	metabolite	NOUN
bionys-650	121	14	in	in	ADP
bionys-650	121	15	the	the	DET
bionys-650	121	16	bloodstream	bloodstream	NOUN
bionys-650	121	17	,	,	PUNCT
bionys-650	121	18	potentially	potentially	ADV
bionys-650	121	19	reducing	reduce	VERB
bionys-650	121	20	their	their	PRON
bionys-650	121	21	bioavailability	bioavailability	NOUN
bionys-650	121	22	and	and	CCONJ
bionys-650	121	23	limiting	limit	VERB
bionys-650	121	24	cellular	cellular	ADJ
bionys-650	121	25	uptake	uptake	NOUN
bionys-650	121	26	at	at	ADP
bionys-650	121	27	target	target	NOUN
bionys-650	121	28	sites	site	NOUN
bionys-650	121	29	.	.	PUNCT
bionys-650	122	1	such	such	ADJ
bionys-650	122	2	disruption	disruption	NOUN
bionys-650	122	3	could	could	AUX
bionys-650	122	4	contribute	contribute	VERB
bionys-650	122	5	to	to	ADP
bionys-650	122	6	the	the	DET
bionys-650	122	7	metabolic	metabolic	NOUN
bionys-650	122	8	dysfunction	dysfunction	NOUN
bionys-650	122	9	associated	associate	VERB
bionys-650	122	10	with	with	ADP
bionys-650	122	11	t2d	t2d	NUM
bionys-650	122	12	,	,	PUNCT
bionys-650	122	13	despite	despite	SCONJ
bionys-650	122	14	the	the	DET
bionys-650	122	15	presence	presence	NOUN
bionys-650	122	16	of	of	ADP
bionys-650	122	17	measurable	measurable	ADJ
bionys-650	122	18	vitamin	vitamin	NOUN
bionys-650	122	19	d	d	NOUN
bionys-650	122	20	levels	level	NOUN
bionys-650	122	21	.	.	PUNCT
bionys-650	123	1	notably	notably	ADV
bionys-650	123	2	,	,	PUNCT
bionys-650	123	3	these	these	DET
bionys-650	123	4	findings	finding	NOUN
bionys-650	123	5	diverge	diverge	VERB
bionys-650	123	6	from	from	ADP
bionys-650	123	7	those	those	PRON
bionys-650	123	8	reported	report	VERB
bionys-650	123	9	,	,	PUNCT
bionys-650	123	10	which	which	PRON
bionys-650	123	11	found	find	VERB
bionys-650	123	12	no	no	DET
bionys-650	123	13	significant	significant	ADJ
bionys-650	123	14	differences	difference	NOUN
bionys-650	123	15	in	in	ADP
bionys-650	123	16	vdbp	vdbp	NOUN
bionys-650	123	17	levels	level	NOUN
bionys-650	123	18	between	between	ADP
bionys-650	123	19	individuals	individual	NOUN
bionys-650	123	20	with	with	ADP
bionys-650	123	21	diabetes	diabetes	NOUN
bionys-650	123	22	and	and	CCONJ
bionys-650	123	23	those	those	PRON
bionys-650	123	24	without	without	ADP
bionys-650	123	25	diabetes	diabetes	NOUN
bionys-650	123	26	.	.	PUNCT
bionys-650	124	1	the	the	DET
bionys-650	124	2	discrepancy	discrepancy	NOUN
bionys-650	124	3	may	may	AUX
bionys-650	124	4	be	be	AUX
bionys-650	124	5	attributed	attribute	VERB
bionys-650	124	6	to	to	ADP
bionys-650	124	7	population	population	NOUN
bionys-650	124	8	-	-	PUNCT
bionys-650	124	9	specific	specific	ADJ
bionys-650	124	10	factors	factor	NOUN
bionys-650	124	11	or	or	CCONJ
bionys-650	124	12	differences	difference	NOUN
bionys-650	124	13	in	in	ADP
bionys-650	124	14	study	study	NOUN
bionys-650	124	15	design	design	NOUN
bionys-650	124	16	,	,	PUNCT
bionys-650	124	17	underscoring	underscore	VERB
bionys-650	124	18	the	the	DET
bionys-650	124	19	need	need	NOUN
bionys-650	124	20	for	for	ADP
bionys-650	124	21	further	further	ADJ
bionys-650	124	22	investigation	investigation	NOUN
bionys-650	124	23	into	into	ADP
bionys-650	124	24	vdbp	vdbp	NOUN
bionys-650	124	25	’s	’s	PART
bionys-650	124	26	role	role	NOUN
bionys-650	124	27	in	in	ADP
bionys-650	124	28	vitamin	vitamin	NOUN
bionys-650	124	29	d	d	NOUN
bionys-650	124	30	metabolism	metabolism	NOUN
bionys-650	124	31	and	and	CCONJ
bionys-650	124	32	diabetes	diabetes	NOUN
bionys-650	124	33	pathogenesis	pathogenesis	NOUN
bionys-650	124	34	(	(	PUNCT
bionys-650	124	35	arafat	arafat	PROPN
bionys-650	124	36	et	et	PROPN
bionys-650	124	37	al	al	PROPN
bionys-650	124	38	.	.	PROPN
bionys-650	124	39	,	,	PUNCT
bionys-650	124	40	2020	2020	NUM
bionys-650	124	41	)	)	PUNCT
bionys-650	124	42	.	.	PUNCT
bionys-650	125	1	analysis	analysis	NOUN
bionys-650	125	2	of	of	ADP
bionys-650	125	3	liver	liver	NOUN
bionys-650	125	4	function	function	NOUN
bionys-650	125	5	parameters	parameter	NOUN
bionys-650	125	6	revealed	reveal	VERB
bionys-650	125	7	several	several	ADJ
bionys-650	125	8	biochemical	biochemical	ADJ
bionys-650	125	9	distinctions	distinction	NOUN
bionys-650	125	10	between	between	ADP
bionys-650	125	11	diabetic	diabetic	ADJ
bionys-650	125	12	patients	patient	NOUN
bionys-650	125	13	and	and	CCONJ
bionys-650	125	14	control	control	NOUN
bionys-650	125	15	subjects	subject	NOUN
bionys-650	125	16	.	.	PUNCT
bionys-650	126	1	tsb	tsb	PROPN
bionys-650	126	2	levels	level	NOUN
bionys-650	126	3	were	be	AUX
bionys-650	126	4	modest	modest	ADJ
bionys-650	126	5	but	but	CCONJ
bionys-650	126	6	significantly	significantly	ADV
bionys-650	126	7	elevated	elevate	VERB
bionys-650	126	8	in	in	ADP
bionys-650	126	9	the	the	DET
bionys-650	126	10	diabetic	diabetic	ADJ
bionys-650	126	11	group	group	NOUN
bionys-650	126	12	(	(	PUNCT
bionys-650	126	13	0.833±0.087	0.833±0.087	NOUN
bionys-650	126	14	mg	mg	PROPN
bionys-650	126	15	/	/	SYM
bionys-650	126	16	dl	dl	PROPN
bionys-650	126	17	)	)	PUNCT
bionys-650	126	18	compared	compare	VERB
bionys-650	126	19	to	to	ADP
bionys-650	126	20	controls	control	NOUN
bionys-650	126	21	(	(	PUNCT
bionys-650	126	22	0.793±0.090	0.793±0.090	NUM
bionys-650	126	23	mg	mg	PROPN
bionys-650	126	24	/	/	SYM
bionys-650	126	25	dl	dl	PROPN
bionys-650	126	26	)	)	PUNCT
bionys-650	126	27	,	,	PUNCT
bionys-650	126	28	with	with	ADP
bionys-650	126	29	a	a	DET
bionys-650	126	30	p	p	NOUN
bionys-650	126	31	-	-	PUNCT
bionys-650	126	32	value	value	NOUN
bionys-650	126	33	of	of	ADP
bionys-650	126	34	0.015	0.015	NUM
bionys-650	126	35	.	.	PUNCT
bionys-650	127	1	this	this	PRON
bionys-650	127	2	aligns	align	VERB
bionys-650	127	3	with	with	ADP
bionys-650	127	4	findings	finding	NOUN
bionys-650	127	5	that	that	SCONJ
bionys-650	127	6	elevated	elevated	ADJ
bionys-650	127	7	bilirubin	bilirubin	NOUN
bionys-650	127	8	may	may	AUX
bionys-650	127	9	be	be	AUX
bionys-650	127	10	linked	link	VERB
bionys-650	127	11	to	to	ADP
bionys-650	127	12	a	a	DET
bionys-650	127	13	higher	high	ADJ
bionys-650	127	14	risk	risk	NOUN
bionys-650	127	15	of	of	ADP
bionys-650	127	16	developing	develop	VERB
bionys-650	127	17	type	type	NOUN
bionys-650	127	18	2	2	NUM
bionys-650	127	19	diabetes	diabetes	NOUN
bionys-650	127	20	.	.	PUNCT
bionys-650	128	1	similarly	similarly	ADV
bionys-650	128	2	,	,	PUNCT
bionys-650	128	3	got	get	VERB
bionys-650	128	4	levels	level	NOUN
bionys-650	128	5	were	be	AUX
bionys-650	128	6	significantly	significantly	ADV
bionys-650	128	7	higher	high	ADJ
bionys-650	128	8	in	in	ADP
bionys-650	128	9	t2d	t2d	NOUN
bionys-650	128	10	patients	patient	NOUN
bionys-650	128	11	(	(	PUNCT
bionys-650	128	12	29.38±5.52	29.38±5.52	NUM
bionys-650	128	13	iu	iu	ADP
bionys-650	128	14	/	/	SYM
bionys-650	128	15	l	l	NOUN
bionys-650	128	16	)	)	PUNCT
bionys-650	128	17	than	than	ADP
bionys-650	128	18	in	in	ADP
bionys-650	128	19	the	the	DET
bionys-650	128	20	control	control	NOUN
bionys-650	128	21	group	group	NOUN
bionys-650	128	22	(	(	PUNCT
bionys-650	128	23	26.73±5.46	26.73±5.46	NUM
bionys-650	128	24	iu	iu	PROPN
bionys-650	128	25	/	/	SYM
bionys-650	128	26	l	l	NOUN
bionys-650	128	27	;	;	PUNCT
bionys-650	128	28	p=0.009	p=0.009	X
bionys-650	128	29	)	)	PUNCT
bionys-650	128	30	,	,	PUNCT
bionys-650	128	31	suggesting	suggest	VERB
bionys-650	128	32	potential	potential	ADJ
bionys-650	128	33	hepatic	hepatic	ADJ
bionys-650	128	34	stress	stress	NOUN
bionys-650	128	35	or	or	CCONJ
bionys-650	128	36	dysfunction	dysfunction	NOUN
bionys-650	128	37	,	,	PUNCT
bionys-650	128	38	which	which	PRON
bionys-650	128	39	has	have	AUX
bionys-650	128	40	been	be	AUX
bionys-650	128	41	implicated	implicate	VERB
bionys-650	128	42	in	in	ADP
bionys-650	128	43	the	the	DET
bionys-650	128	44	pathogenesis	pathogenesis	NOUN
bionys-650	128	45	of	of	ADP
bionys-650	128	46	diabetes	diabetes	NOUN
bionys-650	128	47	.	.	PUNCT
bionys-650	129	1	aligns	align	VERB
bionys-650	129	2	with	with	ADP
bionys-650	129	3	the	the	DET
bionys-650	129	4	findings	finding	NOUN
bionys-650	129	5	,	,	PUNCT
bionys-650	129	6	which	which	PRON
bionys-650	129	7	reported	report	VERB
bionys-650	129	8	that	that	SCONJ
bionys-650	129	9	ferritin	ferritin	ADJ
bionys-650	129	10	concentrations	concentration	NOUN
bionys-650	129	11	were	be	AUX
bionys-650	129	12	not	not	PART
bionys-650	129	13	associated	associate	VERB
bionys-650	129	14	with	with	ADP
bionys-650	129	15	glycemic	glycemic	ADJ
bionys-650	129	16	control	control	NOUN
bionys-650	129	17	in	in	ADP
bionys-650	129	18	t2d	t2d	NOUN
bionys-650	129	19	patients	patient	NOUN
bionys-650	129	20	(	(	PUNCT
bionys-650	129	21	al	al	PROPN
bionys-650	129	22	argan	argan	VERB
bionys-650	129	23	et	et	PROPN
bionys-650	129	24	al	al	PROPN
bionys-650	129	25	.	.	PROPN
bionys-650	129	26	,	,	PUNCT
bionys-650	129	27	2023	2023	NUM
bionys-650	129	28	)	)	PUNCT
bionys-650	129	29	.	.	PUNCT
bionys-650	130	1	previous	previous	ADJ
bionys-650	130	2	research	research	NOUN
bionys-650	130	3	has	have	AUX
bionys-650	130	4	demonstrated	demonstrate	VERB
bionys-650	130	5	a	a	DET
bionys-650	130	6	correlation	correlation	NOUN
bionys-650	130	7	between	between	ADP
bionys-650	130	8	elevated	elevated	ADJ
bionys-650	130	9	ferritin	ferritin	ADJ
bionys-650	130	10	levels	level	NOUN
bionys-650	130	11	and	and	CCONJ
bionys-650	130	12	an	an	DET
bionys-650	130	13	increased	increase	VERB
bionys-650	130	14	risk	risk	NOUN
bionys-650	130	15	of	of	ADP
bionys-650	130	16	t2d	t2d	NOUN
bionys-650	130	17	.	.	PUNCT
bionys-650	131	1	however	however	ADV
bionys-650	131	2	,	,	PUNCT
bionys-650	131	3	it	it	PRON
bionys-650	131	4	remains	remain	VERB
bionys-650	131	5	unclear	unclear	ADJ
bionys-650	131	6	whether	whether	SCONJ
bionys-650	131	7	this	this	DET
bionys-650	131	8	elevation	elevation	NOUN
bionys-650	131	9	plays	play	VERB
bionys-650	131	10	a	a	DET
bionys-650	131	11	causal	causal	ADJ
bionys-650	131	12	role	role	NOUN
bionys-650	131	13	in	in	ADP
bionys-650	131	14	the	the	DET
bionys-650	131	15	onset	onset	NOUN
bionys-650	131	16	of	of	ADP
bionys-650	131	17	diabetes	diabetes	NOUN
bionys-650	131	18	or	or	CCONJ
bionys-650	131	19	merely	merely	ADV
bionys-650	131	20	reflects	reflect	VERB
bionys-650	131	21	the	the	DET
bionys-650	131	22	progression	progression	NOUN
bionys-650	131	23	of	of	ADP
bionys-650	131	24	insulin	insulin	NOUN
bionys-650	131	25	resistance	resistance	NOUN
bionys-650	131	26	,	,	PUNCT
bionys-650	131	27	a	a	DET
bionys-650	131	28	recognized	recognize	VERB
bionys-650	131	29	precursor	precursor	NOUN
bionys-650	131	30	to	to	ADP
bionys-650	131	31	t2d	t2d	NOUN
bionys-650	131	32	(	(	PUNCT
bionys-650	131	33	podmore	podmore	ADV
bionys-650	131	34	et	et	PROPN
bionys-650	131	35	al	al	PROPN
bionys-650	131	36	.	.	PROPN
bionys-650	131	37	,	,	PUNCT
bionys-650	131	38	2016	2016	NUM
bionys-650	131	39	)	)	PUNCT
bionys-650	131	40	.	.	PUNCT
bionys-650	132	1	additionally	additionally	ADV
bionys-650	132	2	,	,	PUNCT
bionys-650	132	3	it	it	PRON
bionys-650	132	4	was	be	AUX
bionys-650	132	5	found	find	VERB
bionys-650	132	6	that	that	SCONJ
bionys-650	132	7	individuals	individual	NOUN
bionys-650	132	8	with	with	ADP
bionys-650	132	9	t2d	t2d	NUM
bionys-650	132	10	exhibited	exhibit	VERB
bionys-650	132	11	increased	increase	VERB
bionys-650	132	12	ferritin	ferritin	ADJ
bionys-650	132	13	levels	level	NOUN
bionys-650	132	14	,	,	PUNCT
bionys-650	132	15	which	which	PRON
bionys-650	132	16	may	may	AUX
bionys-650	132	17	be	be	AUX
bionys-650	132	18	linked	link	VERB
bionys-650	132	19	to	to	ADP
bionys-650	132	20	prolonged	prolonged	ADJ
bionys-650	132	21	hyperglycemia	hyperglycemia	NOUN
bionys-650	132	22	,	,	PUNCT
bionys-650	132	23	showing	show	VERB
bionys-650	132	24	a	a	DET
bionys-650	132	25	strong	strong	ADJ
bionys-650	132	26	positive	positive	ADJ
bionys-650	132	27	correlation	correlation	NOUN
bionys-650	132	28	with	with	ADP
bionys-650	132	29	glycemic	glycemic	ADJ
bionys-650	132	30	markers	marker	NOUN
bionys-650	132	31	such	such	ADJ
bionys-650	132	32	as	as	ADP
bionys-650	132	33	fasting	fast	VERB
bionys-650	132	34	blood	blood	NOUN
bionys-650	132	35	glucose	glucose	NOUN
bionys-650	132	36	and	and	CCONJ
bionys-650	132	37	hba1c	hba1c	PROPN
bionys-650	132	38	(	(	PUNCT
bionys-650	132	39	bayih	bayih	NOUN
bionys-650	132	40	et	et	PROPN
bionys-650	132	41	al	al	PROPN
bionys-650	132	42	.	.	PROPN
bionys-650	132	43	,	,	PUNCT
bionys-650	132	44	2024	2024	NUM
bionys-650	132	45	)	)	PUNCT
bionys-650	132	46	.	.	PUNCT
bionys-650	133	1	taken	take	VERB
bionys-650	133	2	together	together	ADV
bionys-650	133	3	,	,	PUNCT
bionys-650	133	4	these	these	DET
bionys-650	133	5	findings	finding	NOUN
bionys-650	133	6	suggest	suggest	VERB
bionys-650	133	7	that	that	SCONJ
bionys-650	133	8	while	while	SCONJ
bionys-650	133	9	ferritin	ferritin	ADJ
bionys-650	133	10	may	may	AUX
bionys-650	133	11	play	play	VERB
bionys-650	133	12	a	a	DET
bionys-650	133	13	role	role	NOUN
bionys-650	133	14	in	in	ADP
bionys-650	133	15	metabolic	metabolic	NOUN
bionys-650	133	16	disturbance	disturbance	NOUN
bionys-650	133	17	,	,	PUNCT
bionys-650	133	18	its	its	PRON
bionys-650	133	19	diagnostic	diagnostic	ADJ
bionys-650	133	20	value	value	NOUN
bionys-650	133	21	in	in	ADP
bionys-650	133	22	t2d	t2d	NOUN
bionys-650	133	23	requires	require	VERB
bionys-650	133	24	further	further	ADJ
bionys-650	133	25	clarification	clarification	NOUN
bionys-650	133	26	.	.	PUNCT
bionys-650	134	1	although	although	SCONJ
bionys-650	134	2	the	the	DET
bionys-650	134	3	observed	observed	ADJ
bionys-650	134	4	differences	difference	NOUN
bionys-650	134	5	in	in	ADP
bionys-650	134	6	serum	serum	NOUN
bionys-650	134	7	vitamin	vitamin	NOUN
bionys-650	134	8	d3	d3	PROPN
bionys-650	134	9	concentrations	concentration	NOUN
bionys-650	134	10	between	between	ADP
bionys-650	134	11	the	the	DET
bionys-650	134	12	diabetic	diabetic	ADJ
bionys-650	134	13	group	group	NOUN
bionys-650	134	14	(	(	PUNCT
bionys-650	134	15	22.11±12.55	22.11±12.55	NUM
bionys-650	134	16	ng	ng	NOUN
bionys-650	134	17	/	/	SYM
bionys-650	134	18	ml	ml	PROPN
bionys-650	134	19	)	)	PUNCT
bionys-650	134	20	and	and	CCONJ
bionys-650	134	21	the	the	DET
bionys-650	134	22	control	control	NOUN
bionys-650	134	23	group	group	NOUN
bionys-650	134	24	(	(	PUNCT
bionys-650	134	25	26.63±14.68	26.63±14.68	PROPN
bionys-650	134	26	ng	ng	PROPN
bionys-650	134	27	/	/	SYM
bionys-650	134	28	ml	ml	PROPN
bionys-650	134	29	)	)	PUNCT
bionys-650	134	30	did	do	AUX
bionys-650	134	31	not	not	PART
bionys-650	134	32	reach	reach	VERB
bionys-650	134	33	statistical	statistical	ADJ
bionys-650	134	34	significance	significance	NOUN
bionys-650	134	35	(	(	PUNCT
bionys-650	134	36	p=0.072	p=0.072	NOUN
bionys-650	134	37	)	)	PUNCT
bionys-650	134	38	,	,	PUNCT
bionys-650	134	39	this	this	PRON
bionys-650	134	40	does	do	AUX
bionys-650	134	41	not	not	PART
bionys-650	134	42	preclude	preclude	VERB
bionys-650	134	43	a	a	DET
bionys-650	134	44	clinical	clinical	ADJ
bionys-650	134	45	impact	impact	NOUN
bionys-650	134	46	.	.	PUNCT
bionys-650	135	1	the	the	DET
bionys-650	135	2	biological	biological	ADJ
bionys-650	135	3	activity	activity	NOUN
bionys-650	135	4	of	of	ADP
bionys-650	135	5	vitamin	vitamin	NOUN
bionys-650	135	6	d3	d3	PROPN
bionys-650	135	7	depends	depend	VERB
bionys-650	135	8	on	on	ADP
bionys-650	135	9	its	its	PRON
bionys-650	135	10	conversion	conversion	NOUN
bionys-650	135	11	to	to	ADP
bionys-650	135	12	the	the	DET
bionys-650	135	13	active	active	ADJ
bionys-650	135	14	form	form	NOUN
bionys-650	135	15	,	,	PUNCT
bionys-650	135	16	a	a	DET
bionys-650	135	17	process	process	NOUN
bionys-650	135	18	influenced	influence	VERB
bionys-650	135	19	by	by	ADP
bionys-650	135	20	vdbp	vdbp	NOUN
bionys-650	135	21	,	,	PUNCT
bionys-650	135	22	tsb	tsb	ADJ
bionys-650	135	23	,	,	PUNCT
bionys-650	135	24	and	and	CCONJ
bionys-650	135	25	liver	liver	NOUN
bionys-650	135	26	enzyme	enzyme	NOUN
bionys-650	135	27	levels	level	NOUN
bionys-650	135	28	such	such	ADJ
bionys-650	135	29	as	as	ADP
bionys-650	135	30	got	get	VERB
bionys-650	135	31	.	.	PUNCT
bionys-650	136	1	disruptions	disruption	NOUN
bionys-650	136	2	in	in	ADP
bionys-650	136	3	these	these	DET
bionys-650	136	4	factors	factor	NOUN
bionys-650	136	5	—	—	PUNCT
bionys-650	136	6	common	common	ADJ
bionys-650	136	7	in	in	ADP
bionys-650	136	8	individuals	individual	NOUN
bionys-650	136	9	with	with	ADP
bionys-650	136	10	t2d	t2d	NOUN
bionys-650	136	11	—	—	PUNCT
bionys-650	136	12	may	may	AUX
bionys-650	136	13	contribute	contribute	VERB
bionys-650	136	14	to	to	ADP
bionys-650	136	15	reduced	reduced	ADJ
bionys-650	136	16	levels	level	NOUN
bionys-650	136	17	of	of	ADP
bionys-650	136	18	active	active	ADJ
bionys-650	136	19	vitamin	vitamin	NOUN
bionys-650	136	20	d3	d3	PROPN
bionys-650	136	21	,	,	PUNCT
bionys-650	136	22	thereby	thereby	ADV
bionys-650	136	23	impairing	impair	VERB
bionys-650	136	24	glucose	glucose	NOUN
bionys-650	136	25	metabolism	metabolism	NOUN
bionys-650	136	26	and	and	CCONJ
bionys-650	136	27	insulin	insulin	NOUN
bionys-650	136	28	sensitivity	sensitivity	NOUN
bionys-650	136	29	.	.	PUNCT
bionys-650	137	1	a	a	DET
bionys-650	137	2	study	study	NOUN
bionys-650	137	3	reported	report	VERB
bionys-650	137	4	that	that	SCONJ
bionys-650	137	5	vitamin	vitamin	NOUN
bionys-650	137	6	d	d	NOUN
bionys-650	137	7	deficiency	deficiency	NOUN
bionys-650	137	8	is	be	AUX
bionys-650	137	9	associated	associate	VERB
bionys-650	137	10	with	with	ADP
bionys-650	137	11	deteriorating	deteriorate	VERB
bionys-650	137	12	glycemic	glycemic	ADJ
bionys-650	137	13	control	control	NOUN
bionys-650	137	14	(	(	PUNCT
bionys-650	137	15	pittas	pitta	NOUN
bionys-650	137	16	et	et	PROPN
bionys-650	137	17	al	al	PROPN
bionys-650	137	18	.	.	PROPN
bionys-650	137	19	,	,	PUNCT
bionys-650	137	20	2007	2007	NUM
bionys-650	137	21	)	)	PUNCT
bionys-650	137	22	.	.	PUNCT
bionys-650	138	1	furthermore	furthermore	ADV
bionys-650	138	2	,	,	PUNCT
bionys-650	138	3	longitudinal	longitudinal	ADJ
bionys-650	138	4	data	datum	NOUN
bionys-650	138	5	suggest	suggest	VERB
bionys-650	138	6	that	that	SCONJ
bionys-650	138	7	low	low	ADJ
bionys-650	138	8	vitamin	vitamin	NOUN
bionys-650	138	9	d	d	NOUN
bionys-650	138	10	status	status	NOUN
bionys-650	138	11	may	may	AUX
bionys-650	138	12	predict	predict	VERB
bionys-650	138	13	the	the	DET
bionys-650	138	14	future	future	ADJ
bionys-650	138	15	onset	onset	NOUN
bionys-650	138	16	of	of	ADP
bionys-650	138	17	t2d	t2d	NOUN
bionys-650	138	18	(	(	PUNCT
bionys-650	138	19	forouhi	forouhi	NOUN
bionys-650	138	20	et	et	PROPN
bionys-650	138	21	al	al	PROPN
bionys-650	138	22	.	.	PROPN
bionys-650	138	23	,	,	PUNCT
bionys-650	138	24	2008	2008	NUM
bionys-650	138	25	)	)	PUNCT
bionys-650	138	26	.	.	PUNCT
bionys-650	139	1	it	it	PRON
bionys-650	139	2	was	be	AUX
bionys-650	139	3	also	also	ADV
bionys-650	139	4	highlighted	highlight	VERB
bionys-650	139	5	that	that	SCONJ
bionys-650	139	6	vitamin	vitamin	NOUN
bionys-650	139	7	d	d	NOUN
bionys-650	139	8	deficiency	deficiency	NOUN
bionys-650	139	9	is	be	AUX
bionys-650	139	10	prevalent	prevalent	ADJ
bionys-650	139	11	control	control	NOUN
bionys-650	139	12	group	group	NOUN
bionys-650	139	13	,	,	PUNCT
bionys-650	139	14	n=60	n=60	PROPN
bionys-650	139	15	t2d	t2d	NOUN
bionys-650	139	16	patients	patient	NOUN
bionys-650	139	17	,	,	PUNCT
bionys-650	139	18	n=60	n=60	NOUN
bionys-650	139	19	parameters	parameter	NOUN
bionys-650	139	20	mean	mean	VERB
bionys-650	139	21	sd	sd	INTJ
bionys-650	139	22	mean	mean	VERB
bionys-650	139	23	sd	sd	ADP
bionys-650	139	24	p	p	NOUN
bionys-650	139	25	-	-	PUNCT
bionys-650	139	26	value	value	NOUN
bionys-650	139	27	tsb	tsb	ADJ
bionys-650	139	28	(	(	PUNCT
bionys-650	139	29	mg	mg	PROPN
bionys-650	139	30	/	/	SYM
bionys-650	139	31	dl	dl	PROPN
bionys-650	139	32	)	)	PUNCT
bionys-650	139	33	0.793	0.793	NUM
bionys-650	139	34	0.09	0.09	NUM
bionys-650	139	35	0.833	0.833	NUM
bionys-650	139	36	0.087	0.087	NUM
bionys-650	139	37	0.015	0.015	NUM
bionys-650	139	38	*	*	PUNCT
bionys-650	139	39	gpt	gpt	NOUN
bionys-650	139	40	(	(	PUNCT
bionys-650	139	41	iu	iu	PROPN
bionys-650	139	42	/	/	SYM
bionys-650	139	43	l	l	NOUN
bionys-650	139	44	)	)	PUNCT
bionys-650	139	45	31.38	31.38	NUM
bionys-650	139	46	6.023	6.023	NUM
bionys-650	139	47	30.417	30.417	NUM
bionys-650	139	48	5.907	5.907	NUM
bionys-650	139	49	0.377	0.377	NUM
bionys-650	139	50	got	get	VERB
bionys-650	139	51	(	(	PUNCT
bionys-650	139	52	iu	iu	PROPN
bionys-650	139	53	/	/	SYM
bionys-650	139	54	l	l	NOUN
bionys-650	139	55	)	)	PUNCT
bionys-650	140	1	26.73	26.73	NUM
bionys-650	140	2	5.455	5.455	NUM
bionys-650	140	3	29.383	29.383	NUM
bionys-650	140	4	5.521	5.521	NUM
bionys-650	140	5	0.009	0.009	NUM
bionys-650	140	6	*	*	PUNCT
bionys-650	140	7	alp	alp	NOUN
bionys-650	140	8	(	(	PUNCT
bionys-650	140	9	iu	iu	PROPN
bionys-650	140	10	/	/	SYM
bionys-650	140	11	l	l	NOUN
bionys-650	140	12	)	)	PUNCT
bionys-650	140	13	76.63	76.63	NUM
bionys-650	140	14	10.84	10.84	NUM
bionys-650	140	15	78.7	78.7	NUM
bionys-650	140	16	9.968	9.968	NUM
bionys-650	140	17	0.279	0.279	NUM
bionys-650	140	18	table	table	NOUN
bionys-650	140	19	4	4	NUM
bionys-650	140	20	.	.	PUNCT
bionys-650	141	1	the	the	DET
bionys-650	141	2	statistical	statistical	ADJ
bionys-650	141	3	disparities	disparity	NOUN
bionys-650	141	4	among	among	ADP
bionys-650	141	5	control	control	NOUN
bionys-650	141	6	and	and	CCONJ
bionys-650	141	7	t2d	t2d	NOUN
bionys-650	141	8	patients	patient	NOUN
bionys-650	141	9	for	for	ADP
bionys-650	141	10	liver	liver	NOUN
bionys-650	141	11	function	function	NOUN
bionys-650	141	12	parameters	parameter	NOUN
bionys-650	141	13	*	*	PUNCT
bionys-650	141	14	significant	significant	ADJ
bionys-650	141	15	at	at	ADP
bionys-650	141	16	p≤0.05	p≤0.05	NOUN
bionys-650	141	17	,	,	PUNCT
bionys-650	141	18	*	*	PUNCT
bionys-650	141	19	*	*	PUNCT
bionys-650	141	20	highly	highly	ADV
bionys-650	141	21	significant	significant	ADJ
bionys-650	141	22	p<0.001	p<0.001	NOUN
bionys-650	141	23	,	,	PUNCT
bionys-650	141	24	ns	ns	NUM
bionys-650	141	25	:	:	PUNCT
bionys-650	141	26	non	non	ADJ
bionys-650	141	27	-	-	ADJ
bionys-650	141	28	significant	significant	ADJ
bionys-650	141	29	control	control	NOUN
bionys-650	141	30	group	group	NOUN
bionys-650	141	31	,	,	PUNCT
bionys-650	141	32	n=60	n=60	PROPN
bionys-650	141	33	t2d	t2d	NOUN
bionys-650	141	34	patients	patient	NOUN
bionys-650	141	35	,	,	PUNCT
bionys-650	141	36	n=60	n=60	NOUN
bionys-650	141	37	parameters	parameter	NOUN
bionys-650	141	38	mean	mean	VERB
bionys-650	141	39	sd	sd	INTJ
bionys-650	141	40	mean	mean	VERB
bionys-650	141	41	sd	sd	ADP
bionys-650	141	42	p	p	ADJ
bionys-650	141	43	-	-	PUNCT
bionys-650	141	44	value	value	NOUN
bionys-650	141	45	urea	urea	NOUN
bionys-650	141	46	(	(	PUNCT
bionys-650	141	47	mg	mg	NOUN
bionys-650	141	48	/	/	SYM
bionys-650	141	49	ml	ml	VERB
bionys-650	141	50	)	)	PUNCT
bionys-650	141	51	32.05	32.05	NUM
bionys-650	141	52	4.252	4.252	NUM
bionys-650	141	53	31.85	31.85	NUM
bionys-650	141	54	4.697	4.697	NUM
bionys-650	141	55	0.807	0.807	NUM
bionys-650	141	56	creatinine	creatinine	NOUN
bionys-650	141	57	(	(	PUNCT
bionys-650	141	58	mg	mg	NOUN
bionys-650	141	59	/	/	SYM
bionys-650	141	60	ml	ml	NOUN
bionys-650	141	61	)	)	PUNCT
bionys-650	141	62	0.73	0.73	NUM
bionys-650	141	63	0.125	0.125	NUM
bionys-650	141	64	0.76	0.76	NUM
bionys-650	141	65	0.121	0.121	NUM
bionys-650	141	66	0.185	0.185	NUM
bionys-650	141	67	table	table	NOUN
bionys-650	141	68	5	5	NUM
bionys-650	141	69	.	.	PUNCT
bionys-650	142	1	the	the	DET
bionys-650	142	2	statistical	statistical	ADJ
bionys-650	142	3	disparities	disparity	NOUN
bionys-650	142	4	among	among	ADP
bionys-650	142	5	control	control	NOUN
bionys-650	142	6	and	and	CCONJ
bionys-650	142	7	t2d	t2d	NOUN
bionys-650	142	8	patients	patient	NOUN
bionys-650	142	9	for	for	ADP
bionys-650	142	10	renal	renal	ADJ
bionys-650	142	11	function	function	NOUN
bionys-650	142	12	parameters	parameter	NOUN
bionys-650	142	13	*	*	PUNCT
bionys-650	142	14	significant	significant	ADJ
bionys-650	142	15	at	at	ADP
bionys-650	142	16	p≤0.05	p≤0.05	NOUN
bionys-650	142	17	,	,	PUNCT
bionys-650	142	18	*	*	PUNCT
bionys-650	142	19	*	*	PUNCT
bionys-650	142	20	highly	highly	ADV
bionys-650	142	21	significant	significant	ADJ
bionys-650	142	22	p<0.001	p<0.001	NOUN
bionys-650	142	23	,	,	PUNCT
bionys-650	142	24	ns	ns	NUM
bionys-650	142	25	:	:	PUNCT
bionys-650	142	26	non	non	ADJ
bionys-650	142	27	-	-	ADJ
bionys-650	142	28	significant	significant	ADJ
bionys-650	142	29	progression	progression	NOUN
bionys-650	142	30	and	and	CCONJ
bionys-650	142	31	highlight	highlight	VERB
bionys-650	142	32	that	that	DET
bionys-650	142	33	diminished	diminish	VERB
bionys-650	142	34	vitamin	vitamin	NOUN
bionys-650	142	35	d	d	NOUN
bionys-650	142	36	bioavailability	bioavailability	NOUN
bionys-650	142	37	,	,	PUNCT
bionys-650	142	38	despite	despite	SCONJ
bionys-650	142	39	normal	normal	ADJ
bionys-650	142	40	serum	serum	NOUN
bionys-650	142	41	levels	level	NOUN
bionys-650	142	42	,	,	PUNCT
bionys-650	142	43	may	may	AUX
bionys-650	142	44	stem	stem	VERB
bionys-650	142	45	from	from	ADP
bionys-650	142	46	compromised	compromise	VERB
bionys-650	142	47	liver	liver	NOUN
bionys-650	142	48	function	function	NOUN
bionys-650	142	49	and	and	CCONJ
bionys-650	142	50	reduced	reduce	VERB
bionys-650	142	51	vdbp	vdbp	NOUN
bionys-650	142	52	.	.	PUNCT
bionys-650	143	1	together	together	ADV
bionys-650	143	2	,	,	PUNCT
bionys-650	143	3	these	these	DET
bionys-650	143	4	findings	finding	NOUN
bionys-650	143	5	underscore	underscore	VERB
bionys-650	143	6	the	the	DET
bionys-650	143	7	importance	importance	NOUN
bionys-650	143	8	of	of	ADP
bionys-650	143	9	evaluating	evaluate	VERB
bionys-650	143	10	not	not	PART
bionys-650	143	11	only	only	ADV
bionys-650	143	12	vitamin	vitamin	NOUN
bionys-650	143	13	d	d	NOUN
bionys-650	143	14	levels	level	NOUN
bionys-650	143	15	but	but	CCONJ
bionys-650	143	16	also	also	ADV
bionys-650	143	17	its	its	PRON
bionys-650	143	18	transport	transport	NOUN
bionys-650	143	19	and	and	CCONJ
bionys-650	143	20	activation	activation	NOUN
bionys-650	143	21	pathways	pathway	NOUN
bionys-650	143	22	in	in	ADP
bionys-650	143	23	understanding	understanding	NOUN
bionys-650	143	24	and	and	CCONJ
bionys-650	143	25	managing	manage	VERB
bionys-650	143	26	t2d	t2d	PROPN
bionys-650	143	27	.	.	PUNCT
bionys-650	144	1	references	reference	NOUN
bionys-650	144	2	abu	abu	PROPN
bionys-650	144	3	-	-	PUNCT
bionys-650	144	4	shana	shana	PROPN
bionys-650	144	5	,	,	PUNCT
bionys-650	144	6	j.	j.	PROPN
bionys-650	144	7	h.	h.	PROPN
bionys-650	144	8	,	,	PUNCT
bionys-650	144	9	abdulkareem	abdulkareem	PROPN
bionys-650	144	10	,	,	PUNCT
bionys-650	144	11	n.	n.	PROPN
bionys-650	144	12	g.	g.	PROPN
bionys-650	144	13	,	,	PUNCT
bionys-650	144	14	jasim	jasim	NOUN
bionys-650	144	15	,	,	PUNCT
bionys-650	144	16	a.	a.	NOUN
bionys-650	144	17	o.	o.	PROPN
bionys-650	144	18	,	,	PUNCT
bionys-650	144	19	&	&	CCONJ
bionys-650	144	20	abbood	abbood	PROPN
bionys-650	144	21	,	,	PUNCT
bionys-650	144	22	y.	y.	PROPN
bionys-650	144	23	h.	h.	PROPN
bionys-650	145	1	(	(	PUNCT
bionys-650	145	2	2024	2024	NUM
bionys-650	145	3	)	)	PUNCT
bionys-650	145	4	.	.	PUNCT
bionys-650	146	1	effect	effect	NOUN
bionys-650	146	2	of	of	ADP
bionys-650	146	3	diabetes	diabetes	NOUN
bionys-650	146	4	mellitus	mellitus	NOUN
bionys-650	146	5	type	type	VERB
bionys-650	146	6	2	2	NUM
bionys-650	146	7	on	on	ADP
bionys-650	146	8	the	the	DET
bionys-650	146	9	correlation	correlation	NOUN
bionys-650	146	10	of	of	ADP
bionys-650	146	11	vitamin	vitamin	NOUN
bionys-650	146	12	d	d	NOUN
bionys-650	146	13	with	with	ADP
bionys-650	146	14	lipid	lipid	NOUN
bionys-650	146	15	profile	profile	NOUN
bionys-650	146	16	in	in	ADP
bionys-650	146	17	iraqi	iraqi	ADJ
bionys-650	146	18	patients	patient	NOUN
bionys-650	146	19	.	.	PUNCT
bionys-650	147	1	iraqi	iraqi	ADJ
bionys-650	147	2	journal	journal	PROPN
bionys-650	147	3	of	of	ADP
bionys-650	147	4	science	science	NOUN
bionys-650	147	5	,	,	PUNCT
bionys-650	147	6	65(9	65(9	NUM
bionys-650	147	7	)	)	PUNCT
bionys-650	147	8	,	,	PUNCT
bionys-650	147	9	4881–4889	4881–4889	NOUN
bionys-650	147	10	.	.	PUNCT
bionys-650	148	1	https://doi.org/10.24996/	https://doi.org/10.24996/	PROPN
bionys-650	148	2	ijs.2024.65.9.5	ijs.2024.65.9.5	NOUN
bionys-650	148	3	al	al	PROPN
bionys-650	148	4	argan	argan	PROPN
bionys-650	148	5	,	,	PUNCT
bionys-650	148	6	r.	r.	PROPN
bionys-650	148	7	,	,	PUNCT
bionys-650	148	8	alkhafaji	alkhafaji	PROPN
bionys-650	148	9	,	,	PUNCT
bionys-650	148	10	d.	d.	PROPN
bionys-650	148	11	,	,	PUNCT
bionys-650	148	12	al	al	PROPN
bionys-650	148	13	elq	elq	PROPN
bionys-650	148	14	,	,	PUNCT
bionys-650	148	15	a.	a.	NOUN
bionys-650	148	16	,	,	PUNCT
bionys-650	148	17	albaker	albaker	PROPN
bionys-650	148	18	,	,	PUNCT
bionys-650	148	19	w.	w.	PROPN
bionys-650	148	20	,	,	PUNCT
bionys-650	148	21	elamin	elamin	NOUN
bionys-650	148	22	,	,	PUNCT
bionys-650	148	23	y.	y.	PROPN
bionys-650	148	24	,	,	PUNCT
bionys-650	148	25	alwaheed	alwaheed	PROPN
bionys-650	148	26	,	,	PUNCT
bionys-650	148	27	a.	a.	PROPN
bionys-650	148	28	,	,	PUNCT
bionys-650	148	29	zeeshan	zeeshan	PROPN
bionys-650	148	30	,	,	PUNCT
bionys-650	148	31	m.	m.	NOUN
bionys-650	148	32	,	,	PUNCT
bionys-650	148	33	alelq	alelq	PROPN
bionys-650	148	34	,	,	PUNCT
bionys-650	148	35	z.	z.	PROPN
bionys-650	148	36	,	,	PUNCT
bionys-650	148	37	alkhalifa	alkhalifa	PROPN
bionys-650	148	38	,	,	PUNCT
bionys-650	148	39	m.	m.	NOUN
bionys-650	148	40	,	,	PUNCT
bionys-650	148	41	al	al	PROPN
bionys-650	148	42	mansour	mansour	PROPN
bionys-650	148	43	,	,	PUNCT
bionys-650	148	44	r.	r.	PROPN
bionys-650	148	45	,	,	PUNCT
bionys-650	148	46	alghamdi	alghamdi	NOUN
bionys-650	148	47	,	,	PUNCT
bionys-650	148	48	s.	s.	PROPN
bionys-650	148	49	,	,	PUNCT
bionys-650	148	50	al	al	PROPN
bionys-650	148	51	ghamdi	ghamdi	PROPN
bionys-650	148	52	,	,	PUNCT
bionys-650	148	53	a.	a.	PROPN
bionys-650	148	54	,	,	PUNCT
bionys-650	148	55	ismaeel	ismaeel	PROPN
bionys-650	148	56	,	,	PUNCT
bionys-650	148	57	f.	f.	PROPN
bionys-650	148	58	,	,	PUNCT
bionys-650	148	59	almarzouq	almarzouq	ADV
bionys-650	148	60	,	,	PUNCT
bionys-650	148	61	a.	a.	NOUN
bionys-650	148	62	,	,	PUNCT
bionys-650	148	63	zainuddin	zainuddin	PROPN
bionys-650	148	64	,	,	PUNCT
bionys-650	148	65	f.	f.	PROPN
bionys-650	148	66	,	,	PUNCT
bionys-650	148	67	&	&	CCONJ
bionys-650	148	68	alsulaiman	alsulaiman	PROPN
bionys-650	148	69	,	,	PUNCT
bionys-650	148	70	r.	r.	PROPN
bionys-650	148	71	(	(	PUNCT
bionys-650	148	72	2023	2023	NUM
bionys-650	148	73	)	)	PUNCT
bionys-650	148	74	.	.	PUNCT
bionys-650	149	1	the	the	DET
bionys-650	149	2	association	association	NOUN
bionys-650	149	3	between	between	ADP
bionys-650	149	4	serum	serum	NOUN
bionys-650	149	5	ferritin	ferritin	ADJ
bionys-650	149	6	and	and	CCONJ
bionys-650	149	7	bilirubin	bilirubin	NOUN
bionys-650	149	8	with	with	ADP
bionys-650	149	9	glycemic	glycemic	ADJ
bionys-650	149	10	control	control	NOUN
bionys-650	149	11	among	among	ADP
bionys-650	149	12	patients	patient	NOUN
bionys-650	149	13	with	with	ADP
bionys-650	149	14	type	type	NOUN
bionys-650	149	15	2	2	NUM
bionys-650	149	16	diabetes	diabetes	NOUN
bionys-650	149	17	mellitus	mellitus	NOUN
bionys-650	149	18	.	.	PUNCT
bionys-650	150	1	journal	journal	PROPN
bionys-650	150	2	of	of	ADP
bionys-650	150	3	medicine	medicine	NOUN
bionys-650	150	4	and	and	CCONJ
bionys-650	150	5	life	life	NOUN
bionys-650	150	6	,	,	PUNCT
bionys-650	150	7	16(11	16(11	NUM
bionys-650	150	8	)	)	PUNCT
bionys-650	150	9	,	,	PUNCT
bionys-650	150	10	1670–1677	1670–1677	NUM
bionys-650	150	11	.	.	PUNCT
bionys-650	151	1	https://doi.org/10.25122/jml2023-0136	https://doi.org/10.25122/jml2023-0136	PROPN
bionys-650	151	2	american	american	ADJ
bionys-650	151	3	diabetes	diabetes	PROPN
bionys-650	151	4	association	association	PROPN
bionys-650	151	5	.	.	PUNCT
bionys-650	152	1	(	(	PUNCT
bionys-650	152	2	2018	2018	NUM
bionys-650	152	3	)	)	PUNCT
bionys-650	152	4	.	.	PUNCT
bionys-650	153	1	classification	classification	NOUN
bionys-650	153	2	and	and	CCONJ
bionys-650	153	3	diagnosis	diagnosis	NOUN
bionys-650	153	4	of	of	ADP
bionys-650	153	5	diabetes	diabetes	NOUN
bionys-650	153	6	:	:	PUNCT
bionys-650	153	7	standards	standard	NOUN
bionys-650	153	8	of	of	ADP
bionys-650	153	9	medical	medical	ADJ
bionys-650	153	10	care	care	NOUN
bionys-650	153	11	in	in	ADP
bionys-650	153	12	diabetes—2018	diabetes—2018	NOUN
bionys-650	153	13	.	.	PUNCT
bionys-650	154	1	diabetes	diabetes	NOUN
bionys-650	154	2	care	care	NOUN
bionys-650	154	3	,	,	PUNCT
bionys-650	154	4	41(suppl_1	41(suppl_1	NUM
bionys-650	154	5	)	)	PUNCT
bionys-650	154	6	,	,	PUNCT
bionys-650	154	7	s13	s13	PROPN
bionys-650	154	8	–	–	PUNCT
bionys-650	154	9	s27	s27	PROPN
bionys-650	154	10	.	.	PUNCT
bionys-650	155	1	https://doi.org/10.2337/	https://doi.org/10.2337/	PROPN
bionys-650	155	2	dc18	dc18	PROPN
bionys-650	155	3	-	-	PUNCT
bionys-650	155	4	s002	s002	PROPN
bionys-650	155	5	antar	antar	PROPN
bionys-650	155	6	,	,	PUNCT
bionys-650	155	7	s.	s.	PROPN
bionys-650	155	8	a.	a.	PROPN
bionys-650	155	9	,	,	PUNCT
bionys-650	155	10	ashour	ashour	PROPN
bionys-650	155	11	,	,	PUNCT
bionys-650	155	12	n.	n.	PROPN
bionys-650	155	13	a.	a.	PROPN
bionys-650	155	14	,	,	PUNCT
bionys-650	155	15	sharaky	sharaky	PROPN
bionys-650	155	16	,	,	PUNCT
bionys-650	155	17	m.	m.	NOUN
bionys-650	155	18	,	,	PUNCT
bionys-650	155	19	khattab	khattab	NOUN
bionys-650	155	20	,	,	PUNCT
bionys-650	155	21	m.	m.	NOUN
bionys-650	155	22	,	,	PUNCT
bionys-650	155	23	ashour	ashour	NOUN
bionys-650	155	24	,	,	PUNCT
bionys-650	155	25	n.	n.	PROPN
bionys-650	155	26	a.	a.	PROPN
bionys-650	155	27	,	,	PUNCT
bionys-650	155	28	zaid	zaid	PROPN
bionys-650	155	29	,	,	PUNCT
bionys-650	155	30	r.	r.	PROPN
bionys-650	155	31	t.	t.	PROPN
bionys-650	155	32	,	,	PUNCT
bionys-650	155	33	roh	roh	PROPN
bionys-650	155	34	,	,	PUNCT
bionys-650	155	35	e.	e.	PROPN
bionys-650	155	36	j.	j.	PROPN
bionys-650	155	37	,	,	PUNCT
bionys-650	155	38	elkamhawy	elkamhawy	PROPN
bionys-650	155	39	,	,	PUNCT
bionys-650	155	40	a.	a.	PROPN
bionys-650	155	41	,	,	PUNCT
bionys-650	155	42	&	&	CCONJ
bionys-650	155	43	al	al	PROPN
bionys-650	155	44	-	-	PUNCT
bionys-650	155	45	karmalawy	karmalawy	PROPN
bionys-650	155	46	,	,	PUNCT
bionys-650	155	47	a.	a.	NOUN
bionys-650	155	48	a.	a.	NOUN
bionys-650	155	49	(	(	PUNCT
bionys-650	155	50	2023	2023	NUM
bionys-650	155	51	)	)	PUNCT
bionys-650	155	52	.	.	PUNCT
bionys-650	156	1	diabetes	diabetes	NOUN
bionys-650	156	2	mellitus	mellitus	NOUN
bionys-650	156	3	:	:	PUNCT
bionys-650	156	4	classification	classification	NOUN
bionys-650	156	5	,	,	PUNCT
bionys-650	156	6	mediators	mediator	NOUN
bionys-650	156	7	,	,	PUNCT
bionys-650	156	8	and	and	CCONJ
bionys-650	156	9	complications	complication	NOUN
bionys-650	156	10	;	;	PUNCT
bionys-650	156	11	a	a	DET
bionys-650	156	12	gate	gate	NOUN
bionys-650	156	13	to	to	PART
bionys-650	156	14	identify	identify	VERB
bionys-650	156	15	potential	potential	ADJ
bionys-650	156	16	targets	target	NOUN
bionys-650	156	17	for	for	ADP
bionys-650	156	18	the	the	DET
bionys-650	156	19	development	development	NOUN
bionys-650	156	20	of	of	ADP
bionys-650	156	21	new	new	ADJ
bionys-650	156	22	effective	effective	ADJ
bionys-650	156	23	treatments	treatment	NOUN
bionys-650	156	24	.	.	PUNCT
bionys-650	157	1	biomedicine	biomedicine	NOUN
bionys-650	157	2	&	&	CCONJ
bionys-650	157	3	pharmacotherapy	pharmacotherapy	NOUN
bionys-650	157	4	,	,	PUNCT
bionys-650	157	5	168	168	NUM
bionys-650	157	6	,	,	PUNCT
bionys-650	157	7	article	article	NOUN
bionys-650	157	8	115734	115734	NUM
bionys-650	157	9	.	.	PUNCT
bionys-650	158	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
bionys-650	158	2	.	.	PUNCT
bionys-650	159	1	biopha.2023.115734	biopha.2023.115734	PRON
bionys-650	159	2	arafat	arafat	PROPN
bionys-650	159	3	,	,	PUNCT
bionys-650	159	4	e.	e.	PROPN
bionys-650	159	5	,	,	PUNCT
bionys-650	159	6	taha	taha	PROPN
bionys-650	159	7	,	,	PUNCT
bionys-650	159	8	i.	i.	PROPN
bionys-650	159	9	,	,	PUNCT
bionys-650	159	10	kattan	kattan	PROPN
bionys-650	159	11	,	,	PUNCT
bionys-650	159	12	s.	s.	PROPN
bionys-650	159	13	,	,	PUNCT
bionys-650	159	14	babteen	babteen	PROPN
bionys-650	159	15	,	,	PUNCT
bionys-650	159	16	n.	n.	PROPN
bionys-650	159	17	,	,	PUNCT
bionys-650	159	18	&	&	CCONJ
bionys-650	159	19	fawzy	fawzy	PROPN
bionys-650	159	20	,	,	PUNCT
bionys-650	159	21	i.	i.	PROPN
bionys-650	159	22	(	(	PUNCT
bionys-650	159	23	2020	2020	NUM
bionys-650	159	24	)	)	PUNCT
bionys-650	159	25	.	.	PUNCT
bionys-650	160	1	associations	association	NOUN
bionys-650	160	2	between	between	ADP
bionys-650	160	3	vitamin	vitamin	NOUN
bionys-650	160	4	d	d	NOUN
bionys-650	160	5	and	and	CCONJ
bionys-650	160	6	type	type	NOUN
bionys-650	160	7	2	2	NUM
bionys-650	160	8	diabetes	diabetes	NOUN
bionys-650	160	9	mellitus	mellitus	NOUN
bionys-650	160	10	:	:	PUNCT
bionys-650	160	11	the	the	DET
bionys-650	160	12	role	role	NOUN
bionys-650	160	13	of	of	ADP
bionys-650	160	14	vitamin	vitamin	NOUN
bionys-650	160	15	d	d	NOUN
bionys-650	160	16	receptor	receptor	NOUN
bionys-650	160	17	and	and	CCONJ
bionys-650	160	18	binding	bind	VERB
bionys-650	160	19	protein	protein	NOUN
bionys-650	160	20	.	.	PUNCT
bionys-650	161	1	journal	journal	PROPN
bionys-650	161	2	of	of	ADP
bionys-650	161	3	diabetes	diabete	NOUN
bionys-650	161	4	mellitus	mellitus	NOUN
bionys-650	161	5	,	,	PUNCT
bionys-650	161	6	10(4	10(4	NUM
bionys-650	161	7	)	)	PUNCT
bionys-650	161	8	,	,	PUNCT
bionys-650	161	9	222–235	222–235	NUM
bionys-650	161	10	.	.	PUNCT
bionys-650	162	1	https://doi.org/10.4236/	https://doi.org/10.4236/	PROPN
bionys-650	162	2	jdm.2020.104018	jdm.2020.104018	PROPN
bionys-650	162	3	bayih	bayih	NOUN
bionys-650	162	4	,	,	PUNCT
bionys-650	162	5	a.	a.	NOUN
bionys-650	162	6	,	,	PUNCT
bionys-650	162	7	dedefo	dedefo	PROPN
bionys-650	162	8	,	,	PUNCT
bionys-650	162	9	g.	g.	PROPN
bionys-650	162	10	,	,	PUNCT
bionys-650	162	11	kinde	kinde	PROPN
bionys-650	162	12	,	,	PUNCT
bionys-650	162	13	s.	s.	PROPN
bionys-650	162	14	,	,	PUNCT
bionys-650	162	15	&	&	CCONJ
bionys-650	162	16	et	et	PROPN
bionys-650	162	17	al	al	PROPN
bionys-650	162	18	.	.	PROPN
bionys-650	162	19	(	(	PUNCT
bionys-650	162	20	2024	2024	NUM
bionys-650	162	21	)	)	PUNCT
bionys-650	162	22	.	.	PUNCT
bionys-650	163	1	serum	serum	PROPN
bionys-650	163	2	ferritin	ferritin	ADJ
bionys-650	163	3	level	level	NOUN
bionys-650	163	4	and	and	CCONJ
bionys-650	163	5	associated	associated	ADJ
bionys-650	163	6	factors	factor	NOUN
bionys-650	163	7	among	among	ADP
bionys-650	163	8	uncontrolled	uncontrolled	ADJ
bionys-650	163	9	adult	adult	NOUN
bionys-650	163	10	type	type	NOUN
bionys-650	163	11	ii	ii	PROPN
bionys-650	163	12	diabetic	diabetic	ADJ
bionys-650	163	13	follow	follow	NOUN
bionys-650	163	14	-	-	PUNCT
bionys-650	163	15	up	up	ADP
bionys-650	163	16	patients	patient	NOUN
bionys-650	163	17	:	:	PUNCT
bionys-650	163	18	comparative	comparative	NOUN
bionys-650	163	19	-	-	PUNCT
bionys-650	163	20	based	base	VERB
bionys-650	163	21	cross	cross	ADJ
bionys-650	163	22	-	-	ADJ
bionys-650	163	23	sectional	sectional	ADJ
bionys-650	163	24	study	study	NOUN
bionys-650	163	25	.	.	PUNCT
bionys-650	164	1	bmc	bmc	ADJ
bionys-650	164	2	endocrine	endocrine	NOUN
bionys-650	164	3	disorders	disorder	NOUN
bionys-650	164	4	,	,	PUNCT
bionys-650	164	5	24(144	24(144	NOUN
bionys-650	164	6	)	)	PUNCT
bionys-650	164	7	.	.	PUNCT
bionys-650	165	1	https://doi	https://doi	X
bionys-650	165	2	.	.	PUNCT
bionys-650	165	3	org/10.1186	org/10.1186	PROPN
bionys-650	165	4	/	/	SYM
bionys-650	165	5	s12902	s12902	PROPN
bionys-650	165	6	-	-	PUNCT
bionys-650	165	7	024	024	NUM
bionys-650	165	8	-	-	PUNCT
bionys-650	165	9	01665	01665	NUM
bionys-650	165	10	-	-	PUNCT
bionys-650	165	11	7	7	NUM
bionys-650	165	12	crook	crook	NOUN
bionys-650	165	13	,	,	PUNCT
bionys-650	165	14	d.	d.	PROPN
bionys-650	165	15	,	,	PUNCT
bionys-650	165	16	&	&	CCONJ
bionys-650	165	17	godsland	godsland	PROPN
bionys-650	165	18	,	,	PUNCT
bionys-650	165	19	i.	i.	PROPN
bionys-650	165	20	(	(	PUNCT
bionys-650	165	21	1998	1998	NUM
bionys-650	165	22	)	)	PUNCT
bionys-650	165	23	.	.	PUNCT
bionys-650	166	1	safety	safety	NOUN
bionys-650	166	2	evaluation	evaluation	NOUN
bionys-650	166	3	by	by	ADP
bionys-650	166	4	contrast	contrast	NOUN
bionys-650	166	5	,	,	PUNCT
bionys-650	166	6	no	no	DET
bionys-650	166	7	statistically	statistically	ADV
bionys-650	166	8	significant	significant	ADJ
bionys-650	166	9	differences	difference	NOUN
bionys-650	166	10	were	be	AUX
bionys-650	166	11	found	find	VERB
bionys-650	166	12	in	in	ADP
bionys-650	166	13	gpt	gpt	NOUN
bionys-650	166	14	and	and	CCONJ
bionys-650	166	15	alp	alp	PROPN
bionys-650	166	16	levels	level	NOUN
bionys-650	166	17	between	between	ADP
bionys-650	166	18	the	the	DET
bionys-650	166	19	two	two	NUM
bionys-650	166	20	groups	group	NOUN
bionys-650	166	21	.	.	PUNCT
bionys-650	167	1	nonetheless	nonetheless	ADV
bionys-650	167	2	,	,	PUNCT
bionys-650	167	3	previous	previous	ADJ
bionys-650	167	4	research	research	NOUN
bionys-650	167	5	indicates	indicate	VERB
bionys-650	167	6	that	that	SCONJ
bionys-650	167	7	elevated	elevated	ADJ
bionys-650	167	8	gpt	gpt	NOUN
bionys-650	167	9	and	and	CCONJ
bionys-650	167	10	alp	alp	NOUN
bionys-650	167	11	may	may	AUX
bionys-650	167	12	arise	arise	VERB
bionys-650	167	13	from	from	ADP
bionys-650	167	14	liver	liver	NOUN
bionys-650	167	15	conditions	condition	NOUN
bionys-650	167	16	such	such	ADJ
bionys-650	167	17	as	as	ADP
bionys-650	167	18	hepatitis	hepatitis	NOUN
bionys-650	167	19	or	or	CCONJ
bionys-650	167	20	biliary	biliary	NOUN
bionys-650	167	21	disorders	disorder	NOUN
bionys-650	167	22	.	.	PUNCT
bionys-650	168	1	it	it	PRON
bionys-650	168	2	may	may	AUX
bionys-650	168	3	also	also	ADV
bionys-650	168	4	be	be	AUX
bionys-650	168	5	linked	link	VERB
bionys-650	168	6	to	to	ADP
bionys-650	168	7	abnormalities	abnormality	NOUN
bionys-650	168	8	in	in	ADP
bionys-650	168	9	bone	bone	NOUN
bionys-650	168	10	metabolism	metabolism	NOUN
bionys-650	168	11	or	or	CCONJ
bionys-650	168	12	long	long	ADJ
bionys-650	168	13	-	-	PUNCT
bionys-650	168	14	term	term	NOUN
bionys-650	168	15	hyperglycemia	hyperglycemia	NOUN
bionys-650	168	16	(	(	PUNCT
bionys-650	168	17	rafaqat	rafaqat	NOUN
bionys-650	168	18	et	et	PROPN
bionys-650	168	19	al	al	PROPN
bionys-650	168	20	.	.	PROPN
bionys-650	168	21	,	,	PUNCT
bionys-650	168	22	2023	2023	NUM
bionys-650	168	23	)	)	PUNCT
bionys-650	168	24	.	.	PUNCT
bionys-650	169	1	these	these	DET
bionys-650	169	2	parameters	parameter	NOUN
bionys-650	169	3	,	,	PUNCT
bionys-650	169	4	relevant	relevant	ADJ
bionys-650	169	5	in	in	ADP
bionys-650	169	6	specific	specific	ADJ
bionys-650	169	7	metabolic	metabolic	NOUN
bionys-650	169	8	or	or	CCONJ
bionys-650	169	9	comorbid	comorbid	NOUN
bionys-650	169	10	contexts	context	NOUN
bionys-650	169	11	.	.	PUNCT
bionys-650	170	1	importantly	importantly	ADV
bionys-650	170	2	,	,	PUNCT
bionys-650	170	3	liver	liver	NOUN
bionys-650	170	4	function	function	NOUN
bionys-650	170	5	plays	play	VERB
bionys-650	170	6	a	a	DET
bionys-650	170	7	crucial	crucial	ADJ
bionys-650	170	8	role	role	NOUN
bionys-650	170	9	in	in	ADP
bionys-650	170	10	the	the	DET
bionys-650	170	11	hydroxylation	hydroxylation	NOUN
bionys-650	170	12	and	and	CCONJ
bionys-650	170	13	activation	activation	NOUN
bionys-650	170	14	of	of	ADP
bionys-650	170	15	vitamin	vitamin	NOUN
bionys-650	170	16	d.	d.	PROPN
bionys-650	171	1	any	any	DET
bionys-650	171	2	hepatic	hepatic	ADJ
bionys-650	171	3	impairment	impairment	NOUN
bionys-650	171	4	can	can	AUX
bionys-650	171	5	disrupt	disrupt	VERB
bionys-650	171	6	this	this	DET
bionys-650	171	7	conversion	conversion	NOUN
bionys-650	171	8	,	,	PUNCT
bionys-650	171	9	potentially	potentially	ADV
bionys-650	171	10	reducing	reduce	VERB
bionys-650	171	11	active	active	ADJ
bionys-650	171	12	vitamin	vitamin	NOUN
bionys-650	171	13	d	d	NOUN
bionys-650	171	14	availability	availability	NOUN
bionys-650	171	15	and	and	CCONJ
bionys-650	171	16	contributing	contribute	VERB
bionys-650	171	17	to	to	ADP
bionys-650	171	18	the	the	DET
bionys-650	171	19	progression	progression	NOUN
bionys-650	171	20	of	of	ADP
bionys-650	171	21	t2d	t2d	NOUN
bionys-650	171	22	.	.	PUNCT
bionys-650	172	1	the	the	DET
bionys-650	172	2	observed	observe	VERB
bionys-650	172	3	elevations	elevation	NOUN
bionys-650	172	4	in	in	ADP
bionys-650	172	5	tsb	tsb	PROPN
bionys-650	172	6	and	and	CCONJ
bionys-650	172	7	got	get	VERB
bionys-650	172	8	levels	level	NOUN
bionys-650	172	9	may	may	AUX
bionys-650	172	10	reflect	reflect	VERB
bionys-650	172	11	subtle	subtle	ADJ
bionys-650	172	12	liver	liver	NOUN
bionys-650	172	13	dysfunction	dysfunction	NOUN
bionys-650	172	14	in	in	ADP
bionys-650	172	15	diabetic	diabetic	ADJ
bionys-650	172	16	individuals	individual	NOUN
bionys-650	172	17	,	,	PUNCT
bionys-650	172	18	underscoring	underscore	VERB
bionys-650	172	19	the	the	DET
bionys-650	172	20	interconnected	interconnected	ADJ
bionys-650	172	21	nature	nature	NOUN
bionys-650	172	22	of	of	ADP
bionys-650	172	23	hepatic	hepatic	ADJ
bionys-650	172	24	health	health	NOUN
bionys-650	172	25	and	and	CCONJ
bionys-650	172	26	vitamin	vitamin	NOUN
bionys-650	172	27	d	d	NOUN
bionys-650	172	28	metabolism	metabolism	NOUN
bionys-650	172	29	.	.	PUNCT
bionys-650	173	1	renal	renal	ADJ
bionys-650	173	2	function	function	NOUN
bionys-650	173	3	analysis	analysis	NOUN
bionys-650	173	4	revealed	reveal	VERB
bionys-650	173	5	no	no	DET
bionys-650	173	6	statistically	statistically	ADV
bionys-650	173	7	significant	significant	ADJ
bionys-650	173	8	differences	difference	NOUN
bionys-650	173	9	in	in	ADP
bionys-650	173	10	urea	urea	NOUN
bionys-650	173	11	or	or	CCONJ
bionys-650	173	12	creatinine	creatinine	NOUN
bionys-650	173	13	levels	level	NOUN
bionys-650	173	14	between	between	ADP
bionys-650	173	15	participants	participant	NOUN
bionys-650	173	16	with	with	ADP
bionys-650	173	17	diabetes	diabetes	NOUN
bionys-650	173	18	and	and	CCONJ
bionys-650	173	19	those	those	PRON
bionys-650	173	20	without	without	ADP
bionys-650	173	21	diabetes	diabetes	NOUN
bionys-650	173	22	.	.	PUNCT
bionys-650	174	1	urea	urea	PROPN
bionys-650	174	2	concentrations	concentration	NOUN
bionys-650	174	3	were	be	AUX
bionys-650	174	4	comparable	comparable	ADJ
bionys-650	174	5	between	between	ADP
bionys-650	174	6	the	the	DET
bionys-650	174	7	t2d	t2d	NOUN
bionys-650	174	8	group	group	NOUN
bionys-650	174	9	(	(	PUNCT
bionys-650	174	10	31.85±4.70	31.85±4.70	NUM
bionys-650	174	11	mg	mg	PROPN
bionys-650	174	12	/	/	SYM
bionys-650	174	13	dl	dl	PROPN
bionys-650	174	14	)	)	PUNCT
bionys-650	174	15	and	and	CCONJ
bionys-650	174	16	the	the	DET
bionys-650	174	17	control	control	NOUN
bionys-650	174	18	group	group	NOUN
bionys-650	174	19	(	(	PUNCT
bionys-650	174	20	32.05±4.25	32.05±4.25	PROPN
bionys-650	174	21	mg/	mg/	PROPN
bionys-650	174	22	dl	dl	PROPN
bionys-650	174	23	;	;	PUNCT
bionys-650	174	24	p=0.807	p=0.807	NUM
bionys-650	174	25	)	)	PUNCT
bionys-650	174	26	.	.	PUNCT
bionys-650	175	1	similarly	similarly	ADV
bionys-650	175	2	,	,	PUNCT
bionys-650	175	3	creatinine	creatinine	NOUN
bionys-650	175	4	levels	level	NOUN
bionys-650	175	5	showed	show	VERB
bionys-650	175	6	minimal	minimal	ADJ
bionys-650	175	7	variation	variation	NOUN
bionys-650	175	8	,	,	PUNCT
bionys-650	175	9	with	with	ADP
bionys-650	175	10	the	the	DET
bionys-650	175	11	diabetic	diabetic	ADJ
bionys-650	175	12	group	group	NOUN
bionys-650	175	13	averaging	average	VERB
bionys-650	175	14	0.76±0.12	0.76±0.12	NUM
bionys-650	175	15	mg	mg	PROPN
bionys-650	175	16	/	/	SYM
bionys-650	175	17	dl	dl	PROPN
bionys-650	175	18	and	and	CCONJ
bionys-650	175	19	the	the	DET
bionys-650	175	20	control	control	NOUN
bionys-650	175	21	group	group	NOUN
bionys-650	175	22	averaging	average	VERB
bionys-650	175	23	0.73±0.13	0.73±0.13	NOUN
bionys-650	175	24	mg	mg	PROPN
bionys-650	175	25	/	/	SYM
bionys-650	175	26	dl	dl	PROPN
bionys-650	175	27	(	(	PUNCT
bionys-650	175	28	p=0.185	p=0.185	NOUN
bionys-650	175	29	)	)	PUNCT
bionys-650	175	30	.	.	PUNCT
bionys-650	176	1	these	these	DET
bionys-650	176	2	findings	finding	NOUN
bionys-650	176	3	suggest	suggest	VERB
bionys-650	176	4	that	that	SCONJ
bionys-650	176	5	renal	renal	ADJ
bionys-650	176	6	impairment	impairment	NOUN
bionys-650	176	7	was	be	AUX
bionys-650	176	8	not	not	PART
bionys-650	176	9	apparent	apparent	ADJ
bionys-650	176	10	within	within	ADP
bionys-650	176	11	the	the	DET
bionys-650	176	12	study	study	NOUN
bionys-650	176	13	population	population	NOUN
bionys-650	176	14	.	.	PUNCT
bionys-650	177	1	however	however	ADV
bionys-650	177	2	,	,	PUNCT
bionys-650	177	3	this	this	PRON
bionys-650	177	4	contrasts	contrast	VERB
bionys-650	177	5	with	with	ADP
bionys-650	177	6	prior	prior	ADJ
bionys-650	177	7	research	research	NOUN
bionys-650	177	8	indicating	indicate	VERB
bionys-650	177	9	that	that	SCONJ
bionys-650	177	10	elevated	elevated	ADJ
bionys-650	177	11	urea	urea	NOUN
bionys-650	177	12	and	and	CCONJ
bionys-650	177	13	creatinine	creatinine	NOUN
bionys-650	177	14	are	be	AUX
bionys-650	177	15	commonly	commonly	ADV
bionys-650	177	16	observed	observe	VERB
bionys-650	177	17	in	in	ADP
bionys-650	177	18	patients	patient	NOUN
bionys-650	177	19	with	with	ADP
bionys-650	177	20	t2d	t2d	NOUN
bionys-650	177	21	,	,	PUNCT
bionys-650	177	22	reflecting	reflect	VERB
bionys-650	177	23	progressive	progressive	ADJ
bionys-650	177	24	kidney	kidney	NOUN
bionys-650	177	25	damage	damage	NOUN
bionys-650	177	26	(	(	PUNCT
bionys-650	177	27	lad	lad	NOUN
bionys-650	177	28	&	&	CCONJ
bionys-650	177	29	kava	kava	PROPN
bionys-650	177	30	,	,	PUNCT
bionys-650	177	31	2019	2019	NUM
bionys-650	177	32	)	)	PUNCT
bionys-650	177	33	.	.	PUNCT
bionys-650	178	1	a	a	DET
bionys-650	178	2	high	high	ADJ
bionys-650	178	3	prevalence	prevalence	NOUN
bionys-650	178	4	of	of	ADP
bionys-650	178	5	renal	renal	ADJ
bionys-650	178	6	dysfunction	dysfunction	NOUN
bionys-650	178	7	has	have	AUX
bionys-650	178	8	also	also	ADV
bionys-650	178	9	been	be	AUX
bionys-650	178	10	documented	document	VERB
bionys-650	178	11	among	among	ADP
bionys-650	178	12	individuals	individual	NOUN
bionys-650	178	13	with	with	ADP
bionys-650	178	14	diabetes	diabetes	NOUN
bionys-650	178	15	,	,	PUNCT
bionys-650	178	16	highlighting	highlight	VERB
bionys-650	178	17	the	the	DET
bionys-650	178	18	importance	importance	NOUN
bionys-650	178	19	of	of	ADP
bionys-650	178	20	early	early	ADJ
bionys-650	178	21	screening	screening	NOUN
bionys-650	178	22	and	and	CCONJ
bionys-650	178	23	ongoing	ongoing	ADJ
bionys-650	178	24	monitoring	monitoring	NOUN
bionys-650	178	25	of	of	ADP
bionys-650	178	26	kidney	kidney	NOUN
bionys-650	178	27	health	health	NOUN
bionys-650	178	28	in	in	ADP
bionys-650	178	29	this	this	DET
bionys-650	178	30	population	population	NOUN
bionys-650	178	31	(	(	PUNCT
bionys-650	178	32	shahwan	shahwan	PROPN
bionys-650	178	33	et	et	PROPN
bionys-650	178	34	al	al	PROPN
bionys-650	178	35	.	.	PROPN
bionys-650	178	36	,	,	PUNCT
bionys-650	178	37	2019	2019	NUM
bionys-650	178	38	)	)	PUNCT
bionys-650	178	39	.	.	PUNCT
bionys-650	179	1	it	it	PRON
bionys-650	179	2	is	be	AUX
bionys-650	179	3	essential	essential	ADJ
bionys-650	179	4	to	to	PART
bionys-650	179	5	note	note	VERB
bionys-650	179	6	that	that	SCONJ
bionys-650	179	7	the	the	DET
bionys-650	179	8	kidneys	kidney	NOUN
bionys-650	179	9	play	play	VERB
bionys-650	179	10	a	a	DET
bionys-650	179	11	crucial	crucial	ADJ
bionys-650	179	12	role	role	NOUN
bionys-650	179	13	in	in	ADP
bionys-650	179	14	converting	convert	VERB
bionys-650	179	15	vitamin	vitamin	NOUN
bionys-650	179	16	d	d	NOUN
bionys-650	179	17	into	into	ADP
bionys-650	179	18	its	its	PRON
bionys-650	179	19	active	active	ADJ
bionys-650	179	20	form	form	NOUN
bionys-650	179	21	.	.	PUNCT
bionys-650	180	1	any	any	DET
bionys-650	180	2	decline	decline	NOUN
bionys-650	180	3	in	in	ADP
bionys-650	180	4	renal	renal	ADJ
bionys-650	180	5	function	function	NOUN
bionys-650	180	6	may	may	AUX
bionys-650	180	7	compromise	compromise	VERB
bionys-650	180	8	vitamin	vitamin	NOUN
bionys-650	180	9	d	d	NOUN
bionys-650	180	10	activation	activation	NOUN
bionys-650	180	11	,	,	PUNCT
bionys-650	180	12	thereby	thereby	ADV
bionys-650	180	13	reduce	reduce	VERB
bionys-650	180	14	its	its	PRON
bionys-650	180	15	physiological	physiological	ADJ
bionys-650	180	16	effectiveness	effectiveness	NOUN
bionys-650	180	17	and	and	CCONJ
bionys-650	180	18	increase	increase	VERB
bionys-650	180	19	susceptibility	susceptibility	NOUN
bionys-650	180	20	to	to	ADP
bionys-650	180	21	metabolic	metabolic	NOUN
bionys-650	180	22	disturbances	disturbance	NOUN
bionys-650	180	23	,	,	PUNCT
bionys-650	180	24	such	such	ADJ
bionys-650	180	25	as	as	ADP
bionys-650	180	26	type	type	NOUN
bionys-650	180	27	2	2	NUM
bionys-650	180	28	diabetes	diabetes	NOUN
bionys-650	180	29	.	.	PUNCT
bionys-650	181	1	conclusion	conclusion	NOUN
bionys-650	181	2	in	in	ADP
bionys-650	181	3	conclusion	conclusion	NOUN
bionys-650	181	4	,	,	PUNCT
bionys-650	181	5	this	this	DET
bionys-650	181	6	study	study	NOUN
bionys-650	181	7	demonstrates	demonstrate	VERB
bionys-650	181	8	that	that	SCONJ
bionys-650	181	9	while	while	SCONJ
bionys-650	181	10	vitamin	vitamin	NOUN
bionys-650	181	11	d3	d3	PROPN
bionys-650	181	12	levels	level	NOUN
bionys-650	181	13	did	do	AUX
bionys-650	181	14	not	not	PART
bionys-650	181	15	differ	differ	VERB
bionys-650	181	16	significantly	significantly	ADV
bionys-650	181	17	between	between	ADP
bionys-650	181	18	diabetic	diabetic	ADJ
bionys-650	181	19	and	and	CCONJ
bionys-650	181	20	non	non	ADJ
bionys-650	181	21	-	-	ADJ
bionys-650	181	22	diabetic	diabetic	ADJ
bionys-650	181	23	iraqi	iraqi	ADJ
bionys-650	181	24	men	man	NOUN
bionys-650	181	25	,	,	PUNCT
bionys-650	181	26	functional	functional	ADJ
bionys-650	181	27	disruptions	disruption	NOUN
bionys-650	181	28	in	in	ADP
bionys-650	181	29	vitamin	vitamin	NOUN
bionys-650	181	30	d	d	NOUN
bionys-650	181	31	transport	transport	NOUN
bionys-650	181	32	and	and	CCONJ
bionys-650	181	33	activation	activation	NOUN
bionys-650	181	34	—	—	PUNCT
bionys-650	181	35	reflected	reflect	VERB
bionys-650	181	36	in	in	ADP
bionys-650	181	37	altered	altered	ADJ
bionys-650	181	38	vdbp	vdbp	NOUN
bionys-650	181	39	concentrations	concentration	NOUN
bionys-650	181	40	and	and	CCONJ
bionys-650	181	41	liver	liver	NOUN
bionys-650	181	42	functions	function	NOUN
bionys-650	181	43	—	—	PUNCT
bionys-650	181	44	may	may	AUX
bionys-650	181	45	contribute	contribute	VERB
bionys-650	181	46	to	to	ADP
bionys-650	181	47	impaired	impaired	ADJ
bionys-650	181	48	metabolic	metabolic	NOUN
bionys-650	181	49	regulation	regulation	NOUN
bionys-650	181	50	in	in	ADP
bionys-650	181	51	type	type	NOUN
bionys-650	181	52	2	2	NUM
bionys-650	181	53	diabetes	diabetes	NOUN
bionys-650	181	54	.	.	PUNCT
bionys-650	182	1	the	the	DET
bionys-650	182	2	data	datum	NOUN
bionys-650	182	3	affirm	affirm	NOUN
bionys-650	182	4	the	the	DET
bionys-650	182	5	central	central	ADJ
bionys-650	182	6	role	role	NOUN
bionys-650	182	7	of	of	ADP
bionys-650	182	8	insulin	insulin	NOUN
bionys-650	182	9	resistance	resistance	NOUN
bionys-650	182	10	in	in	ADP
bionys-650	182	11	disease	disease	NOUN
bionys-650	182	12	biologica	biologica	PROPN
bionys-650	182	13	nyssana	nyssana	PROPN
bionys-650	182	14	●	●	PUNCT
bionys-650	182	15	16	16	NUM
bionys-650	182	16	(	(	PUNCT
bionys-650	182	17	2	2	NUM
bionys-650	182	18	)	)	PUNCT
bionys-650	182	19	december	december	PROPN
bionys-650	182	20	2025	2025	NUM
bionys-650	182	21	:	:	PUNCT
bionys-650	182	22	kadhim	kadhim	PROPN
bionys-650	182	23	et	et	PROPN
bionys-650	182	24	al	al	PROPN
bionys-650	182	25	.	.	PUNCT
bionys-650	183	1	●	●	PUNCT
bionys-650	183	2	the	the	DET
bionys-650	183	3	association	association	NOUN
bionys-650	183	4	of	of	ADP
bionys-650	183	5	vitamin	vitamin	NOUN
bionys-650	183	6	d	d	PROPN
bionys-650	183	7	,	,	PUNCT
bionys-650	183	8	vitamin	vitamin	NOUN
bionys-650	183	9	d	d	NOUN
bionys-650	183	10	-	-	ADJ
bionys-650	183	11	binding	bind	VERB
bionys-650	183	12	protein	protein	NOUN
bionys-650	183	13	,	,	PUNCT
bionys-650	183	14	and	and	CCONJ
bionys-650	183	15	ferritin	ferritin	ADJ
bionys-650	183	16	levels	level	NOUN
bionys-650	183	17	in	in	ADP
bionys-650	183	18	iraqi	iraqi	ADJ
bionys-650	183	19	men	man	NOUN
bionys-650	183	20	with	with	ADP
bionys-650	183	21	type	type	NOUN
bionys-650	183	22	2	2	NUM
bionys-650	183	23	diabetes	diabetes	NOUN
bionys-650	183	24	of	of	ADP
bionys-650	183	25	modern	modern	ADJ
bionys-650	183	26	oral	oral	ADJ
bionys-650	183	27	contraceptives	contraceptive	NOUN
bionys-650	183	28	:	:	PUNCT
bionys-650	183	29	effects	effect	NOUN
bionys-650	183	30	on	on	ADP
bionys-650	183	31	lipoprotein	lipoprotein	ADJ
bionys-650	183	32	and	and	CCONJ
bionys-650	183	33	carbohydrate	carbohydrate	VERB
bionys-650	183	34	metabolism	metabolism	NOUN
bionys-650	183	35	.	.	PUNCT
bionys-650	184	1	contraception	contraception	NOUN
bionys-650	184	2	,	,	PUNCT
bionys-650	184	3	57(3	57(3	NUM
bionys-650	184	4	)	)	PUNCT
bionys-650	184	5	,	,	PUNCT
bionys-650	184	6	189–201	189–201	NUM
bionys-650	184	7	.	.	PUNCT
bionys-650	185	1	https://doi.org/10.1016/s00107824(98)00018-3	https://doi.org/10.1016/s00107824(98)00018-3	PROPN
bionys-650	185	2	forouhi	forouhi	PROPN
bionys-650	185	3	,	,	PUNCT
bionys-650	185	4	n.	n.	PROPN
bionys-650	185	5	g.	g.	PROPN
bionys-650	185	6	,	,	PUNCT
bionys-650	185	7	luan	luan	PROPN
bionys-650	185	8	,	,	PUNCT
bionys-650	185	9	j.	j.	PROPN
bionys-650	185	10	,	,	PUNCT
bionys-650	185	11	cooper	cooper	PROPN
bionys-650	185	12	,	,	PUNCT
bionys-650	185	13	a.	a.	PROPN
bionys-650	185	14	,	,	PUNCT
bionys-650	185	15	boucher	boucher	PROPN
bionys-650	185	16	,	,	PUNCT
bionys-650	185	17	b.	b.	PROPN
bionys-650	185	18	j.	j.	PROPN
bionys-650	185	19	,	,	PUNCT
bionys-650	185	20	&	&	CCONJ
bionys-650	185	21	wareham	wareham	PROPN
bionys-650	185	22	,	,	PUNCT
bionys-650	185	23	n.	n.	PROPN
bionys-650	185	24	j.	j.	PROPN
bionys-650	185	25	(	(	PUNCT
bionys-650	185	26	2008	2008	NUM
bionys-650	185	27	)	)	PUNCT
bionys-650	185	28	.	.	PUNCT
bionys-650	186	1	baseline	baseline	PROPN
bionys-650	186	2	serum	serum	PROPN
bionys-650	186	3	25	25	NUM
bionys-650	186	4	-	-	PUNCT
bionys-650	186	5	hydroxy	hydroxy	NOUN
bionys-650	186	6	vitamin	vitamin	NOUN
bionys-650	186	7	d	d	NOUN
bionys-650	186	8	is	be	AUX
bionys-650	186	9	predictive	predictive	ADJ
bionys-650	186	10	of	of	ADP
bionys-650	186	11	future	future	ADJ
bionys-650	186	12	glycemic	glycemic	ADJ
bionys-650	186	13	status	status	NOUN
bionys-650	186	14	and	and	CCONJ
bionys-650	186	15	insulin	insulin	NOUN
bionys-650	186	16	resistance	resistance	NOUN
bionys-650	186	17	:	:	PUNCT
bionys-650	186	18	the	the	DET
bionys-650	186	19	medical	medical	PROPN
bionys-650	186	20	research	research	PROPN
bionys-650	186	21	council	council	PROPN
bionys-650	186	22	ely	ely	ADV
bionys-650	186	23	prospective	prospective	ADJ
bionys-650	186	24	study	study	NOUN
bionys-650	186	25	1990	1990	NUM
bionys-650	186	26	–	–	PUNCT
bionys-650	186	27	2000	2000	NUM
bionys-650	186	28	.	.	PUNCT
bionys-650	187	1	diabetes	diabetes	NOUN
bionys-650	187	2	,	,	PUNCT
bionys-650	187	3	57(10	57(10	NUM
bionys-650	187	4	)	)	PUNCT
bionys-650	187	5	,	,	PUNCT
bionys-650	187	6	2619–2625	2619–2625	NUM
bionys-650	187	7	.	.	PUNCT
bionys-650	188	1	https://doi	https://doi	X
bionys-650	188	2	.	.	PUNCT
bionys-650	188	3	org/10.2337	org/10.2337	NOUN
bionys-650	188	4	/	/	SYM
bionys-650	188	5	db08	db08	PROPN
bionys-650	188	6	-	-	PUNCT
bionys-650	188	7	0593	0593	NUM
bionys-650	188	8	janoušek	janoušek	NOUN
bionys-650	188	9	,	,	PUNCT
bionys-650	188	10	j.	j.	PROPN
bionys-650	188	11	,	,	PUNCT
bionys-650	188	12	pilařová	pilařová	PROPN
bionys-650	188	13	,	,	PUNCT
bionys-650	188	14	v.	v.	ADV
bionys-650	188	15	,	,	PUNCT
bionys-650	188	16	macáková	macáková	PROPN
bionys-650	188	17	,	,	PUNCT
bionys-650	188	18	k.	k.	PROPN
bionys-650	188	19	,	,	PUNCT
bionys-650	188	20	nomura	nomura	NOUN
bionys-650	188	21	,	,	PUNCT
bionys-650	188	22	a.	a.	NOUN
bionys-650	188	23	,	,	PUNCT
bionys-650	188	24	veiga	veiga	ADJ
bionys-650	188	25	-	-	PUNCT
bionys-650	188	26	matos	matos	X
bionys-650	188	27	,	,	PUNCT
bionys-650	188	28	j.	j.	PROPN
bionys-650	188	29	,	,	PUNCT
bionys-650	188	30	silva	silva	PROPN
bionys-650	188	31	,	,	PUNCT
bionys-650	188	32	d.	d.	PROPN
bionys-650	188	33	d.	d.	PROPN
bionys-650	188	34	da	da	PROPN
bionys-650	188	35	,	,	PUNCT
bionys-650	188	36	…	…	PUNCT
bionys-650	188	37	mladěnka	mladěnka	NOUN
bionys-650	188	38	,	,	PUNCT
bionys-650	188	39	p.	p.	NOUN
bionys-650	188	40	(	(	PUNCT
bionys-650	188	41	2022	2022	NUM
bionys-650	188	42	)	)	PUNCT
bionys-650	188	43	.	.	PUNCT
bionys-650	189	1	vitamin	vitamin	NOUN
bionys-650	189	2	d	d	NOUN
bionys-650	189	3	:	:	PUNCT
bionys-650	189	4	sources	source	NOUN
bionys-650	189	5	,	,	PUNCT
bionys-650	189	6	physiological	physiological	ADJ
bionys-650	189	7	role	role	NOUN
bionys-650	189	8	,	,	PUNCT
bionys-650	189	9	biokinetics	biokinetic	NOUN
bionys-650	189	10	,	,	PUNCT
bionys-650	189	11	deficiency	deficiency	NOUN
bionys-650	189	12	,	,	PUNCT
bionys-650	189	13	therapeutic	therapeutic	ADJ
bionys-650	189	14	use	use	NOUN
bionys-650	189	15	,	,	PUNCT
bionys-650	189	16	toxicity	toxicity	NOUN
bionys-650	189	17	,	,	PUNCT
bionys-650	189	18	and	and	CCONJ
bionys-650	189	19	overview	overview	NOUN
bionys-650	189	20	of	of	ADP
bionys-650	189	21	analytical	analytical	ADJ
bionys-650	189	22	methods	method	NOUN
bionys-650	189	23	for	for	ADP
bionys-650	189	24	detection	detection	NOUN
bionys-650	189	25	of	of	ADP
bionys-650	189	26	vitamin	vitamin	NOUN
bionys-650	189	27	d	d	NOUN
bionys-650	189	28	and	and	CCONJ
bionys-650	189	29	its	its	PRON
bionys-650	189	30	metabolites	metabolite	NOUN
bionys-650	189	31	.	.	PUNCT
bionys-650	190	1	critical	critical	ADJ
bionys-650	190	2	reviews	review	NOUN
bionys-650	190	3	in	in	ADP
bionys-650	190	4	clinical	clinical	ADJ
bionys-650	190	5	laboratory	laboratory	NOUN
bionys-650	190	6	sciences	science	NOUN
bionys-650	190	7	,	,	PUNCT
bionys-650	190	8	59(8	59(8	NUM
bionys-650	190	9	)	)	PUNCT
bionys-650	190	10	,	,	PUNCT
bionys-650	190	11	517–554	517–554	NUM
bionys-650	190	12	.	.	PUNCT
bionys-650	191	1	https://doi.org/10.1080/10408363.2022.2070595	https://doi.org/10.1080/10408363.2022.2070595	PROPN
bionys-650	191	2	kakil	kakil	PROPN
bionys-650	191	3	,	,	PUNCT
bionys-650	191	4	d.	d.	PROPN
bionys-650	191	5	a.	a.	PROPN
bionys-650	191	6	,	,	PUNCT
bionys-650	191	7	&	&	CCONJ
bionys-650	191	8	meena	meena	PROPN
bionys-650	191	9	,	,	PUNCT
bionys-650	191	10	m.	m.	NOUN
bionys-650	191	11	q.	q.	PROPN
bionys-650	191	12	(	(	PUNCT
bionys-650	191	13	2020	2020	NUM
bionys-650	191	14	)	)	PUNCT
bionys-650	191	15	.	.	PUNCT
bionys-650	192	1	association	association	NOUN
bionys-650	192	2	of	of	ADP
bionys-650	192	3	serum	serum	NOUN
bionys-650	192	4	vitamin	vitamin	NOUN
bionys-650	192	5	d	d	NOUN
bionys-650	192	6	level	level	NOUN
bionys-650	192	7	with	with	ADP
bionys-650	192	8	glycemic	glycemic	ADJ
bionys-650	192	9	control	control	NOUN
bionys-650	192	10	in	in	ADP
bionys-650	192	11	patients	patient	NOUN
bionys-650	192	12	with	with	ADP
bionys-650	192	13	type	type	NOUN
bionys-650	192	14	2	2	NUM
bionys-650	192	15	diabetes	diabetes	NOUN
bionys-650	192	16	mellitus	mellitus	NOUN
bionys-650	192	17	.	.	PUNCT
bionys-650	193	1	zanco	zanco	PROPN
bionys-650	193	2	journal	journal	PROPN
bionys-650	193	3	of	of	ADP
bionys-650	193	4	medical	medical	ADJ
bionys-650	193	5	sciences	science	NOUN
bionys-650	193	6	,	,	PUNCT
bionys-650	193	7	24(3	24(3	NUM
bionys-650	193	8	)	)	PUNCT
bionys-650	193	9	,	,	PUNCT
bionys-650	193	10	395–400	395–400	NUM
bionys-650	193	11	.	.	PUNCT
bionys-650	194	1	https://doi	https://doi	X
bionys-650	194	2	.	.	PUNCT
bionys-650	194	3	org/10.15218	org/10.15218	PROPN
bionys-650	194	4	/	/	SYM
bionys-650	194	5	zjms.2020.047	zjms.2020.047	PROPN
bionys-650	194	6	lad	lad	PROPN
bionys-650	194	7	,	,	PUNCT
bionys-650	194	8	h.	h.	PROPN
bionys-650	194	9	d.	d.	PROPN
bionys-650	194	10	,	,	PUNCT
bionys-650	194	11	&	&	CCONJ
bionys-650	194	12	kava	kava	PROPN
bionys-650	194	13	,	,	PUNCT
bionys-650	194	14	d.	d.	PROPN
bionys-650	194	15	m.	m.	PROPN
bionys-650	194	16	(	(	PUNCT
bionys-650	194	17	2019	2019	NUM
bionys-650	194	18	)	)	PUNCT
bionys-650	194	19	.	.	PUNCT
bionys-650	195	1	comparative	comparative	ADJ
bionys-650	195	2	assessment	assessment	NOUN
bionys-650	195	3	of	of	ADP
bionys-650	195	4	renal	renal	ADJ
bionys-650	195	5	function	function	NOUN
bionys-650	195	6	between	between	ADP
bionys-650	195	7	type	type	NOUN
bionys-650	195	8	ii	ii	PROPN
bionys-650	195	9	diabetes	diabetes	NOUN
bionys-650	195	10	mellitus	mellitus	NOUN
bionys-650	195	11	and	and	CCONJ
bionys-650	195	12	non	non	ADJ
bionys-650	195	13	-	-	ADJ
bionys-650	195	14	diabetic	diabetic	ADJ
bionys-650	195	15	individuals	individual	NOUN
bionys-650	195	16	.	.	PUNCT
bionys-650	196	1	medpulse	medpulse	PROPN
bionys-650	196	2	international	international	PROPN
bionys-650	196	3	journal	journal	PROPN
bionys-650	196	4	of	of	ADP
bionys-650	196	5	biochemistry	biochemistry	NOUN
bionys-650	196	6	,	,	PUNCT
bionys-650	196	7	11(3	11(3	NUM
bionys-650	196	8	)	)	PUNCT
bionys-650	196	9	,	,	PUNCT
bionys-650	196	10	82–86	82–86	NUM
bionys-650	196	11	.	.	PUNCT
bionys-650	197	1	https://doi.org/10.26611/10021132	https://doi.org/10.26611/10021132	NOUN
bionys-650	197	2	pittas	pitta	NOUN
bionys-650	197	3	,	,	PUNCT
bionys-650	197	4	a.	a.	NOUN
bionys-650	197	5	g.	g.	PROPN
bionys-650	197	6	,	,	PUNCT
bionys-650	197	7	lau	lau	PROPN
bionys-650	197	8	,	,	PUNCT
bionys-650	197	9	j.	j.	PROPN
bionys-650	197	10	,	,	PUNCT
bionys-650	197	11	hu	hu	PROPN
bionys-650	197	12	,	,	PUNCT
bionys-650	197	13	f.	f.	PROPN
bionys-650	197	14	b.	b.	PROPN
bionys-650	197	15	,	,	PUNCT
bionys-650	197	16	&	&	CCONJ
bionys-650	197	17	dawson	dawson	PROPN
bionys-650	197	18	-	-	PUNCT
bionys-650	197	19	hughes	hughes	PROPN
bionys-650	197	20	,	,	PUNCT
bionys-650	197	21	b.	b.	PROPN
bionys-650	197	22	(	(	PUNCT
bionys-650	197	23	2007	2007	NUM
bionys-650	197	24	)	)	PUNCT
bionys-650	197	25	.	.	PUNCT
bionys-650	198	1	the	the	DET
bionys-650	198	2	role	role	NOUN
bionys-650	198	3	of	of	ADP
bionys-650	198	4	vitamin	vitamin	NOUN
bionys-650	198	5	d	d	NOUN
bionys-650	198	6	and	and	CCONJ
bionys-650	198	7	calcium	calcium	NOUN
bionys-650	198	8	in	in	ADP
bionys-650	198	9	type	type	NOUN
bionys-650	198	10	2	2	NUM
bionys-650	198	11	diabetes	diabetes	NOUN
bionys-650	198	12	:	:	PUNCT
bionys-650	198	13	a	a	DET
bionys-650	198	14	systematic	systematic	ADJ
bionys-650	198	15	review	review	NOUN
bionys-650	198	16	and	and	CCONJ
bionys-650	198	17	metaanalysis	metaanalysis	NOUN
bionys-650	198	18	.	.	PUNCT
bionys-650	199	1	the	the	DET
bionys-650	199	2	journal	journal	NOUN
bionys-650	199	3	of	of	ADP
bionys-650	199	4	clinical	clinical	ADJ
bionys-650	199	5	endocrinology	endocrinology	NOUN
bionys-650	199	6	&	&	CCONJ
bionys-650	199	7	metabolism	metabolism	NOUN
bionys-650	199	8	,	,	PUNCT
bionys-650	199	9	92(6	92(6	NOUN
bionys-650	199	10	)	)	PUNCT
bionys-650	199	11	,	,	PUNCT
bionys-650	199	12	2017–2029	2017–2029	NUM
bionys-650	199	13	.	.	PUNCT
bionys-650	200	1	https://doi	https://doi	NOUN
bionys-650	200	2	.	.	PUNCT
bionys-650	200	3	org/10.1210	org/10.1210	PROPN
bionys-650	200	4	/	/	SYM
bionys-650	200	5	jc.2007	jc.2007	PROPN
bionys-650	200	6	-	-	PUNCT
bionys-650	200	7	0298	0298	NUM
bionys-650	200	8	podmore	podmore	ADJ
bionys-650	200	9	,	,	PUNCT
bionys-650	200	10	c.	c.	NOUN
bionys-650	200	11	,	,	PUNCT
bionys-650	200	12	meidtner	meidtner	NOUN
bionys-650	200	13	,	,	PUNCT
bionys-650	200	14	k.	k.	PROPN
bionys-650	200	15	,	,	PUNCT
bionys-650	200	16	schulze	schulze	PROPN
bionys-650	200	17	,	,	PUNCT
bionys-650	200	18	m.	m.	PROPN
bionys-650	200	19	b.	b.	PROPN
bionys-650	200	20	,	,	PUNCT
bionys-650	200	21	scott	scott	PROPN
bionys-650	200	22	,	,	PUNCT
bionys-650	200	23	r.	r.	PROPN
bionys-650	200	24	a.	a.	PROPN
bionys-650	200	25	,	,	PUNCT
bionys-650	200	26	ramond	ramond	ADJ
bionys-650	200	27	,	,	PUNCT
bionys-650	200	28	a.	a.	NOUN
bionys-650	200	29	,	,	PUNCT
bionys-650	200	30	butterworth	butterworth	PROPN
bionys-650	200	31	,	,	PUNCT
bionys-650	200	32	a.	a.	PROPN
bionys-650	200	33	s.	s.	PROPN
bionys-650	200	34	,	,	PUNCT
bionys-650	200	35	di	di	PROPN
bionys-650	200	36	angelantonio	angelantonio	PROPN
bionys-650	200	37	,	,	PUNCT
bionys-650	200	38	e.	e.	PROPN
bionys-650	200	39	,	,	PUNCT
bionys-650	200	40	danesh	danesh	PROPN
bionys-650	200	41	,	,	PUNCT
bionys-650	200	42	j.	j.	PROPN
bionys-650	200	43	,	,	PUNCT
bionys-650	200	44	…	…	PUNCT
bionys-650	200	45	wareham	wareham	PROPN
bionys-650	200	46	,	,	PUNCT
bionys-650	200	47	n.	n.	PROPN
bionys-650	200	48	j.	j.	PROPN
bionys-650	200	49	(	(	PUNCT
bionys-650	200	50	2016	2016	NUM
bionys-650	200	51	)	)	PUNCT
bionys-650	200	52	.	.	PUNCT
bionys-650	201	1	association	association	NOUN
bionys-650	201	2	of	of	ADP
bionys-650	201	3	multiple	multiple	ADJ
bionys-650	201	4	biomarkers	biomarker	NOUN
bionys-650	201	5	of	of	ADP
bionys-650	201	6	iron	iron	NOUN
bionys-650	201	7	metabolism	metabolism	NOUN
bionys-650	201	8	and	and	CCONJ
bionys-650	201	9	type	type	NOUN
bionys-650	201	10	2	2	NUM
bionys-650	201	11	diabetes	diabete	NOUN
bionys-650	201	12	:	:	PUNCT
bionys-650	201	13	the	the	DET
bionys-650	201	14	epic	epic	ADJ
bionys-650	201	15	-	-	PUNCT
bionys-650	201	16	interact	interact	ADJ
bionys-650	201	17	study	study	NOUN
bionys-650	201	18	.	.	PUNCT
bionys-650	202	1	diabetes	diabetes	NOUN
bionys-650	202	2	care	care	NOUN
bionys-650	202	3	,	,	PUNCT
bionys-650	202	4	39(4	39(4	NOUN
bionys-650	202	5	)	)	PUNCT
bionys-650	202	6	,	,	PUNCT
bionys-650	202	7	572–581	572–581	NUM
bionys-650	202	8	.	.	PUNCT
bionys-650	203	1	https://doi	https://doi	PROPN
bionys-650	203	2	.	.	PUNCT
bionys-650	203	3	org/10.2337	org/10.2337	NOUN
bionys-650	203	4	/	/	SYM
bionys-650	203	5	dc15	dc15	PROPN
bionys-650	203	6	-	-	PUNCT
bionys-650	203	7	0257	0257	NUM
bionys-650	203	8	polonsky	polonsky	NOUN
bionys-650	203	9	,	,	PUNCT
bionys-650	203	10	k.	k.	PROPN
bionys-650	203	11	s.	s.	PROPN
bionys-650	203	12	,	,	PUNCT
bionys-650	203	13	&	&	CCONJ
bionys-650	203	14	burant	burant	PROPN
bionys-650	203	15	,	,	PUNCT
bionys-650	203	16	c.	c.	PROPN
bionys-650	203	17	f.	f.	PROPN
bionys-650	203	18	(	(	PUNCT
bionys-650	203	19	2015	2015	NUM
bionys-650	203	20	)	)	PUNCT
bionys-650	203	21	.	.	PUNCT
bionys-650	204	1	type	type	NOUN
bionys-650	204	2	2	2	NUM
bionys-650	204	3	diabetes	diabetes	NOUN
bionys-650	204	4	mellitus	mellitus	NOUN
bionys-650	204	5	.	.	PUNCT
bionys-650	205	1	in	in	ADP
bionys-650	205	2	williams	williams	PROPN
bionys-650	205	3	textbook	textbook	NOUN
bionys-650	205	4	of	of	ADP
bionys-650	205	5	endocrinology	endocrinology	NOUN
bionys-650	205	6	(	(	PUNCT
bionys-650	205	7	thirteenth	thirteenth	NOUN
bionys-650	205	8	edition	edition	NOUN
bionys-650	205	9	,	,	PUNCT
bionys-650	205	10	pp	pp	ADP
bionys-650	205	11	.	.	PUNCT
bionys-650	205	12	1385	1385	NUM
bionys-650	205	13	–	–	PUNCT
bionys-650	205	14	1450	1450	NUM
bionys-650	205	15	)	)	PUNCT
bionys-650	205	16	.	.	PUNCT
bionys-650	206	1	https://doi.org/10.1016/b978-0-323-297387.00031-9	https://doi.org/10.1016/b978-0-323-297387.00031-9	X
bionys-650	206	2	porchia	porchia	PROPN
bionys-650	206	3	,	,	PUNCT
bionys-650	206	4	l.	l.	PROPN
bionys-650	206	5	m.	m.	PROPN
bionys-650	206	6	,	,	PUNCT
bionys-650	206	7	ochoa	ochoa	NOUN
bionys-650	206	8	-	-	PUNCT
bionys-650	206	9	precoma	precoma	NOUN
bionys-650	206	10	,	,	PUNCT
bionys-650	206	11	r.	r.	PROPN
bionys-650	206	12	,	,	PUNCT
bionys-650	206	13	reyesalbarracín	reyesalbarracín	NOUN
bionys-650	206	14	,	,	PUNCT
bionys-650	206	15	y.	y.	PROPN
bionys-650	206	16	,	,	PUNCT
bionys-650	206	17	gonzalez	gonzalez	PROPN
bionys-650	206	18	-	-	PUNCT
bionys-650	206	19	mejia	mejia	PROPN
bionys-650	206	20	,	,	PUNCT
bionys-650	206	21	m.	m.	PROPN
bionys-650	206	22	e.	e.	PROPN
bionys-650	206	23	,	,	PUNCT
bionys-650	206	24	&	&	CCONJ
bionys-650	206	25	lópezbayghen	lópezbayghen	PROPN
bionys-650	206	26	,	,	PUNCT
bionys-650	206	27	e.	e.	PROPN
bionys-650	206	28	(	(	PUNCT
bionys-650	206	29	2024	2024	NUM
bionys-650	206	30	)	)	PUNCT
bionys-650	206	31	.	.	PUNCT
bionys-650	207	1	age	age	NOUN
bionys-650	207	2	-	-	PUNCT
bionys-650	207	3	related	relate	VERB
bionys-650	207	4	differences	difference	NOUN
bionys-650	207	5	in	in	ADP
bionys-650	207	6	fluctuations	fluctuation	NOUN
bionys-650	207	7	in	in	ADP
bionys-650	207	8	insulin	insulin	NOUN
bionys-650	207	9	resistance	resistance	NOUN
bionys-650	207	10	evaluated	evaluate	VERB
bionys-650	207	11	with	with	ADP
bionys-650	207	12	homa	homa	NOUN
bionys-650	207	13	-	-	PUNCT
bionys-650	207	14	ir	ir	PROPN
bionys-650	207	15	and	and	CCONJ
bionys-650	207	16	triglyceride	triglyceride	ADJ
bionys-650	207	17	and	and	CCONJ
bionys-650	207	18	glucose	glucose	NOUN
bionys-650	207	19	-	-	PUNCT
bionys-650	207	20	based	base	VERB
bionys-650	207	21	indices	index	NOUN
bionys-650	207	22	during	during	ADP
bionys-650	207	23	the	the	DET
bionys-650	207	24	menstrual	menstrual	ADJ
bionys-650	207	25	cycle	cycle	NOUN
bionys-650	207	26	,	,	PUNCT
bionys-650	207	27	as	as	SCONJ
bionys-650	207	28	determined	determine	VERB
bionys-650	207	29	using	use	VERB
bionys-650	207	30	the	the	DET
bionys-650	207	31	nhanes	nhane	NOUN
bionys-650	207	32	cross	cross	ADJ
bionys-650	207	33	-	-	ADJ
bionys-650	207	34	sectional	sectional	ADJ
bionys-650	207	35	dataset	dataset	NOUN
bionys-650	207	36	.	.	PUNCT
bionys-650	208	1	maturitas	maturita	NOUN
bionys-650	208	2	,	,	PUNCT
bionys-650	208	3	188	188	NUM
bionys-650	208	4	,	,	PUNCT
bionys-650	208	5	108085	108085	NUM
bionys-650	208	6	.	.	PUNCT
bionys-650	209	1	https://doi.org/10.1016/j	https://doi.org/10.1016/j	NOUN
bionys-650	209	2	.	.	PUNCT
bionys-650	210	1	maturitas.2024.108085	maturitas.2024.108085	PROPN
bionys-650	210	2	rafaqat	rafaqat	PROPN
bionys-650	210	3	,	,	PUNCT
bionys-650	210	4	s.	s.	PROPN
bionys-650	210	5	,	,	PUNCT
bionys-650	210	6	sattar	sattar	PROPN
bionys-650	210	7	,	,	PUNCT
bionys-650	210	8	a.	a.	PROPN
bionys-650	210	9	,	,	PUNCT
bionys-650	210	10	khalid	khalid	PROPN
bionys-650	210	11	,	,	PUNCT
bionys-650	210	12	a.	a.	PROPN
bionys-650	210	13	,	,	PUNCT
bionys-650	210	14	&	&	CCONJ
bionys-650	210	15	rafaqat	rafaqat	PROPN
bionys-650	210	16	,	,	PUNCT
bionys-650	210	17	s.	s.	PROPN
bionys-650	210	18	(	(	PUNCT
bionys-650	210	19	2023	2023	NUM
bionys-650	210	20	)	)	PUNCT
bionys-650	210	21	.	.	PUNCT
bionys-650	211	1	role	role	NOUN
bionys-650	211	2	of	of	ADP
bionys-650	211	3	liver	liver	NOUN
bionys-650	211	4	parameters	parameter	NOUN
bionys-650	211	5	in	in	ADP
bionys-650	211	6	diabetes	diabetes	NOUN
bionys-650	211	7	mellitus	mellitus	NOUN
bionys-650	211	8	–	–	PUNCT
bionys-650	211	9	a	a	DET
bionys-650	211	10	narrative	narrative	NOUN
bionys-650	211	11	review	review	NOUN
bionys-650	211	12	.	.	PUNCT
bionys-650	212	1	endocrine	endocrine	PROPN
bionys-650	212	2	regulations	regulation	NOUN
bionys-650	212	3	,	,	PUNCT
bionys-650	212	4	57(1	57(1	NUM
bionys-650	212	5	)	)	PUNCT
bionys-650	212	6	,	,	PUNCT
bionys-650	212	7	200–220	200–220	NUM
bionys-650	212	8	.	.	NOUN
bionys-650	212	9	https://doi.org/10.2478/enr-2023-0024	https://doi.org/10.2478/enr-2023-0024	PROPN
bionys-650	212	10	salim	salim	PROPN
bionys-650	212	11	,	,	PUNCT
bionys-650	212	12	k.	k.	PROPN
bionys-650	212	13	s.	s.	PROPN
bionys-650	212	14	,	,	PUNCT
bionys-650	212	15	ghassan	ghassan	PROPN
bionys-650	212	16	,	,	PUNCT
bionys-650	212	17	b.	b.	PROPN
bionys-650	212	18	,	,	PUNCT
bionys-650	212	19	al	al	PROPN
bionys-650	212	20	-	-	PUNCT
bionys-650	212	21	temimi	temimi	PROPN
bionys-650	212	22	,	,	PUNCT
bionys-650	212	23	a.	a.	NOUN
bionys-650	212	24	a.	a.	PROPN
bionys-650	212	25	,	,	PUNCT
bionys-650	212	26	&	&	CCONJ
bionys-650	212	27	alani	alani	PROPN
bionys-650	212	28	,	,	PUNCT
bionys-650	212	29	b.	b.	PROPN
bionys-650	212	30	g.	g.	PROPN
bionys-650	212	31	(	(	PUNCT
bionys-650	212	32	2023	2023	NUM
bionys-650	212	33	)	)	PUNCT
bionys-650	212	34	.	.	PUNCT
bionys-650	213	1	prevalence	prevalence	NOUN
bionys-650	213	2	of	of	ADP
bionys-650	213	3	vitamin	vitamin	NOUN
bionys-650	213	4	d	d	NOUN
bionys-650	213	5	deficiency	deficiency	NOUN
bionys-650	213	6	among	among	ADP
bionys-650	213	7	population	population	NOUN
bionys-650	213	8	in	in	ADP
bionys-650	213	9	iraq	iraq	PROPN
bionys-650	213	10	:	:	PUNCT
bionys-650	213	11	review	review	NOUN
bionys-650	213	12	article	article	NOUN
bionys-650	213	13	.	.	PUNCT
bionys-650	214	1	international	international	ADJ
bionys-650	214	2	journal	journal	PROPN
bionys-650	214	3	of	of	ADP
bionys-650	214	4	medical	medical	ADJ
bionys-650	214	5	science	science	NOUN
bionys-650	214	6	and	and	CCONJ
bionys-650	214	7	clinical	clinical	ADJ
bionys-650	214	8	research	research	NOUN
bionys-650	214	9	studies	study	NOUN
bionys-650	214	10	,	,	PUNCT
bionys-650	214	11	3(4	3(4	NUM
bionys-650	214	12	)	)	PUNCT
bionys-650	214	13	,	,	PUNCT
bionys-650	214	14	731–734	731–734	NUM
bionys-650	214	15	.	.	PUNCT
bionys-650	215	1	https://	https://	PROPN
bionys-650	215	2	doi.org/10.47191/ijmscrs/v3-i4-29	doi.org/10.47191/ijmscrs/v3-i4-29	NUM
bionys-650	215	3	shahwan	shahwan	PROPN
bionys-650	215	4	,	,	PUNCT
bionys-650	215	5	m.	m.	NOUN
bionys-650	215	6	j.	j.	PROPN
bionys-650	215	7	,	,	PUNCT
bionys-650	215	8	hassan	hassan	PROPN
bionys-650	215	9	,	,	PUNCT
bionys-650	215	10	n.	n.	PROPN
bionys-650	215	11	a.	a.	NOUN
bionys-650	215	12	g.	g.	PROPN
bionys-650	215	13	,	,	PUNCT
bionys-650	215	14	&	&	CCONJ
bionys-650	215	15	shaheen	shaheen	PROPN
bionys-650	215	16	,	,	PUNCT
bionys-650	215	17	r.	r.	PROPN
bionys-650	215	18	a.	a.	PROPN
bionys-650	215	19	(	(	PUNCT
bionys-650	215	20	2019	2019	NUM
bionys-650	215	21	)	)	PUNCT
bionys-650	215	22	.	.	PUNCT
bionys-650	216	1	assessment	assessment	NOUN
bionys-650	216	2	of	of	ADP
bionys-650	216	3	kidney	kidney	NOUN
bionys-650	216	4	function	function	NOUN
bionys-650	216	5	and	and	CCONJ
bionys-650	216	6	associated	associate	VERB
bionys-650	216	7	risk	risk	NOUN
bionys-650	216	8	factors	factor	NOUN
bionys-650	216	9	among	among	ADP
bionys-650	216	10	type	type	NOUN
bionys-650	216	11	2	2	NUM
bionys-650	216	12	diabetic	diabetic	ADJ
bionys-650	216	13	patients	patient	NOUN
bionys-650	216	14	.	.	PUNCT
bionys-650	217	1	diabetes	diabetes	NOUN
bionys-650	217	2	&	&	CCONJ
bionys-650	217	3	metabolic	metabolic	PROPN
bionys-650	217	4	syndrome	syndrome	PROPN
bionys-650	217	5	:	:	PUNCT
bionys-650	217	6	clinical	clinical	ADJ
bionys-650	217	7	research	research	NOUN
bionys-650	217	8	&	&	CCONJ
bionys-650	217	9	reviews	review	NOUN
bionys-650	217	10	,	,	PUNCT
bionys-650	217	11	13(4	13(4	NUM
bionys-650	217	12	)	)	PUNCT
bionys-650	217	13	,	,	PUNCT
bionys-650	217	14	2661–2665	2661–2665	NUM
bionys-650	217	15	.	.	PUNCT
bionys-650	218	1	https://doi	https://doi	X
bionys-650	218	2	.	.	PUNCT
bionys-650	218	3	org/10.1016	org/10.1016	PROPN
bionys-650	218	4	/	/	SYM
bionys-650	218	5	j.dsx.2019.07.025	j.dsx.2019.07.025	NOUN
bionys-650	218	6	szymczak	szymczak	NOUN
bionys-650	218	7	-	-	PUNCT
bionys-650	218	8	pajor	pajor	NOUN
bionys-650	218	9	,	,	PUNCT
bionys-650	218	10	i.	i.	NOUN
bionys-650	218	11	,	,	PUNCT
bionys-650	218	12	&	&	CCONJ
bionys-650	218	13	śliwińska	śliwińska	PROPN
bionys-650	218	14	,	,	PUNCT
bionys-650	218	15	a.	a.	NOUN
bionys-650	218	16	(	(	PUNCT
bionys-650	218	17	2019	2019	NUM
bionys-650	218	18	)	)	PUNCT
bionys-650	218	19	.	.	PUNCT
bionys-650	219	1	analysis	analysis	NOUN
bionys-650	219	2	of	of	ADP
bionys-650	219	3	association	association	NOUN
bionys-650	219	4	between	between	ADP
bionys-650	219	5	vitamin	vitamin	NOUN
bionys-650	219	6	d	d	NOUN
bionys-650	219	7	deficiency	deficiency	NOUN
bionys-650	219	8	and	and	CCONJ
bionys-650	219	9	insulin	insulin	NOUN
bionys-650	219	10	resistance	resistance	NOUN
bionys-650	219	11	.	.	PUNCT
bionys-650	220	1	nutrients	nutrient	NOUN
bionys-650	220	2	,	,	PUNCT
bionys-650	220	3	11(4	11(4	NUM
bionys-650	220	4	)	)	PUNCT
bionys-650	220	5	,	,	PUNCT
bionys-650	220	6	article	article	NOUN
bionys-650	220	7	794	794	NUM
bionys-650	220	8	.	.	PUNCT
bionys-650	221	1	https://doi.org/10.3390/nu11040794	https://doi.org/10.3390/nu11040794	X
bionys-650	221	2	world	world	PROPN
bionys-650	221	3	health	health	PROPN
bionys-650	221	4	organization	organization	PROPN
bionys-650	221	5	regional	regional	ADJ
bionys-650	221	6	office	office	NOUN
bionys-650	221	7	for	for	ADP
bionys-650	221	8	the	the	DET
bionys-650	221	9	eastern	eastern	PROPN
bionys-650	221	10	mediterranean	mediterranean	PROPN
bionys-650	221	11	.	.	PUNCT
bionys-650	222	1	(	(	PUNCT
bionys-650	222	2	2020	2020	NUM
bionys-650	222	3	,	,	PUNCT
bionys-650	222	4	november	november	PROPN
bionys-650	222	5	15	15	NUM
bionys-650	222	6	)	)	PUNCT
bionys-650	222	7	.	.	PUNCT
bionys-650	223	1	world	world	NOUN
bionys-650	223	2	diabetes	diabetes	PROPN
bionys-650	223	3	day	day	NOUN
bionys-650	223	4	2020	2020	NUM
bionys-650	223	5	.	.	PUNCT
bionys-650	224	1	who	who	PRON
bionys-650	224	2	emro	emro	VERB
bionys-650	224	3	.	.	PUNCT
bionys-650	225	1	https://	https://	PROPN
bionys-650	225	2	www.emro.who.int/iraq/news/world-diabetesday-2020.html	www.emro.who.int/iraq/news/world-diabetesday-2020.html	PROPN
bionys-650	225	3	wu	wu	PROPN
bionys-650	225	4	,	,	PUNCT
bionys-650	225	5	j.	j.	PROPN
bionys-650	225	6	,	,	PUNCT
bionys-650	225	7	atkins	atkins	PROPN
bionys-650	225	8	,	,	PUNCT
bionys-650	225	9	a.	a.	PROPN
bionys-650	225	10	,	,	PUNCT
bionys-650	225	11	downes	downe	NOUN
bionys-650	225	12	,	,	PUNCT
bionys-650	225	13	m.	m.	NOUN
bionys-650	225	14	,	,	PUNCT
bionys-650	225	15	&	&	CCONJ
bionys-650	225	16	wei	wei	PROPN
bionys-650	225	17	,	,	PUNCT
bionys-650	225	18	z.	z.	PROPN
bionys-650	225	19	(	(	PUNCT
bionys-650	225	20	2023	2023	NUM
bionys-650	225	21	)	)	PUNCT
bionys-650	225	22	.	.	PUNCT
bionys-650	226	1	vitamin	vitamin	NOUN
bionys-650	226	2	d	d	NOUN
bionys-650	226	3	in	in	ADP
bionys-650	226	4	diabetes	diabetes	NOUN
bionys-650	226	5	:	:	PUNCT
bionys-650	226	6	uncovering	uncover	VERB
bionys-650	226	7	the	the	DET
bionys-650	226	8	sunshine	sunshine	ADJ
bionys-650	226	9	hormone	hormone	NOUN
bionys-650	226	10	’s	’s	PART
bionys-650	226	11	role	role	NOUN
bionys-650	226	12	in	in	ADP
bionys-650	226	13	glucose	glucose	NOUN
bionys-650	226	14	metabolism	metabolism	NOUN
bionys-650	226	15	and	and	CCONJ
bionys-650	226	16	beyond	beyond	ADP
bionys-650	226	17	.	.	PUNCT
bionys-650	227	1	nutrients	nutrient	NOUN
bionys-650	227	2	,	,	PUNCT
bionys-650	227	3	15(8	15(8	NOUN
bionys-650	227	4	)	)	PUNCT
bionys-650	227	5	,	,	PUNCT
bionys-650	227	6	1997	1997	NUM
bionys-650	227	7	.	.	PUNCT
bionys-650	228	1	https://doi.org/10.3390/	https://doi.org/10.3390/	PROPN
bionys-650	228	2	nu15081997	nu15081997	NOUN
bionys-650	228	3	zhang	zhang	PROPN
bionys-650	228	4	,	,	PUNCT
bionys-650	228	5	y.	y.	PROPN
bionys-650	228	6	,	,	PUNCT
bionys-650	228	7	tan	tan	PROPN
bionys-650	228	8	,	,	PUNCT
bionys-650	228	9	h.	h.	PROPN
bionys-650	228	10	,	,	PUNCT
bionys-650	228	11	tang	tang	PROPN
bionys-650	228	12	,	,	PUNCT
bionys-650	228	13	j.	j.	PROPN
bionys-650	228	14	,	,	PUNCT
bionys-650	228	15	li	li	PROPN
bionys-650	228	16	,	,	PUNCT
bionys-650	228	17	j.	j.	PROPN
bionys-650	228	18	,	,	PUNCT
bionys-650	228	19	chong	chong	PROPN
bionys-650	228	20	,	,	PUNCT
bionys-650	228	21	w.	w.	PROPN
bionys-650	228	22	,	,	PUNCT
bionys-650	228	23	hai	hai	PROPN
bionys-650	228	24	,	,	PUNCT
bionys-650	228	25	y.	y.	PROPN
bionys-650	228	26	,	,	PUNCT
bionys-650	228	27	feng	feng	PROPN
bionys-650	228	28	,	,	PUNCT
bionys-650	228	29	y.	y.	PROPN
bionys-650	228	30	,	,	PUNCT
bionys-650	228	31	&	&	CCONJ
bionys-650	228	32	jia	jia	PROPN
bionys-650	228	33	,	,	PUNCT
bionys-650	228	34	d.	d.	PROPN
bionys-650	228	35	(	(	PUNCT
bionys-650	228	36	2020	2020	NUM
bionys-650	228	37	)	)	PUNCT
bionys-650	228	38	.	.	PUNCT
bionys-650	229	1	effects	effect	NOUN
bionys-650	229	2	of	of	ADP
bionys-650	229	3	vitamin	vitamin	NOUN
bionys-650	229	4	d	d	NOUN
bionys-650	229	5	supplementation	supplementation	NOUN
bionys-650	229	6	on	on	ADP
bionys-650	229	7	prevention	prevention	NOUN
bionys-650	229	8	of	of	ADP
bionys-650	229	9	t2d	t2d	NOUN
bionys-650	229	10	in	in	ADP
bionys-650	229	11	patients	patient	NOUN
bionys-650	229	12	with	with	ADP
bionys-650	229	13	prediabetes	prediabete	NOUN
bionys-650	229	14	:	:	PUNCT
bionys-650	229	15	a	a	DET
bionys-650	229	16	systematic	systematic	ADJ
bionys-650	229	17	review	review	NOUN
bionys-650	229	18	and	and	CCONJ
bionys-650	229	19	meta	meta	ADJ
bionys-650	229	20	-	-	PUNCT
bionys-650	229	21	analysis	analysis	NOUN
bionys-650	229	22	.	.	PUNCT
bionys-650	230	1	diabetes	diabetes	NOUN
bionys-650	230	2	care	care	NOUN
bionys-650	230	3	,	,	PUNCT
bionys-650	230	4	43(7	43(7	PROPN
bionys-650	230	5	)	)	PUNCT
bionys-650	230	6	,	,	PUNCT
bionys-650	230	7	1650–1658	1650–1658	NUM
bionys-650	230	8	.	.	PUNCT
bionys-650	231	1	https://doi.org	https://doi.org	VERB
bionys-650	231	2	kadhim	kadhim	PROPN
bionys-650	231	3	et	et	PROPN
bionys-650	231	4	al	al	PROPN
bionys-650	231	5	.	.	PUNCT
bionys-650	232	1	●	●	PUNCT
bionys-650	232	2	the	the	DET
bionys-650	232	3	association	association	NOUN
bionys-650	232	4	of	of	ADP
bionys-650	232	5	vitamin	vitamin	NOUN
bionys-650	232	6	d	d	PROPN
bionys-650	232	7	,	,	PUNCT
bionys-650	232	8	vitamin	vitamin	NOUN
bionys-650	232	9	d	d	NOUN
bionys-650	232	10	-	-	ADJ
bionys-650	232	11	binding	bind	VERB
bionys-650	232	12	protein	protein	NOUN
bionys-650	232	13	,	,	PUNCT
bionys-650	232	14	and	and	CCONJ
bionys-650	232	15	ferritin	ferritin	ADJ
bionys-650	232	16	levels	level	NOUN
bionys-650	232	17	in	in	ADP
bionys-650	232	18	iraqi	iraqi	ADJ
bionys-650	232	19	men	man	NOUN
bionys-650	232	20	with	with	ADP
bionys-650	232	21	type	type	NOUN
bionys-650	232	22	2	2	NUM
bionys-650	232	23	diabetes	diabetes	NOUN
bionys-650	232	24	biologica	biologica	PROPN
bionys-650	232	25	nyssana	nyssana	PROPN
bionys-650	232	26	●	●	PUNCT
bionys-650	232	27	16	16	NUM
bionys-650	232	28	(	(	PUNCT
bionys-650	232	29	2	2	NUM
bionys-650	232	30	)	)	PUNCT
bionys-650	232	31	december	december	PROPN
bionys-650	232	32	2025	2025	NUM
bionys-650	232	33	:	:	PUNCT